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Abstract  
Background 
Perinatal morbidity and mortality remain significant public health issues globally, with enduring 
impact on the health and wellbeing of women and their families. Pregnant women who adopt, 
practice and maintain healthy behaviours can potentially improve the health of themselves and their 
babies. Stillbirth affects over 2,100 families annually in Australia, often preceded by maternal 
perception of decreased fetal movement. Mobile applications (apps) have become an integral source 
of information for women during pregnancy, as evidenced by the hundreds of millions of pregnant 
women downloading and using them, and information contained within these apps may influence 
maternal awareness about decreased fetal movement. However, limited evidence exists to support 
the impact of mobile apps, compared to other communication methods, on maternal behaviour 
change or perinatal health outcomes. Similarly, few studies have reviewed content of pregnancy 
apps to assess accuracy of information or appropriateness of recommendations for maternal 
concerns about fetal movement. 
Aims 
The primary aim of this thesis is to assess the effect of mobile application interventions on health 
care-seeking behaviour and perinatal health outcomes among pregnant women with concerns about 
fetal movement.  
Methods 
In order to achieve this aim, this thesis was designed with four components: 
▪ Update and publication of the clinical practice guideline on care of women with decreased 
fetal movements; 
▪ Systematic review of effect of mobile applications on maternal health care-seeking 
behaviour and perinatal outcomes; 
▪ Content analysis and review of information about decreased fetal movement presented by 
mobile applications intended for use by pregnant women; and 
▪ Analysis of mobile application uptake, reporting of decreased fetal movement and perinatal 
health outcomes for users of the My Baby’s Movements app. 
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Results   
Studies have demonstrated linkages between provision of information about decreased fetal 
movement and improved perinatal health outcomes, including reduced stillbirth rates. Such findings 
have prompted an update to the clinical practice guideline and recommendations for improved 
guidance and care for pregnant women. Mobile apps have been proposed as an effective mode of 
sharing information with women during pregnancy. However, our systematic review to understand 
the effect of mobile app interventions on maternal health care-seeking behaviour and perinatal 
health outcomes yielded only four studies, and while these studies reported on the primary outcome, 
“change in maternal behaviours by intervention goals,” the specific outcomes reported varied 
widely by intervention. None of the studies included in this review reported statistically significant 
differences between intervention and control groups for neonatal outcomes, delivery or pregnancy 
complications. To understand the information accessed by women through publicly-available apps, 
a content review and analysis was performed to specifically address content about decreased fetal 
movement. Information provided by the 24 apps in the sample was highly variable, and the majority 
of apps guided women to perform actions to stimulate or track fetal movement that were counter to 
clinical practice guideline recommendations.  
Finally, a mobile app intervention to raise awareness about fetal movement was designed and tested 
as part of a large randomised trial, and data from one hospital were analysed as a prospective cohort 
study. In this sample, 15.3% of all women birthing at the hospital over one year chose to download 
and use the app. The tool was popular among younger women and those expecting their first child, 
but perinatal health outcomes, including reporting of decreased fetal movement, labour induction 
rates, gestational week at birth and stillbirth rates, were largely similar between cohort groups. 
Conclusions 
Mobile applications are a popular means of accessing information during pregnancy. However, it 
has yet to be proven whether mobile app interventions achieve better results compared to other 
communication modalities. Factors that may influence uptake, usage and outcomes may include 
maternal characteristics such as age, or features deemed of interest to users. It is anticipated that the 
findings of this thesis will help inform future digital health interventions for pregnant women, to 
improve the health of mothers and babies.  
 
LM Daly                                                                Page iii 
                                                                                            
 
Declaration by author 
This thesis is composed of my original work, and contains no material previously published or 
written by another person except where due reference has been made in the text. I have clearly 
stated the contribution by others to jointly-authored works that I have included in my thesis. 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional editorial 
advice, financial support and any other original research work used or reported in my thesis. The 
content of my thesis is the result of work I have carried out since the commencement of my higher 
degree by research candidature and does not include a substantial part of work that has been 
submitted to qualify for the award of any other degree or diploma in any university or other tertiary 
institution. I have clearly stated which parts of my thesis, if any, have been submitted to qualify for 
another award. 
I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, 
subject to the policy and procedures of The University of Queensland, the thesis be made available 
for research and study in accordance with the Copyright Act 1968 unless a period of embargo has 
been approved by the Dean of the Graduate School.  
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 
copyright holder to reproduce material in this thesis and have sought permission from co-authors for 
any jointly authored works included in the thesis. 
  
LM Daly                                                                Page iv 
                                                                                            
 
Publications included in this thesis 
Daly LM, Gardener G, Bowring V, Burton W, Chadha Y, Ellwood D, Frøen F, Gordon A, Heazell 
A, Mahomed K, McDonald S, Norman JE, Oats J, Flenady V. Care of pregnant women with 
decreased fetal movements: Update of a clinical practice guideline for Australia and New Zealand. 
Australia and New Zealand Journal of Obstetrics and Gynaecology. 2018;58(4):463-468. DOI: 
10.1111/ajo.12762. 
Daly LM, Boyle FM, Gibbons K, Le H, Roberts J, Flenady V. Mobile applications providing 
guidance about decreased fetal movement: Review and content analysis. Women and Birth 
2019;32(3):e289-e296. DOI: 1016/j.wombi.2018.07.020.  
Daly LM, Horey D, Middleton PF, Boyle FM, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes: 
Systematic review. JMIR mHealth and uHealth 2018;6(8):e10012. DOI: 10.2196/10012. 
Daly LM, Horey D, Middleton PF, Boyle FM, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes: a 
systematic review protocol. Systematic Reviews. 2017;6(1):26. 
 
Submitted manuscripts included in this thesis 
No further manuscripts submitted for publication. 
  
LM Daly                                                                Page v 
                                                                                            
 
Other publications during candidature 
 
Peer-reviewed papers 
Daly LM, Boyle F, Gibbons K, Flenady V. Mobile pregnancy apps, decreased fetal movement and 
self-assessment of risk. Journal of Paediatrics and Child Health 2018;54(S1):15. DOI: 
10.1111/jpc.13882.32. 
Daly LM, Boyle FM, Horey D, Middleton PF, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes:  
A systematic review. Journal of Paediatrics and Child Health 2018;54(S1):71. DOI: 
10.1111/jpc.13882.184. 
Weller M, Gardener G, Henry S, Ellwood D, Daly L, Warrilow K, Boyle F, Flenady V. My Baby’s 
Movements: Integration of a mobile phone application into the antenatal education toolkit. Women 
and Birth. 2018; 31(S1): S1–S54. DOI: 10.1016/j.wombi.2018.08.040. 
Daly LM, Gardener G, Bowring V, Burton W, Chadha Y, Ellwood D, Frøen F, Gordon A, Heazell 
A, Mahomed K, McDonald S, Norman JE, Oats J, Flenady V. Care of pregnant women with 
decreased fetal movements: Update of a clinical practice guideline for Australia and New Zealand. 
Australia and New Zealand Journal of Obstetrics and Gynaecology. 2018;58(4):463-468. DOI: 
10.1111/ajo.12762. 
Daly LM, Boyle FM, Gibbons K, Le H, Roberts J, Flenady V. Mobile applications providing 
guidance about decreased fetal movement: Review and content analysis. Women and Birth 
2019;32(3):e289-e296. DOI: 1016/j.wombi.2018.07.020. 
Daly LM, Horey D, Middleton PF, Boyle FM, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes: 
Systematic review. JMIR mHealth and uHealth 2018;6(8):e10012. DOI: 10.2196/10012. 
Daly L, Flenady V, Le H, Roberts J, Gibbons K. How do mobile pregnancy applications address 
decreased fetal movement as a risk factor for adverse perinatal outcomes and stillbirth? (P103). 
Meeting abstracts from the International Stillbirth Alliance Conference 2017. BMC Pregnancy and 
Childbirth 2017; 17(1):1-47. DOI: 10.1186/s12884-017-1457-7. 
LM Daly                                                                Page vi 
                                                                                            
 
Flenady V, Gardener G, Ellwood D, Middleton P, Boyle F, Crowther C, Coory M, East C, 
Callander E, Gordon A, Morris J, Bowring V, Kent A, Vlack S, Teale G, Daly L, Henry S, 
Reinebrant H, Wojcieszek A, Frøen F, Norman J. My Baby’s Movements: A stepped-wedge, 
cluster-randomised controlled trial testing a mobile application intervention aimed at lowering 
stillbirth rates (P73). Meeting abstracts from the International Stillbirth Alliance Conference 2017. 
BMC Pregnancy and Childbirth 2017; 17(1):1-47. DOI: 10.1186/s12884-017-1457-7.  
Daly LM, Horey D, Middleton PF, Boyle FM, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes: a 
systematic review protocol. Systematic Reviews. 2017;6(1):26. 
 
Conference abstracts 
Daly LM, Boyle F, Gibbons K, Flenady V. Mobile pregnancy apps, decreased fetal movement and 
self-assessment of risk. The University of Queensland, Faculty of Medicine, 2018 Clinical and 
Public Health Symposium, Brisbane (Australia), November 2018 (oral presentation). 
Weller M, Gardener G, Henry S, Ellwood D, Daly L, Warrilow K, Boyle F; Flenady VJ. My Baby's 
Movements: Integration of a mobile phone application into the antenatal education toolkit. 2018 
Australian College of Midwives Annual Conference, Perth (Australia), October 2018 (oral 
presentation). 
Weller M, Gardener G, Henry S, Reinebrant HE, Daly L, Warrilow K, Boyle F, Flenady VJ. My 
Baby’s Movements: Women’s experiences of a mobile phone application aimed at reducing 
stillbirth by increasing awareness of fetal movements in pregnancy. 2018 International Conference 
on Stillbirth, SIDS and Baby Survival, Glasgow (Scotland), June 2018 (oral presentation). 
Daly LM. My Baby’s Movements: A mobile application designed to reduce stillbirth rates in 
Australia. Public Health Association of Australia, Queensland branch symposium. m-Health: 
Opportunities and challenges for improving population health. Brisbane (Australia), May 2018 (oral 
presentation). 
Daly LM, Boyle F, Gibbons K, Flenady V. Mobile pregnancy apps, decreased fetal movement and 
self-assessment of risk. Perinatal Society of Australia and New Zealand (PSANZ) 22nd Annual 
Scientific Congress, Auckland (New Zealand), March 2018 (oral presentation). 
LM Daly                                                                Page vii 
                                                                                            
 
Daly LM, Boyle FM, Horey D, Middleton PF, Flenady V. The effect of mobile application 
interventions on influencing healthy maternal behaviour and improving perinatal health outcomes:  
A systematic review. Perinatal Society of Australia and New Zealand (PSANZ) 22nd Annual 
Scientific Congress, Auckland (New Zealand), March 2018 (poster presentation). 
Weller M, Daly L, Gardener G, Henry S, Reinebrant HE, Warrilow K, Flenady V. My Baby's 
Movements: Women’s Feedback about a Mobile Application Intervention Aimed at Raising 
Awareness of Fetal Movements. Perinatal Society of Australia and New Zealand (PSANZ) 22nd 
Annual Scientific Congress, Auckland (New Zealand), March 2018 (poster presentation). 
Daly L, Flenady V, Le H, Roberts J, Gibbons K. How do mobile pregnancy applications address 
decreased fetal movement as a risk factor for adverse perinatal health outcomes and stillbirth? 
International Stillbirth Alliance Conference, Cork (Ireland), Sept 2017 (poster presentation). 
Flenady V, Gardener G, Ellwood D, Middleton P, Boyle FM, Crowther C, Coory M, East C, 
Callander E, Gordon A, Morris J, Bowring V, Kent A, Vlack S, Teale G, Daly L, Henry S, 
Reinebrant H, Wojcieszek A, Frøen F, Norman J. My Baby's Movements: A stepped-wedge, cluster-
randomised controlled trial testing a mobile application intervention aimed at lowering stillbirth 
rates. International Stillbirth Alliance Conference, Cork (Ireland), Sept 2017 (oral presentation). 
Daly L, Flenady V. My Baby's Movements: a mobile application designed to reduce stillbirth rates 
in Australia. National Health Innovation and Research Symposium, Coffs Harbour, August 2017 
(oral presentation). 
Daly L, Flenady V. Do mobile “pregnancy” applications explicitly link decreased fetal movement 
and adverse perinatal health outcomes, including stillbirth?: A systematic review. Translational 
Poster Symposium, Translational Research Institute, Brisbane, July 2017 (poster presentation). 
Daly L, Flenady V, Boyle F, Gibbons K, Kumar S. My Baby’s Movements: Can a mobile 
application impact stillbirth rates among primiparous women in Queensland? The University of 
Queensland, School of Public Health 2016 RHD Conference, Brisbane, Nov 2016 (oral 
presentation). 
Daly L. My Baby’s Movements: can a mobile application impact stillbirth rates in Australia? 
Public Health Association of Australia (PHAA) 44th Annual Conference, Alice Springs, Sept 2016 
(oral “tabletop” presentation). 
LM Daly                                                                Page viii 
                                                                                            
 
Daly L. Health promotion through mobile applications: Impact on maternal health care-seeking 
behaviour and stillbirth rates. Australian Health Promotion Association (AHPA) 23rd National 
Conference, Perth, June 2016 (oral presentation). 
Daly L. Apps and opps: mobile applications and opportunities for longitudinal data collection 
across the reproductive lifespan. Australian Longitudinal Study of Women’s Health (ALSWH) – 
Scientific Meeting, Newcastle, May 2016 (oral presentation). 
Daly LM, Flenady V. Fetal movement and perinatal mHealth interventions: Translating research 
into practice and practice into research. 3rd Queensland Translating Research into Practice (TRIP) 
Symposium, Brisbane, July 2015 (oral presentation). 
 
Clinical practice guidelines 
Gardener G, Daly L, Bowring V, Burton G, Chadha Y, Ellwood D, Frøen F, Gordon A, Heazell A, 
MacDonald S, Mahomed K, Norman JE, Oats J, Flenady V. Clinical practice guideline for the care 
of women with decreased fetal movements. The Perinatal Society of Australia and New Zealand, 
and the Centre of Research Excellence in Stillbirth. Brisbane, Australia, August 2017. 
 
Position Statements 
Bowring V, Cassidy J, Daly LM, de Jesús G, Ellwood D, Erwich JJ, Filho FMP, Flenady V, Fretts 
R, Frøen F, Gardener G, Gold K, Gross MM, Heazell A, Henry S, Leisher S, Murphy M, Pingray 
V, Siassakos D, Silver R, Ruidiaz J, Storey C, Warland J, and Wojcieszek A. ISA Position 
Statement - Fetal Movement Monitoring: Prenatal surveillance by detection and management of 
decreased (reduced) fetal movements. Version 2, June 2017, International Stillbirth Alliance. 
Available at: http://stillbirthalliance.org/research/position-statements/. 
  
LM Daly                                                                Page ix 
                                                                                            
 
Contributions by others to the thesis  
Professor Vicki Flenady, Professor Sailesh Kumar, Associate Professor Fran Boyle and Associate 
Professor Kristen Gibbons (PhD advisors) provided input into the concept and content of this 
Thesis. They critically reviewed project plans, study protocols and draft manuscripts, and provided 
considerable feedback. 
The My Baby’s Movements trial was funded by the National Health and Medical Research Council 
(NHMRC; Project Grant APP1067363) with Professor Vicki Flenady as Chief investigator (CIA).  
Dr Glenn Gardener (CIB) was the clinical lead investigator. Dr David Ellwood (CIC) was the local 
principal investigator for the Gold Coast University Hospital which contributed data to this thesis, 
with core support from hospital clinical and administrative teams. Staff from Mater Research and 
the NHMRC Centre of Research Excellence (CRE) in Stillbirth were instrumental to the success of 
implementing this trial, submitting ethics and governance applications, guiding app development, 
and collecting data. 
 
Parts of the thesis submitted to qualify for the award of another degree 
No works submitted towards another degree have been included in this thesis. 
 
Research involving human or animal subjects  
Ethics approval has been granted for my study by The University of Queensland, School of Public 
Health, approval number LMD05022015. Ethics approval for the My Baby’s Movements study has 
also been received from the University of Queensland (approval #: 2014001655) and the Mater 
Misericordiae Ltd Human Research Ethics Committee (HREC) for all Queensland sites (reference 
#: HREC/14/MHS/141). A copy of the ethics approval letter is presented in Appendix A. The 
University of Queensland, Office of Research Ethics confirmed via email on 30 August 2018 that 
the original approval was valid, after being informed of a change to my thesis title. 
LM Daly                                                                Page x 
                                                                                            
 
Acknowledgements 
Music has accompanied this academic journey, from inception to completion. When I began this 
thesis in 2015, my children were aged 2 and 4 years old, discovering voice, rhythm and song. My 
gratitude for their presence underscored this exploration of health interventions for pregnant 
women. My PhD advisors – Prof Vicki Flenady, Assoc Prof Fran Boyle, Assoc Prof Kristen 
Gibbons, and Prof Sailesh Kumar – were a winning ensemble and I am thankful for the myriad of 
ways they have encouraged my research, professional development, and personal wellbeing. As my 
primary advisor, Vicki has been a guiding light and mentor, and I am immensely grateful for her 
expertise, dedication and sincerity over the past 4 years. 
Great appreciation is due to my research colleagues and co-authors, all of whom gave generously of 
their time and expertise toward our shared projects. Special thanks to Dr Glenn Gardener, Dr Dell 
Horey, Assoc Prof Philippa Middleton, Ms Janine Roberts and Ms Han Le. In addition, My Baby’s 
Movements trial collaborators and our team at the NHMRC Centre of Research Excellence in 
Stillbirth were instrumental in managing the trial. In particular, I am grateful to Dr Sarah Henry, Dr 
Hanna Reinebrant, Ms Aleena Wojcieszek, Dr Christine Andrews, Ms Megan Weller, Ms Kara 
Warrilow and Dr Upeksha Chandrasiri for their tireless efforts to steer the ship for this clinical trial 
and many other important stillbirth prevention projects. Many thanks to my fellow postgraduate 
students for sharing their knowledge and friendship through the stages of thesis completion, 
particularly Dr Ibi Ibiebele, Ms Anne Schirmann, Ms Jess Sexton and Ms Ellen Dearden. 
Throughout my PhD candidature, I benefited enormously from the feedback of milestone seminar 
reviewers: Prof David Tudehope, Assoc Prof Leigh Tooth, Assoc Prof Sheleigh Lawler, Dr Chi-
Wai Lui, and Assoc Prof Samudragupta Bora. I was also kindly supported by academic and 
operations staff at Mater Research Institute, especially Assoc Prof Paul Dawson, Ms Marilyn 
Wilckens, Ms Donna Simson and Ms Mel Christie. Mentorship from Dr Sophie Hickey provided 
opportunities for reflection on career directions, ethics and cultural capability in research. Dr 
Maureen Cleary OAM offered remarkable wisdom and support before and during this academic 
journey.  
I would like to acknowledge financial support from the Australian Government (Research Training 
Program), a Frank Clair Award from Mater Research Institute, a Top-up Scholarship from the 
NHMRC Centre of Research Excellence in Stillbirth, and a bursary from the National Council of 
Women – Queensland. In addition to my desk at Mater Research Institute, I enjoyed beautiful 
LM Daly                                                                Page xi 
                                                                                            
 
spaces to work and reflect at the State Library of Queensland and Mt. Coot-tha Public Library, in 
Brisbane.  
My mother’s wise, loving counsel has always lifted me to challenge myself while remaining true to 
my values. Until his passing, my father’s empathy toward patients, friends and strangers resonated 
deeply. My parents-in-law, parents’ partners, sister, sisters-in-law and closest friends have always 
been supportive of my endeavours, and I thank them for their belief in me. My most heartfelt 
gratitude is reserved for my husband, Chris Daly. His quoting of poet Seamus Heaney’s phrase “the 
music of what happens” has been a fitting description for our lives together across 20 years and 3 
continents. Many years ago, at my undergraduate graduation ceremony, Heaney counselled all 
assembled to “make the world before you a better one by going into it with all boldness.” Together,  
we continue to strive toward this goal through our convictions and actions. Chris has provided such 
nurture during this academic undertaking, while balancing his own professional and caregiving 
responsibilities for loved ones, young and old.  
The goal of supporting human life is fundamental to stillbirth prevention efforts, which requires 
unique approaches to care and intervention. During the writing of this thesis, I frequently listened to 
and read experiences of stillbirth and maternal trauma. It was humbling to learn from a community 
of women, families and clinicians who have faced such grief and devoted themselves, in whatever 
way possible, to the painstaking process of rebuilding and contributing to change. On many nights, 
after long hours wrestling with data, I would stand quietly in my little boys’ bedroom, listening to 
the music of their peaceful breathing. I have always encouraged them to “carry a little song” in their 
hearts, to draw upon for interest and inspiration. This thesis has been one such song for me, and I 
remain beholden to many people for the opportunity to write, develop and share it. 
LM Daly                                                                Page xii 
                                                                                            
 
Financial support 
Primary financial support for this research was offered through an Australian Government Research 
Training Program Scholarship administered through The University of Queensland (January 2015-
July 2018), and a Frank Clair scholarship administered through the Mater Research Institute 
(January 2015-July 2018). A Top-up Scholarship was also gratefully received from the NHMRC 
Centre of Research Excellence in Stillbirth (2017-2018). The UQ Faculty of Medicine, School of 
Public Health and Mater Research provided funds throughout candidature to support professional 
development, conference attendance and computer software. During candidature, I also received a 
bursary from the National Council of Women – Queensland (2015). 
The My Baby’s Movements (MBM) trial (study presented in Chapter 5) is funded through an 
NHMRC grant (Project Grant APP1067363, for the period 2014-2019), with additional funding and 
support from the Stillbirth Foundation Australia, Mater Foundation, Mater Health Services, Mater 
Research and from the institutions of MBM study investigators representing 27 sites across 
Australia and New Zealand.  
Keywords 
Pregnancy, Maternal, Infant, Fetal movement, Stillbirth, Health promotion, Mobile applications 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
ANZSRC code: 111711, Health Information Systems, 40% 
ANZSRC code: 111712, Health Promotion, 40% 
ANZSRC code: 111402, Obstetrics and Gynaecology, 20% 
Fields of Research (FoR) classification 
FoR code: 1117, Public Health and Health Services, 80% 
FoR code: 1114, Paediatrics and Reproductive Medicine, 20%
LM Daly                                                                Page xiii 
                                                                                            
 
Table of contents  
Preliminary pages 
Abstract .............................................................................................................................................. i 
Declaration by author ...................................................................................................................... iii 
Publications included in this thesis .................................................................................................. iv 
Submitted manuscripts included in this thesis ................................................................................. iv 
Other publications during candidature .............................................................................................. v 
Contributions by others to the thesis ............................................................................................... ix 
Parts of the thesis submitted to qualify for the award of another degree ........................................ ix 
Research involving human or animal subjects ................................................................................ ix 
Acknowledgements ........................................................................................................................... x 
Financial support ............................................................................................................................ xii 
Keywords ........................................................................................................................................ xii 
Australian and New Zealand Standard Research Classifications (ANZSRC) ................................ xii 
Fields of Research (FoR) Classification ......................................................................................... xii 
Table of Contents ........................................................................................................................... xiii 
List of Tables ............................................................................................................................... xviii 
List of Figures ................................................................................................................................ xix 
List of abbreviations and acronyms ................................................................................................ xx 
Chapter 1. Introduction ....................................................................................................................... 1 
Chapter 2. Literature review ............................................................................................................... 4 
 Introduction ................................................................................................................................ 6 
 Decreased fetal movement and stillbirth .................................................................................... 6 
 Stillbirth rates ............................................................................................................................. 8 
 Stillbirth causes......................................................................................................................... 10 
 DFM, stillbirth and maternal risk factors in high-income countries ........................................ 12 
 Primiparity, DFM and stillbirth ...................................................................................... 12 
 Previous pregnancy loss, DFM and stillbirth ................................................................. 15 
 Maternal age, DFM and stillbirth ................................................................................... 17 
 Australian Indigenous ethnicity, DFM and stillbirth ..................................................... 18 
 Socio-economic disadvantage, DFM and stillbirth ........................................................ 20 
 DFM, stillbirth and adverse perinatal health outcomes ............................................................ 23 
 Gestational age at birth, DFM and stillbirth ................................................................... 23 
 Birthweight, DFM and stillbirth ..................................................................................... 26 
LM Daly                                                                Page xiv 
                                                                                            
 
 Labour induction, DFM and stillbirth ............................................................................ 27 
 Mode of birth, DFM and stillbirth .................................................................................. 28 
 Interventions targeting awareness of DFM .............................................................................. 29 
 Clinical practice guidelines for care of pregnant women with DFM ....................................... 32 
 Publication and endorsement ......................................................................................... 33 
 Guideline aim and objectives ......................................................................................... 33 
 Methods .......................................................................................................................... 34 
 Key updates from the 2010 to the 2017 guideline ......................................................... 34 
 Guideline recommendations ........................................................................................... 35 
 Limitations ..................................................................................................................... 39 
 Health care-seeking behaviour of women through mobile applications .................................. 39 
 Emergence of mobile applications as part of health interventions................................. 40 
 Health care-seeking behaviour and mobile health apps ................................................. 41 
 Mobile application usage by pregnant women ............................................................... 42 
 Conclusion ........................................................................................................................... 44 
Chapter 3. Systematic review: Effect of mobile app interventions on influencing healthy maternal 
behaviour and improving perinatal outcomes .................................................................................... 45 
 Review registration ................................................................................................................... 47 
 Background ............................................................................................................................... 47 
 Aim ........................................................................................................................................... 48 
 Methods .................................................................................................................................... 48 
 Protocol .......................................................................................................................... 48 
 Criteria for considering studies for this review .............................................................. 48 
3.4.2.1 Study design ............................................................................................................... 48 
3.4.2.2 Interventions .............................................................................................................. 48 
3.4.2.3 Comparators ............................................................................................................... 49 
3.4.2.4 Outcome measures ..................................................................................................... 49 
 Search methods for identification of studies .................................................................. 50 
3.4.3.1 Sources ....................................................................................................................... 50 
3.4.3.2 Search strategy ........................................................................................................... 50 
3.4.3.3 Study selection ........................................................................................................... 51 
3.4.3.4 Bias assessment .......................................................................................................... 51 
 Data collection and analysis ........................................................................................... 51 
3.4.4.1 Data extraction and management ............................................................................... 51 
3.4.4.2 Synthesis of results .................................................................................................... 51 
 Results ...................................................................................................................................... 52 
 Description of studies ..................................................................................................... 52 
LM Daly                                                                Page xv 
                                                                                            
 
3.5.1.1 Included studies ......................................................................................................... 52 
3.5.1.2 Bias assessment of included studies ........................................................................... 55 
 Description of participants ............................................................................................. 58 
 Description of interventions ........................................................................................... 59 
 Effects of interventions .................................................................................................. 61 
3.5.4.1 Primary outcomes ...................................................................................................... 61 
3.5.4.2 Secondary outcomes .................................................................................................. 62 
 Discussion ................................................................................................................................. 63 
 Principal findings ........................................................................................................... 63 
 Strengths and limitations ................................................................................................ 64 
 Conclusions .............................................................................................................................. 65 
Chapter 4.  Review and content analysis of mobile applications providing guidance about 
decreased fetal movement .................................................................................................................. 66 
 Introduction .............................................................................................................................. 67 
 Objective ................................................................................................................................... 69 
 Methods .................................................................................................................................... 69 
 Study design ................................................................................................................... 69 
 Search and screening strategy ........................................................................................ 69 
 Data extraction and analysis ........................................................................................... 71 
 Results ...................................................................................................................................... 72 
 Search results ................................................................................................................. 72 
 Information about decreased fetal movement ................................................................ 74 
 Tools to assist women with monitoring fetal movement ............................................... 75 
 Discussion ................................................................................................................................. 76 
 Principal findings ........................................................................................................... 76 
 Limitations ..................................................................................................................... 78 
 Conclusion ................................................................................................................................ 79 
Chapter 5. My Baby’s Movements (MBM): A prospective cohort study ........................................ 81 
 Introduction .............................................................................................................................. 81 
 Study aims ................................................................................................................................ 81 
 The My Baby’s Movements trial ............................................................................................... 82 
 Study outcome measures and hypotheses ................................................................................. 82 
 Outcome measures ......................................................................................................... 82 
 Hypotheses ..................................................................................................................... 83 
 Ethics approval ......................................................................................................................... 84 
 Methodology ............................................................................................................................. 84 
LM Daly                                                                Page xvi 
                                                                                            
 
 Design ............................................................................................................................ 84 
 Description of the intervention ....................................................................................... 85 
5.6.2.1 App development ....................................................................................................... 85 
5.6.2.2 App content ................................................................................................................ 86 
 Study population ............................................................................................................ 88 
 Study site ........................................................................................................................ 88 
 Allocation of groups ....................................................................................................... 89 
 Procedure ........................................................................................................................ 89 
 Materials development and appropriateness .................................................................. 90 
 Data collection tools ....................................................................................................... 91 
 Data collection timeline ................................................................................................. 91 
 Data management ........................................................................................................... 92 
 Data analysis .................................................................................................................. 92 
 Results ...................................................................................................................................... 93 
 Study sample .................................................................................................................. 93 
 Primary hypothesis ......................................................................................................... 94 
5.7.2.1 App uptake by maternal characteristics ..................................................................... 94 
5.7.2.2 App usage................................................................................................................... 96 
 Secondary hypothesis ................................................................................................... 104 
5.7.3.1 Birth outcome: Reported decreased fetal movement ............................................... 105 
5.7.3.2 Birth outcome: Gestational age at birth ................................................................... 110 
5.7.3.3 Birth outcome: Stillbirth .......................................................................................... 111 
 User evaluation of the MBM app ................................................................................. 113 
5.7.4.1 Characteristics of survey participants ...................................................................... 113 
5.7.4.2 MBM app user satisfaction ...................................................................................... 114 
5.7.4.3 App usage and healthcare-seeking behaviour related to DFM ................................ 115 
 Discussion ............................................................................................................................... 116 
 Conclusion .............................................................................................................................. 121 
Chapter 6. Conclusion and translational significance ..................................................................... 122 
 Overview of findings .............................................................................................................. 122 
 Study limitations ..................................................................................................................... 126 
 Translational significance of this research ............................................................................. 129 
 Raising awareness of DFM among pregnant women .................................................. 129 
 Mobile app interventions for perinatal health .............................................................. 132 
 Conclusions ............................................................................................................................ 134 
Chapter 7. References ..................................................................................................................... 135 
LM Daly                                                                Page xvii 
                                                                                            
 
Chapter 8. Appendices .................................................................................................................... 151 
 Ethics approval ....................................................................................................... 151 
 Selected conference abstracts ................................................................................. 152 
 Map of Queensland Health, Hospital and Health Services .................................... 161 
 Clinical practice guideline literature review .......................................................... 162 
 Systematic review: PRISMA-P (Protocol) checklist.............................................. 165 
 Systematic review: PRISMA checklist .................................................................. 168 
 Systematic review: Search terms and articles retrieved ......................................... 171 
 Systematic review: Excluded studies ..................................................................... 174 
 Systematic review: Intervention characteristics ..................................................... 181 
 Systematic review: Inventories used in included studies ....................................... 182 
 Systematic review: Secondary outcomes ............................................................... 184 
 Content analysis: Quality and risk of bias checklist............................................... 186 
 Content analysis: Data collection form .................................................................. 187 
 Content analysis: Apps excluded from review ....................................................... 188 
 MBM: Data collection tools ................................................................................... 195 
 MBM: Trial objectives and hypotheses.................................................................. 198 
 Information brochures about fetal movement ........................................................ 199 
 MBM: Your Movements Matter poster for trial sites ............................................. 200 
 MBM: DFM reporting by MBM cohort groups and maternal ethnicity ................ 201 
 Standard Australian Classification of Countries .................................................... 202 
 
  
LM Daly                                                                Page xviii 
                                                                                            
 
List of tables 
Table 2-1. Risk factors for stillbirth in high-income countries .......................................................... 13 
Table 2-2. Pregnancy-associated characteristics and stillbirth .......................................................... 16 
Table 2-3. DFM Clinical practice guidelines recommendations ....................................................... 35 
Table 2-4. Behaviour change theories relevant to perinatal health interventions using mobile apps 42 
Table 3-1. Outcome measures ............................................................................................................ 49 
Table 3-2. Characteristics of included studies ................................................................................... 54 
Table 3-3. Systematic review: Bias assessment ................................................................................. 56 
Table 3-4. Systematic review: Risk assessment................................................................................. 57 
Table 3-5. Participant characteristics ................................................................................................. 58 
Table 3-6. Intervention features by the TIDieR checklist .................................................................. 59 
Table 3-7. Primary maternal outcomes: Change in maternal behaviours by intervention goals ....... 62 
Table 4-1. Eligibility criteria for study sample .................................................................................. 70 
Table 4-2. Study sample characteristics ............................................................................................. 73 
Table 4-3. Illustrative examples of mobile app content and DFM advice ......................................... 74 
Table 5-1. MBM study - Outcome measures ..................................................................................... 83 
Table 5-2. MBM study - Primary hypothesis .................................................................................... 83 
Table 5-3. MBM study - Secondary hypothesis ................................................................................ 84 
Table 5-4. App content: Sections and subsections ............................................................................. 86 
Table 5-5. Maternal characteristics by cohort groups: Gravidity, parity, previous pregnancy loss and 
previous stillbirth ............................................................................................................................... 94 
Table 5-6. Maternal characteristics by cohort groups: Age, ethnicity, region of birth, SES ............. 95 
Table 5-7. App usage by week of gestation and maternal characteristics ......................................... 99 
Table 5-8. MBM frequency of use per app section, by unique users .............................................. 100 
Table 5-9. Kick counter usage and maternal characteristics ............................................................ 103 
Table 5-10. Perinatal health outcomes by MBM user cohort .......................................................... 104 
Table 5-11. MBM cohort, maternal characteristics and reported DFM ........................................... 106 
Table 5-12. DFM reporting among MBM user cohort, by app pages accessed by unique users .... 107 
Table 5-13. Perinatal health outcomes and reported DFM .............................................................. 109 
Table 5-14. Maternal characteristics, MBM cohort group and gestational age at birth .................. 110 
Table 5-15. App survey respondents by maternal characteristics, selected outcomes, app usage ... 113 
Table 5-16. Survey responses querying MBM user experiences ..................................................... 115 
Table 5-17. Responses to user evaluation querying MBM impact on behaviour ............................ 116 
Table 8-1. DFM reporting by MBM cohort groups and maternal ethnicity .................................... 201 
LM Daly                                                                Page xix 
                                                                                            
 
List of figures 
Figure 2-1. Stillbirth rates for Queensland by Hospital and Health Service, 2016.............................. 8 
Figure 2-2. Proportion of births and stillbirths by Queensland HHS................................................... 9 
Figure 2-3. Cause of Perinatal Death, PSANZ-PDC classification (Australia, 2013-2014) ............. 11 
Figure 2-4. Perinatal deaths in Australia, by maternal Indigenous status and cause of death, 2016 . 19 
Figure 2-5. Framework for determinants of health ............................................................................ 21 
Figure 2-6. Proportion of Australian births at term, by parity ........................................................... 24 
Figure 2-7. Risk of stillbirth stratified by maternal age and gestational age ..................................... 25 
Figure 2-8. Effect of intervention on perinatal outcomes, AFFIRM trial .......................................... 32 
Figure 2-9. Care pathway for women presenting with DFM from 28 weeks' gestation .................... 37 
Figure 2-10. Clinical practice points for care of women with DFM.................................................. 38 
Figure 2-11. Display of apps available on a smartphone. .................................................................. 40 
Figure 3-1. PRISMA diagram summarising inclusion of studies ...................................................... 53 
Figure 4-1. A sample of popular pregnancy apps .............................................................................. 68 
Figure 4-2. PRISMA (modified) diagram of app sample .................................................................. 72 
Figure 4-3. Mobile app attributes related to fetal movement awareness and monitoring .................. 75 
Figure 4-4. Variability of guidance on “kick counting” by mobile pregnancy apps ......................... 77 
Figure 5-1. MBM app Welcome page ............................................................................................... 82 
Figure 5-2. MBM app with Indigenous theme ................................................................................... 85 
Figure 5-3. Map of Gold Coast Hospital and Health Service ............................................................ 88 
Figure 5-4. MBM promotional materials ........................................................................................... 90 
Figure 5-5. MBM data collection tools .............................................................................................. 91 
Figure 5-6. Study sample determination ............................................................................................ 93 
Figure 5-7. App usage by maternal characteristics and week of gestation ........................................ 97 
Figure 5-8. App usage by DFM reporting and week of gestation ...................................................... 98 
Figure 5-9. Unique MBM users and app pages accessed ................................................................ 102 
Figure 5-10. User journey of MBM users with birth outcome of stillbirth ..................................... 112 
 
  
LM Daly                                                                Page xx 
                                                                                            
 
List of abbreviations and acronyms 
 
Abbreviation Explanation 
ACM Australian College of Midwives 
AFFIRM Awareness of Fetal Movements and Care Package to Reduce Fetal Mortality 
trial 
AIHW Australian Institute of Health and Welfare 
ANZJOG Australian and New Zealand Journal of Obstetrics and Gynaecology 
ANZSA Australian and New Zealand Stillbirth Alliance 
aOR Adjusted odds ratio 
App Mobile application 
ART Assisted reproductive technology 
BMI Body mass index 
CI Confidence interval 
COPD-6 A proprietary medical device intended for measuring lung function 
CRD Centre for Reviews and Dissemination, University of York (UK) 
CRE Centre of Research Excellence 
CTG Cardiotocography 
DFM Decreased fetal movement 
DOI Digital object identifier 
dPHR Digital Pregnancy Health Record 
FD Fetal death 
FGR Fetal growth restriction 
FMH Fetal to maternal haemorrhage 
FoR Fields of research 
GCUH Gold Coast University Hospital 
GDM Gestational diabetes mellitus 
GP General practitioner 
GRADE Grades of recommendation, assessment, development and evaluation 
HR Hazard ratio 
HREC Human research ethics committee 
ICC Intracluster correlation co-efficient 
ICD-PM International Statistical Classification of Diseases and Related Health Problems 
– Perinatal Mortality 
ID Identification  
iOS iPhone Operating System, developed by Apple Inc.  
IQR Interquartile range 
IRSD Index of Relative Socio-Economic Disadvantage 
IT Information technology 
LGA Large for gestational age 
MBM My Baby’s Movements 
LM Daly                                                                Page xxi 
                                                                                            
 
Abbreviation Explanation 
MCA Doppler  Fetal middle cerebral arterial doppler assessment 
MESH Medical subject headings 
Mhealth Mobile health 
MHS Mater Health Service 
NHMRC National Health and Medical Research Council 
OR Odds ratio 
PAR Population attributable risk 
PMID PubMed IDentifier 
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analysis 
PRISMA-P Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols 
PROSPERO International Prospective Register of Systematic Reviews 
PSANZ Perinatal Society of Australia and New Zealand 
PDC Perinatal Death Classification 
PMR Perinatal mortality rate 
RACGP Royal Australian College of General Practitioners 
RANZCOG Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists 
RCD Routinely-collected data 
RCT Randomised controlled trial 
ROBINS-I Risk of Bias in Non-randomised Studies-of Interventions assessment tool 
RR Risk ratio or Relative risk 
SANDA Stillbirth and Neonatal Death Alliance 
SANDS Miscarriage, stillbirth and neonatal death support 
SCRN Stillbirth Collaborative Research Network 
SD Standard deviation 
SEIFA Socio-Economic Indexes for Areas 
SES Socioeconomic status 
SFH Symphyseal-fundal height 
SGA Small for gestational age 
SMS Short message service 
TIDieR Template for Intervention Description and Replication checklist 
TRIP Translating research into practice 
UQ The University of Queensland 
WAAP Written asthma action plan 
WHO World Health Organization 
 
  
LM Daly                                                                                              Page 1                                                                       
 
Chapter 1. Introduction 
Perinatal morbidity and mortality remain significant public health issues globally, with enduring 
impact on the health and wellbeing of women and their families. Pregnant women who adopt, 
practice and maintain healthy behaviours can potentially improve the health of themselves and their 
babies1. Stillbirth affects over 2,100 families in Australia1, and over 2.64 million families 
worldwide annually2. Half of all stillbirths are preceded by maternal perception of decreased fetal 
movement (DFM)3,4. DFM is also strongly linked to adverse perinatal outcomes such as feto-
maternal haemorrhage, emergency delivery, umbilical cord complications, placental dysfunction, 
low birth weight and fetal growth restriction5,6.  
Studies have shown that at least 40 percent of pregnant women become concerned about DFM 
during pregnancy7, but an equal percentage are unable to recall receiving information from their 
healthcare provider about fetal movements8. Empowering pregnant women to report DFM concerns 
in a timely manner may result in a reduction of stillbirth rates by up to one-third9, owing to 
increased surveillance and timely delivery. 
Health communication methods such as face-to-face education, pamphlets, audio-visual training 
clips and mass media have been employed for decades. Emergence of mobile health modalities 
extends the opportunity to reach, teach, connect, motivate and empower individuals to address 
specific health concerns10. Pregnant women are increasingly turning to digital sources such as 
mobile applications (“apps”) for guidance11. “Pregnancy apps” have been downloaded hundreds of 
millions of times12,13 and are an integral source of information for many women, particularly in 
high-income countries. These apps can include health information, motivational messages, 
monitoring and behaviour change tools, with content tailored by demographics such as maternal 
age, gestational age, health issues or other known risk factors, cultural affiliation or language. 
Broadly, mobile health strategies have the potential to improve perinatal outcomes by improving 
access to health information, modifying demand for quality services and enabling the provision of 
targeted care14. However, limited evidence exists to support the value of mobile apps, compared to 
other communication methods, in terms of maternal behaviour change or perinatal health outcomes. 
Similarly, few studies have reviewed content of pregnancy apps to assess whether it is accurate or 
addresses specific needs of women with high-risk pregnancies or pre-existing medical conditions15, 
and whether there may be potential harms associated with app usage.  
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The primary aim of this thesis is to assess the effect of mobile application interventions on health 
care-seeking behaviour and perinatal health outcomes among pregnant women with concerns about 
fetal movement. In order to achieve this aim, this thesis was designed with four components: 
▪ Update and publication of the clinical practice guideline on Care of women with decreased 
fetal movements (Chapter 2); 
▪ A systematic review of the effect of mobile applications on maternal health care-seeking 
behaviour and perinatal outcomes (Chapter 3); 
▪ A content analysis and review of information about decreased fetal movement presented by 
mobile applications intended for use during pregnancy (Chapter 4); and 
▪ Analysis of mobile application uptake, reporting of decreased fetal movement and perinatal 
health outcomes for users of the My Baby’s Movements app (Chapter 5). 
In the first section of Chapter 2, a literature review is presented describing the association between 
decreased fetal movement, stillbirth, selected adverse perinatal health outcomes and maternal risk 
factors. Further discussion is provided about interventions to educate women and their health care 
providers about these associations, and the emergence of mobile applications as a digital health 
intervention to reach women during pregnancy. The latter half of Chapter 2 includes a published, 
updated clinical practice guideline on the Care of pregnant women with decreased fetal 
movements16,17. These guidelines provide a means of guiding maternal education and offer 
recommendations for fetal movement monitoring and investigations of fetal movement concerns. 
Chapter 3 presents the first published systematic review to assesses the effects of mobile application 
interventions during pregnancy on influencing healthy maternal behaviour and improving perinatal 
health outcomes, compared to interventions using other communication modalities or standard care. 
The primary outcome measure is a change in maternal behaviours (as defined by trial authors), by 
intervention goals. Secondary outcomes address maternal and infant health outcomes, maternal 
experience with the intervention, and health service utilisation measures. Among articles retrieved, 
3,162 articles were screened, and four studies were eligible for the review. Due to considerable 
heterogeneity of participant characteristics, intervention features, and reported outcomes, meta-
analysis could not be performed, and results are summarised as a narrative synthesis.  
Recognising the dearth of information presented in the literature, this thesis also analyses 
information about decreased fetal movement accessible through commercially-available pregnancy 
apps. As described in Chapter 4, a content analysis and review was conducted to explore how 
mobile apps inform women about DFM during pregnancy and encourage them to monitor fetal 
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movement. This review found that information about fetal movement is a cornerstone of antenatal 
education provided by popular pregnancy apps. All 24 apps in this study sample provide 
information to users about DFM, and most encourage women to be aware of their fetal movement; 
however, there is substantial variability of written guidance and features for fetal movement 
monitoring, which may influence the behaviour of women with DFM concerns. 
Chapter 5 focuses on a case study embedded within the My Baby’s Movements (MBM) trial which 
is currently underway at 27 hospitals in Australia and New Zealand. This case study analyses data 
from one of the participating hospitals, Gold Coast University Hospital, analysing the impact of a 
mobile app intervention for fetal movement awareness on perinatal health outcomes. The primary 
hypothesis of this study was that uptake of the app would be associated with primigravidity, 
primiparity, and previous experiences of pregnancy loss and stillbirth. Because no other studies 
have been conducted on this topic, hypotheses were exploratory, asserting whether associations 
were anticipated, rather than magnitude of that association. The secondary hypothesis of this study 
was that selected perinatal health outcomes would be better for MBM app users compared to non-
users, with DFM concerns reported at a higher rate, no difference in gestational week at birth or 
labour induction rates, and lower stillbirth rates.  
This thesis concludes in Chapter 6 where the main findings of these studies are reviewed and 
integrated. Study limitations, implications of the key findings, and strategic implications of this 
research are also included in this chapter. All chapters also contain an introduction, methods 
section, results, discussion and conclusion. Due to the relevance of some published literature to 
multiple chapters, there may be some repetition across these chapters.   
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 Introduction 
This literature review begins by describing the association between decreased fetal movement and 
adverse perinatal health outcomes, including stillbirth. It is further expanded with analysis of 
selected maternal risk factors for stillbirth. Interventions to educate women and their health care 
providers about this association have demonstrated measurable impact on pregnant women 
promptly alerting their care providers to fetal movement concerns, and on reduced stillbirth rates. 
However, translating maternal knowledge and concern about DFM into health care-seeking 
behaviour remains a challenge. Clinical practice guidelines have been drafted in countries including 
Australia to influence provision of information to women experiencing fetal movement concerns, 
and to guide clinical care. Emerging mobile technologies may offer a further avenue for 
transmitting health information to pregnant women, connecting them to health care settings and 
encouraging behaviour change to improve perinatal outcomes, but these potential benefits require 
review to ensure that they are delivered without introduction of unanticipated negative 
consequences, such as increased maternal anxiety or unnecessary obstetric intervention. 
 Decreased fetal movement and stillbirth 
Maternal perception of fetal movement has long been used as an indicator of fetal wellbeing and 
vitality18. Maternal perception of fetal movement typically commences from 16 to 20 weeks 
gestation19, with these first movements described as “bubbles”, “butterflies” and a “gentle flutter”20. 
Timing and quality of fetal movements reflects maturation of the fetus and neurobehavioural 
development, following a general pattern with advancing gestation20,21. Qualitative descriptions of 
movements change as pregnancy progresses to reflect increasing frequency of movement, more 
complex limb and trunk movements and greater power20,22,23. Variation in maternal perception may 
be influenced by factors such as gestational age, specific movement patterns of the baby, fetal size 
and malformations, amniotic fluid volume, medications, fetal sleep state, obesity, anterior placenta 
placement, smoking and parity19,24-27. The type of fetal movements may change in the third trimester 
as pregnancy advances, but no evidence exists to suggest that the number of fetal movements 
decrease as pregnancy advances28. 
Decreased fetal movement (DFM) is generally defined as maternal perception of significantly 
reduced or absent fetal activity, but there is no universally agreed definition. A pivotal, prospective 
study of 2,519 births by Moore et al in 1989 reported that maternal perception of fewer than 10 
movements over 2 hours was so rare that these parameters were widely adopted in obstetric practice 
as an alarm limit for decreased fetal movement29. This method became known as the “count-to-10” 
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method, and more recent studies of women with uncomplicated pregnancies reported that over 98% 
of women described feeling at least 10 movements within 60 minutes30,31. A mother’s descriptions 
of perceived fetal activity may also be described in more qualitative terms to include aspects of 
intensity, character or duration23. Further studies have reported maternal concerns focused on a 
perceived increase of fetal movement or other descriptions of change32,33.  To reflect this diversity 
of sensation and experience, clinical practice guidelines on care of women reporting concerns of 
decreased fetal movement recommend that “maternal concern of DFM overrides any definition of 
DFM based on numbers of fetal movements”34.  
Decreased fetal movement is a common cause of concern for pregnant women, with 40 percent of 
pregnant women expressing concern about DFM one or more times during pregnancy7, and 4-16% 
of women contacting their health care provider because of fetal movement concerns during the final 
trimester3,28,35.  Women who experience changes in fetal movement may report their concerns to a 
health care provider; however, prompt action to report fetal movement concerns has been found to 
be suboptimal. A 2010 study in six Queensland secondary and tertiary facilities led by Flenady et al 
found that 51% of concerned women waited longer than 24 hours before seeking care36; 
primiparous women may also wait until they perceive an absence of fetal movement before 
approaching clinicians with concerns37.  
Stillbirths are often preceded by maternal perception of decreased fetal movement, in fact, maternal 
perception is often the first sign of fetal compromise. A study by Stacey et al. reported that women 
who had experienced a stillbirth were significantly more likely to indicate a reduction in strength 
and frequency of fetal movements in the weeks preceding the fetal loss, with a 2-fold increase in 
maternal perception of DFM in the two weeks prior to stillbirth38, compared to women in the 
control group with ongoing pregnancies.  
A similar case-control study in the U.K. found that women who reported decreased frequency of 
fetal movements (without increase of strength) in the last 2 weeks were at increased risk of stillbirth 
(aOR 4.51, 95% CI: 2.38-8.55)39. A further study by O’Sullivan et al. described a 2- to 3- fold 
increased risk of stillbirth in women presenting with DFM and a live baby40. A case-control study 
led by Flenady et al. across 6 Queensland maternity hospitals and 18,000 births found stillbirth 
rates, among women coming to hospital with a live baby, of 11.2 per 1000 births among pregnant 
women reporting DFM, compared to 3.3 per 1000 births in the control population41. Despite these 
associations, the majority of women examined for perceived DFM in their third trimester continue 
with uncomplicated pregnancies42; so while maternal perception of DFM is recognised as an 
indicator of potential fetal compromise, its predictive value for adverse outcomes is low. Stillbirths 
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preceded by a reported decrease in fetal activity form an important group on which to focus future 
research. 
 Stillbirth rates 
Stillbirth is a devastating event for a pregnant woman, her family and community. Stillbirth remains 
the most common cause of infant death, accounting for 70% of all perinatal deaths and affecting 
over 2.64 million families worldwide annually2. Stillbirth rates remain nearly ten times higher in 
low-middle income countries than high-income countries; 98% of stillbirths worldwide occur in 
low-income countries2,43.  
Stillbirth rates also vary widely by week of gestation, Australian Indigenous ethnicity and maternal 
age. Overall in Australia, based on 2016 data from the National Perinatal Statistics Unit, there were 
312,683 births and 2,107 stillbirths, yielding a stillbirth rate of 6.7 per 1000 births44. These 
calculations include stillbirths from 20 weeks’ gestation, or weight of ≥ 400 grams. When viewed 
by gestational age, half of all births at gestational weeks 20-27 result in stillbirth (rate of 495.8 
stillbirths per 1000), compared to a rate of 1.0 stillbirth per 1000 births among babies born at term, 
from gestational weeks 37 to 4144. Of the 2,107 stillbirths recorded nationally in 2016, 1,373 of 
these stillbirths occurred during gestational weeks 20-2744.  The stillbirth rate of babies born to 
Aboriginal or Torres Strait Islander mothers was higher than that of babies born to non-Indigenous 
mothers (10.7 versus 6.5 per 1,000 births).  
 
Figure 2-1. Stillbirth rates for Queensland by Hospital and Health Service, 2016 
Source: Data are from Queensland Health, Perinatal Statistics 201645 (Table 10.10).  
Notes: Stillbirth is defined as fetal death of at least 20 weeks’ gestation or at least 400g birthweight. Rate is calculated 
as per 1,000 births of specified Hospital and Health Service of usual residence of mother. 
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Just as there is national variation in stillbirth rates, a wide variance in stillbirth rates exists by state 
health service region and geographic location. In the state of Queensland, the 2016 Perinatal Data 
Collection published by Queensland Health reports 62,779 births, with a stillbirth rate of 6.4 per 
1000 births45. The lowest stillbirth rates are found in the south of the state, with South West 
Hospital and Health Service reporting 2.9 stillbirths per 1,000 births, compared to the highest rates 
reported at Torres and Cape Hospital and Health Service, at 14.4 stillbirths per 1000 births (Figure 
2-1). 
 
Figure 2-2. Proportion of births and stillbirths by Queensland HHS 
Source: Data sourced from Queensland Health, Perinatal Statistics 2016 (Table 10.10)45.  
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In addition, analyses comparing stillbirth rates to birth rates by region provides information that can 
be useful for developing health interventions. For example, as shown in Figure 2-2, the Queensland 
HHS with the greatest number of births in 2016 was Metro South, delivering 24.7% of all 
Queensland births, but with 22.6% of all stillbirths recorded in the state. In comparison, Cairns and 
Hinterland HHS contributes 5.2% of all Queensland births, but 6.7% of all stillbirths, a difference 
of 1.5%. The stillbirth rate of 14 stillbirths per 1,000 births at Torres and Cape HHS is more than 
double most of the other state HHS, and its contribution to state stillbirths (1.7%) is double its 
contribution to state births (0.8%).  A map depicting the Queensland Health, Hospital and Health 
Services is included as Appendix C. 
 
 Stillbirth causes 
Causes of stillbirth are often multifactorial, and clear identification of a single cause is problematic; 
often there is more than one probable or possible cause of death46. The World Health Organization 
(WHO) International Classification of Diseases for Perinatal Mortality (ICD-PM), released in 2016, 
offers a standardised system for classifying stillbirths and neonatal deaths, with the ultimate aim to 
facilitate consistent reporting of the clinical and maternal conditions in perinatal death47. Adoption 
of this global reporting standard was recommended by authors of a recent systematic review of 85 
perinatal mortality reports in 50 countries, which found that information available from the reports 
was inconsistent and often of poor quality48. This review pooled stillbirth causes according to the 
ICD-PM and found that among high-income countries, as defined by the World Bank classification 
of Gross National Income, stillbirth cause was classified as follows: Unexplained (32.1%), 
Antepartum haemorrhage (14.4%), Placental condition (9.3%), Congenital abnormalities (8.4%), 
and All other causes (22.7%)48.  
In Australia, national perinatal mortality data is currently reported using the Perinatal Society of 
Australia and New Zealand Perinatal Mortality Perinatal Death Classification (PSANZ-PDC). In 
contrast to ICD, the PSANZ classification system allows a single cause of death as well as other 
contributing or associated conditions to be identified acknowledging the complex clinical situation 
that often accompanies a perinatal death. The Australian Institute of Health and Welfare (AIHW) 
reported that for 2013-2014, congenital abnormality was the leading cause of stillbirths (28%)49.   
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Figure 2-3. Cause of Perinatal Death, PSANZ-PDC classification (Australia, 2013-2014) 
Source: Australian Institute of Health and Welfare. Perinatal deaths in Australia, 2013-14. Canberra: AIHW; 201849. 
Data sourced from supplementary table A24. 
Other identified causes include perinatal infection (6.0%), antepartum haemorrhage (6.5%), 
maternal conditions (10.8%), specific perinatal conditions (8.6%), fetal growth restriction (5.7%) 
and spontaneous preterm birth prior to 37 weeks’ gestation (7.1%)49 (Figure 2-3). However, 20.0% 
of stillbirths are unexplained, presenting a major barrier to further reduction of stillbirth and 
perinatal mortality rates. Most of these unexplained deaths occur in late gestation in apparently 
healthy pregnancies and is the attributed cause of death for ten percent of the total stillbirths from 
20-25 weeks’ gestation, to over 42.9% of stillbirths after 38 weeks’ gestation. Causal pathways for 
stillbirth frequently involve impaired placental function, either with fetal growth restriction, preterm 
labour, or both50.  
Of note, data may not be fully representative, as autopsy is performed for only 38.1% of stillbirths 
in Australia and one-third of stillbirths in Queensland51. Attributions of stillbirth cause could also be 
contextualized alongside the legal frameworks around pregnancy termination, which varies among 
states and territories of Australia, and across other international jurisdictions. 
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 DFM, stillbirth and maternal risk factors in high-income countries 
Some maternal risk factors for stillbirth have been identified, including demographic and clinical 
attributes. A systematic review and meta-analysis of major risk factors for stillbirth in high-income 
countries, published in The Lancet as part of the 2011 Stillbirth Series, found that the most 
important and potentially-modifiable risk factors for stillbirth include maternal weight, smoking, 
age, primiparity, small size for gestational age, placental abruption, and pre-existing maternal 
diabetes or hypertension52. The interplay of maternal factors, fetal and placental factors and other 
potential stressors may increase risk for stillbirth53.  
As described by Lawn et al. in the 2016 Lancet series on Ending Preventable Stillbirths and 
presented in Table 2-1, many disorders associated with stillbirth coexist and are potentially 
modifiable. Modifiable factors with the highest estimated population attributable fraction (PAF) 
globally include advanced maternal age older than 35 years (6.7%), maternal infections (malaria 
(8.2%) and syphilis (7.7%)), non-communicable diseases, nutrition and lifestyle factors, such as 
obesity (many of which coexist, each contributing to about 10%), and prolonged pregnancy 
(14.0%)54.  
In sections below, stillbirth rates and DFM reporting are described in relation to selected maternal 
characteristics and demographics, including primiparity, previous pregnancy loss or stillbirth, 
maternal age, Australian Indigenous status, and socioeconomic disadvantage. 
 Primiparity, DFM and stillbirth 
Studies have shown a significant association between parity and pregnancy outcomes including 
obstetric complications, neonatal morbidity and perinatal death55. For the purposes of statistical 
analysis in Australia, parity refers to a count of previous pregnancies experienced by a woman that 
have resulted in a live birth or a stillbirth56. Parity is often classified into 3 groups: nulliparity 
(parity 0), low multiparity (parity 1, 2, 3) and grand multiparity (parity 4+)55. According to the 2016 
National Perinatal Data Collection in Australia, 42.8% of women are birthing for the first time, 
53.5% of women birthing have had 1-3 previous births, and 3.3% of women have birthed 4 or more 
times previously44. For the purposes of this thesis, women with no previous birth who are at ≥20 
weeks’ gestation are identified as “primiparous.” Some studies refer to these women who have 
never birthed previously as “nulliparous”57. The National Health Data Dictionary in Australia 
(2015) refers to a “primipara” as a “woman giving birth for the first time with a parity of 0”58. 
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Table 2-1. Risk factors for stillbirth in high-income countries 
Factor aOR (95% CI)   PAR* (%) 
Demographic and fertility 
Maternal age¥ 
35-39 years 1.5 (1.2-1.7) - 
40-44 years 1.8 (1.4-2.3) - 
≥45 years 2.9 (1.9-4.4) - 
>35 years 1.7 (1.6-1.7) 12 
Low education 1.7 (1.4-2.0) 4.9 
Low socioeconomic status 1.2 (1.0-1.4) 9.0 
No antenatal care 3.3 (3.1-3.6) 0.7 
Assisted reproductive technology (ART), singleton pregnancy 2.7 (1.6-4.7) 3.1 
Primiparity 1.4 (1.3-1.5) 15 
Previous stillbirth 3.4 (2.6-4.4) π  1 π 
Non-communicable disease and obesity 
Body mass index (BMI; kg/m2) € 
25-30 1.2 (1.1-1.4) - 
>30 1.6 (1.4-2.0)  
>25  8-18 
Pre-existing diabetes  2.9 (2.1-4.1) 2-3 
Pre-existing hypertension  2.6 (2.1-3.1) 5-10 
Pre-eclampsia  1.6 (1.1-2.2) 3.1 
Eclampsia  2.2 (1.5-3.2) 0.1 
Fetal factors 
Small for gestational age (<10 centile)  3.9 (3.0-5.1) 23.3 
Post-term pregnancy (≥42 weeks)  1.3 (1.1-1.7)  0.3 
Rhesus disease 2.6 (2.0-3.2) ± 0.6± 
Lifestyle factors 
Smoking  1.4 (1.3-1.5) 4-7 
Illicit drug use 1.9 (1.2-3.0) 2.1 
Source: Unless otherwise stated: Flenady V, Koopmans L, Middleton P, et al. Major risk factors for stillbirth in high-
income countries: a systematic review and meta-analysis. Lancet 2011; 377(9774): 1331-40. ±Lawn JE, Blencowe H, 
Waiswa P et al. Stillbirths: Stillbirths: rates, risk factors and potential for progress towards 2030. Lancet 2016; 387: 
587–603. πLamont K, Scott NW, Jones GT, Bhattacharya S. Risk of recurrent stillbirth: systematic review and meta-
analysis. BMJ 2015; 350: h3080. 
Notes: High-income countries for aOR and PAR calculations include Australia, Canada, USA, UK and the Netherlands. 
∑ aOR=adjusted odds ratio (95% confidence interval). *PAR=population attributable risk (the proportion of cases that 
would not occur in a population if the factor were eliminated). Calculated using a prevalence of 0.05%. ¥Reference < 35 
years of age. €Reference BMI < 25.  
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Primiparous women in Australia are more likely to experience stillbirth than their multiparous 
counterparts, with a stillbirth rate of 7.8 per 1000 births for primiparous women compared to 6.5 per 
1000 births for women who have birthed one or more children59. A cross-sectional analysis by Bai 
et al. of 512,733 births in New South Wales, Australia from 1992-1997 found that the risk of 
pregnancy complications was highest for primiparous women (OR=1.75; 95%CI: 1.71-1.78), lowest 
for multiparous women with one previous birth (OR=0.96; 95%CI: 0.94-0.99), and intermediate for 
grand multiparous women with ≥4 previous births (OR=1.19; 95%CI: 1.12-1.23); similarly, the risk 
of perinatal death was significantly higher among primiparous women and grand multiparous 
women, compared to the reference group of women with one previous birth, after controlling for 
potential confounders of maternal age, smoking, private health insurance and English-speaking 
background status55.  
These trends are mirrored in findings from studies across other high-income countries. The meta-
analysis by Flenady et al. of stillbirth risk in high-income countries found that primiparity was 
associated with a 42% increase in the odds of stillbirth, when controlling for potential 
confounders52. This same analysis among five countries found a population-attributable risk for 
stillbirth attributed to primiparity at around 15%, more than any other risk factor except for 
abruption or fetal growth restriction52.  
Population-based cohort studies in the U.K and U.S. have published similar findings. A study in the 
U.K. found that among a multiethnic maternity population of 92,218 women, women expecting 
their first child comprised over half of all stillbirths; primiparous women had almost twice the risk 
of stillbirth compared to women expecting their second child (RR=1.9; 95%CI: 1.4-2.4)60. The 
Stillbirth Collaborative Research Network (SCRN) has studied stillbirth occurring at 59 tertiary and 
community hospitals in the U.S. and found that primiparous women are 1.5 times as likely as 
multiparous women to experience a stillbirth (95%CI: 1.22-1.83)61. While not the focus of this 
thesis, a similar association between stillbirth and primiparity has been seen among women in low- 
to middle-income settings. A prospective, population-based observational study of 272,089 births 
across seven low-resource settings found that primiparous women were 30% more likely to 
experience a stillbirth compared to women who had birthed 1-2 children previously (RR=1.3; 
95%CI: 1.2-1.3)43.  
However, while the associations between primiparity and stillbirth are well-established, the 
association between parity and the reporting of DFM is not as clear. A retrospective cohort study 
conducted by Ahiram et al. in a single, tertiary medical centre in Israel reported that among 37,856 
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births during the study period, a similar proportion of primiparous women (2.4%) and multiparous 
women (2.1%) from 37 weeks’ gestation presented to the delivery ward with DFM concerns62. A 
historic cohort study conducted by Mohr Sasson et al. of 22,005 women at 24 weeks’ gestation and 
beyond presenting to the maternity emergency room of another Israeli hospital found an association 
between reporting of DFM and primiparity. In this study, women reporting DFM had lower 
gravidity and parity (1.05 ± 1.31 versus 1.25 ± 1.31, p=.0004); primiparity was associated with 
DFM for the whole study group (OR=1.73; 95%CI: 1.40–2.13), but this association was only 
significant among women at 28 weeks’ gestation or beyond63. A prospective, population-based 
cohort study of 2,374 pregnant women presenting with DFM among 14 delivery units in Norway, 
matched to 614 controls not reporting DFM, found that 51% of women in the DFM group were 
primiparous, compared to 39% of the control group (OR=1.6; 95%CI: 1.3-2.0, p˂0.001)42. This 
association was the same even after adjusting for maternal age, smoking status and high BMI. 
 Previous pregnancy loss, DFM and stillbirth 
Previous history of spontaneous pregnancy loss before 20 weeks’ gestation has been shown to have 
an association with stillbirth rates, particularly among primiparous women. A miscarriage, also 
referred to as a spontaneous abortion, is defined as a spontaneous loss of a clinical pregnancy before 
20 completed weeks of gestation; or if gestational age is unknown, a weight of 400 grams or less58. 
Spontaneous miscarriage occurs naturally and may be caused by fetal or maternal factors; however, 
the cause is often not established64. In Australia, one in four women have experienced pregnancy 
loss prior to 20 weeks gestation65, although incidence may be higher due to underreporting by 
women who may not know a miscarriage has occurred, or who do not report it as a clinical event. In 
Australia, the National Health Data Dictionary defines stillbirth as “fetal death prior to the complete 
expulsion or extraction from its mother of a product of conception of 20 or more completed weeks 
of gestation or of 400 grams or more birthweight58.”  
In the U.S., a population-based study of stillbirth by the Stillbirth Collaborative Research Network 
(SCRN) reported that at the time of pregnancy confirmation, pregnancy history was the strongest 
risk factor for stillbirth. This study documented an increased risk of stillbirth among women who 
had been pregnant previously but had not delivered a live or stillborn infant after 20 weeks’ 
gestation46,61,66. There was a progressive increase in the risk for stillbirth based on primiparity, 
previous losses at less than 20 weeks’ gestation, and then multiparas with a previous stillbirth61 
(Table 2-2).  
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Findings in this study were similar to a population-based, cross-sectional study led by Räisänen et 
al. of 604,047 singleton pregnancies (from the years 2000-2010) as recorded in the Finnish Medical 
Birth Register. This study found that previous pregnancy loss was in independent risk factor for 
stillbirth, irrespective of the number of prior deliveries67. Parity and previous pregnancy loss were 
significantly associated with stillbirth (p˂0.001). 
Table 2-2. Pregnancy-associated characteristics and stillbirth 
Pregnancy-associated characteristics and 
stillbirth 
SCRN, U.S. 
(2011)61 
OR (95% CI) 
(N=2,430) 
Räisänen, Finland 
(2018)67 
OR (95% CI) 
(N=604,047) 
Primiparous, previous lossesa 2.80 (1.91-4.12) 1.38 (1.14-1.67) 
Primiparous, no previous losses 1.58 (1.25-2.00) 1.18 (1.01-1.24) 
Multiparous, no previous losses or stillbirth 
(Reference) 
1 1 
Multiparous, previous losses but no stillbirth 1.22 (0.91-1.63) - 
Multiparous, previous stillbirth 6.41 (3.77-10.91) - 
Multiparous, previous losses or stillbirth - 1.37 (1.20-1.55) 
Notes: aSCRN study calculated previous pregnancy losses at <20 weeks, including stillbirth. Räisänen study calculated 
previous pregnancy losses at <22 weeks. OR=odds ratio (crude). CI-confidence intervals. SCRN=Stillbirth 
Collaborative Research Network. - = Not reported. 
A large, population-based cohort study of Swedish Medical Birth Register data (from the years 
1995-2009) by Gunnarsdottir et al. including 619,587 primiparous women investigated the 
association between prior miscarriages and the risks of adverse perinatal health outcomes including 
stillbirth, birth of a small for gestational age (SGA) infant and spontaneous preterm birth68. 
Compared with women who had no prior reported miscarriage, women with 1 or 2 prior 
miscarriages did not have increased risks of stillbirth (calculated at 28 weeks’ gestation or later). 
However, all adverse outcomes analysed were higher for women with 3 or more prior miscarriages 
compared with women without prior miscarriages, including stillbirth (0.7% versus 0.3%), SGA 
infant (5.1% versus 3.2%) and spontaneous preterm birth (6.5% vs 4.4%). Authors concluded that 
all women with a history of 3 or more prior miscarriages should be managed as a high-risk group 
during all subsequent pregnancies. 
In addition to women who have experienced miscarriage, multiparous women who have had a 
previous stillbirth have a 5- to 10-fold increased recurrent risk for stillbirth, compared to those 
without a previous stillbirth69. In a systematic review and meta-analysis of risk of recurrent 
stillbirth, Lamont et al. found that compared to women who had a live birth in their first pregnancy, 
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those who experienced a stillbirth in their first pregnancy were over four times more likely to 
experience recurrent stillbirth69. In high-income countries, Flenady et al. demonstrated in a 
systematic review and meta-analysis of five studies that previous stillbirth was associated with 
stillbirth, with an aOR of 2.61 (95% CI: 1.50-4.55)52 As demonstrated by these findings, history of 
pregnancy losses and stillbirth place women at higher risk of stillbirth. 
Despite an extensive search, no studies were found assessing previous pregnancy loss or stillbirth 
with DFM reporting in subsequent pregnancy. Findings from the My Baby’s Movements case study 
presented in Chapter 5 provide more information. 
 Maternal age, DFM and stillbirth 
In many higher-income countries, women increasingly commence child bearing at later ages, which 
is leading to a more advanced age of primiparity. In Australia, the maternal age at first birth has 
risen steadily. As perinatal statistics at both national and state level in Queensland demonstrate, 
over one-quarter of women giving birth aged 35 years and above are having their first child44,70. In 
Queensland in 2016, 20% of mothers giving birth were aged 35 years and older, compared to 8% in 
198745,71. Interestingly, at a national level, this trend is reversed when analysed by Indigenous 
status, with only 9% of Indigenous mothers aged 35 years or older, compared with 23% of 
Australian mothers birthing in 2016 who do not identify as Indigenous; moreover, Indigenous 
women are seven times more likely to be teenage mothers than their non-Indigenous counterparts1. 
Studies have shown that women at highest risk of stillbirth are those at either end of the age 
spectrum. Advanced maternal age and primiparity have been identified as both independent and 
associated risk factors for fetal death52,72-74. A systematic review by Huang et al. found a 
statistically significant association between maternal age and stillbirth risk among 24 of 31 
retrospective cohort studies and all six case-control studies analysed75. The reported crude relative 
risk of stillbirth varied from 1.20 to 4.53 for older versus younger women; the risk ratios or odds 
ratios did not change extensively in either magnitude or direction when controlling for potential 
confounders such as parity, smoking, BMI, race/ethnicity or education, suggesting that the 
association between maternal age and stillbirth risk may be independent of these other known risk 
factors. It has been postulated that the increased risk could be related to the association between 
older women and higher prevalence of maternal morbidity, such as chronic diseases or pregnancy-
induced hypertensive disorders or diabetes75.  
In Australia, according to the 2016 National Perinatal Data Collection published by the Australian 
Institute for Health and Welfare (AIHW), the proportion of women experiencing a stillbirth aged 35 
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years and above (0.75%) is higher than for women aged below 35 years (0.61%)44. These trends are 
reflected in the perinatal statistics reported in the state of Queensland, with 0.95% of all births to 
women aged 35 years and older resulting in a stillbirth, compared to 0.74% of births to women aged 
below 35 years45. A retrospective cohort study of 77,739 births at a Mater Mothers’ Hospital in 
Brisbane, over the period 1998-2008, reported that women aged ≥ 40 years accounted for 3.5% of 
all births, yet 8.5% of term stillbirths; furthermore, multivariate logistic regression analysis found 
that both advanced maternal age (aOR=2.42; 95% CI: 1.04-5.62) and having a small-for-gestational 
age baby (aOR=3.65; 95% CI: 2.18-6.11) were independently associated with term stillbirth76. 
In New South Wales, Australia, a review of 327,690 births conducted by Gordon et al. found that 
maternal age was a significant independent risk factor for antepartum stillbirth (HR=1.4; 95%CI: 
1.12-1.75) for women aged 35-39 years and women above 40 years of age (HR=2.41; 95%CI: 1.8-
3.23). In this study, the risk was highest for primiparous women aged 40 and above, with 1 in 247 
ongoing pregnancies resulting in an antepartum stillbirth73. A population-based registry study by 
Waldenström et al. of 1.8 million pregnancies in Sweden over a 21-year period found that age-
related risk of stillbirth was primarily restricted to first births77. Compared to maternal age of 25-29 
years as the reference group, stillbirth rates increased by approximately 25% at 30-34 years of age 
and doubled at age 35 years or older. For multiparous women, stillbirth risk increased with maternal 
age among women with low and middle level of educational attainment, but not in women with 
high education. The authors assert that age-related risk is reduced or eliminated in parous women, 
possibly as a result of physiologic adaptations during the first pregnancy77. 
While the association between maternal age and stillbirth is established, the relationship between 
maternal age and DFM reporting is less clear. The Mohr Sasson et al. historic cohort study in Tel 
Aviv, Israel found a significant association between maternal age and DFM reporting (p=0.007); 
women who reported DFM were younger (32.4±5.6 years) compared to a control group who had 
not reported DFM (33.2±5.1 years)63. However, the prospective population-based cohort study by 
Tveit et al. in Norway reported that maternal age was not significantly associated with DFM 
reporting, with 16% of women reporting DFM over the age of 35 years, comparable to 20% of 
women not reporting DFM in that age bracket (OR=0.8; 95% CI: 0.6-1.0, p=0.05)42. 
 Australian Indigenous ethnicity, DFM and stillbirth 
Australian Indigenous ethnicity is associated with higher rates of stillbirth. In 2016, there were 11 
stillbirths for every 1,000 births among babies of Indigenous mothers, amounting to 2.75 times the 
rate for babies of non‑Indigenous mothers (4 per 1,000 births)1. In Queensland in 2016, women 
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identifying as Aboriginal and/or Torres Strait Islander ethnicity accounted for 6.7% of all births 
(4,230 of 62,779 births), but 10.2% of all stillbirths (41 of 402 stillbirths)45. Compared to non-
Indigenous mothers, Indigenous women are also 14 times more likely to live remotely/very 
remotely, which may influence care accessibility1.  
However, while Indigenous women have almost twice the risk of stillbirth as non-Indigenous 
women, the gap in stillbirth rates is narrowing; a recent analysis of outcome data from the 
Queensland Perinatal Data Collection demonstrated a 57% reduction in the disparity gap from 1995 
to 201178. The causes that contribute most strongly to higher perinatal mortality rates among 
Indigenous women in Queensland include perinatal infection and maternal conditions such as pre-
existing and gestational diabetes, hypertension, antepartum haemorrhage and spontaneous preterm 
birth78,79, mirroring what has been reported nationally (Figure 2-4). As seen below, the most notable 
differences in causes of perinatal death between babies of Australian Indigenous and non-
Indigenous mothers are for unexplained antepartum death and spontaneous preterm births.  
 
Figure 2-4. Perinatal deaths in Australia, by maternal Indigenous status and cause of death, 2016 
Source: Source: Australian Institute of Health and Welfare. Perinatal data visualisations 2016. Canberra: AIHW; 2018. 
Data sourced from Table 33. 
Note: Perinatal deaths include stillbirths and deaths up to 28 days after birth. Perinatal deaths classified according to 
PSANZ-PDC: https://www.psanz.com.au/assets/Uploads/Section-7-Version-2.2-April-2009.pdf 
A service evaluation led by Kildea et al. of routinely-collected data from a large urban hospital in 
Queensland found that among 45,216 births (including 1,523 Indigenous mothers) between the 
years 1998–2009, Indigenous babies were more likely to be born preterm < 37 weeks (12.7%) and 
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be of low birthweight < 2500 g (13.2%), compared to non-Indigenous births at the same hospital 
(8.9% and 8.2%, respectively)80. Stillbirth rates in this urban population were similar, with 0.8% of 
births among Indigenous mothers resulting in stillbirth, compared to 0.7% of births among non-
Indigenous mothers. Put another way, combining stillbirth and neonatal deaths, the perinatal 
survival rate for babies of Indigenous mothers was 98.4%, compared to 98.8% of babies of non-
Indigenous mothers80. Thus stillbirth rates for Australian Indigenous women residing in this urban 
area were not significantly higher than their non-Indigenous counterparts, despite significantly 
higher rates of teenage pregnancy, preterm birth, low birthweight and maternal smoking – all 
maternal factors associated with increased stillbirth rates. Study authors recommend targeting 
modifiable risk factors with culturally-responsive interventions that span the continuum of care 
from preconception to infancy. 
Despite extensive searching, published data were not found on associations between Indigenous 
Australian ethnicity (Aboriginal and/or Torres Strait Islander) and reporting of decreased fetal 
movement. However, original data analysis has been performed as part of the My Baby’s 
Movements case study presented in Chapter 5. 
 Socio-economic disadvantage, DFM and stillbirth 
Maternal factors related to social determinants of health may also impact stillbirth rates in Australia. 
The World Health Organization Commission on the Social Determinants of Health defines these as 
the conditions in which people are born, grow, live, work and age and the systems put in place to 
address illness81:  
The poor health of the poor, the social gradient in health within countries, and the 
marked health inequities between countries are caused by the unequal distribution of 
power, income, goods, and services, globally and nationally, the consequent 
unfairness in the immediate, visible circumstances of peoples’ lives –their access to 
health care, schools, and education, their conditions of work and leisure, their homes, 
communities, towns, or cities –and their chances of leading a flourishing life. This 
unequal distribution of health-damaging experiences is not in any sense a ‘natural’ 
phenomenon….Together, the structural determinants and conditions of daily life 
constitute the social determinants of health81. 
The social and environmental contexts in which people live affect susceptibility, risks and 
opportunities to prevent, diagnose, or treat illness as it occurs (Figure 2-5). Distribution of power, 
resources and finances contribute to shaping these determinants and can lead to health inequities, 
mirrored in patterns of morbidity and mortality82,83. This thesis does not explore social determinants 
of health in detail but acknowledges the interrelated factors that could influence health conditions, 
perinatal health outcomes and uptake of health interventions. 
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Figure 2-5. Framework for determinants of health 
Source: Dahlgren G, Whitehead M. Policies and strategies to promote social equity in health. Background document to 
WHO - Strategy paper for Europe. Institute for Futures Studies. Stockholm: WHO Regional Office for Europe; 1991. 
A systematic review conducted in the U.K. of nearly one million births between 1993 to 2005 found 
that stillbirth rates were 1.5 times higher (95% CI: 1.39-1.72) in the lowest area deprivation 
quintiles compared with the highest84. In Australia, mothers residing in least advantaged areas 
experience higher rates of adverse perinatal health outcomes; for example, these mothers are 30% 
more likely to have a baby with low birthweight than mothers residing in the most economically 
advantaged areas59. Some studies have reported an increased risk of stillbirth associated with low 
socioeconomic status (SES); but it is still unclear what mechanisms underpin this association, and 
how her perinatal health outcomes are directly attributable to related biological or environmental 
factors present throughout a woman’s life course85. Furthermore, the disparate frameworks to define 
low socioeconomic status or disadvantage—whether by census data, median incomes by postcode 
group, electoral ward, maternal education attainment, unemployment or other definitions—makes it 
difficult to compare studies or their outcomes86. The Australian data presented throughout this 
thesis in reference to SES uses the Socio-Economic Indexes for Areas (SEIFA), Index of Relative 
Socioeconomic Disadvantage (IRSD) developed by the Australian Bureau of Statistics for use at 
Statistical Area Level 21, and used in reporting of perinatal health data by AIHW. 
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A study led by Zeitlin et al. as part of the Euro-Peristat collaboration assessed the magnitude of 
social inequalities in stillbirth rates across 29 European countries, using three socioeconomic 
indicators of maternal education and maternal and paternal occupational group. In their analysis, for 
the 19 countries reporting data about maternal education, compared to women with postsecondary 
education, the median risk ratio of stillbirth for women with primary education was 1.9 (IQR: 1.5-
2.4) and lower secondary education was 1.4 (IQR: 1.2-1.6)87. Authors postulate that out of 6337 
stillbirths recorded in these countries, 1606 (25%) may not have occurred if stillbirth rates for all 
women were equal to the women with post-secondary education in each country87.  
A hospital-based cohort study of 84,294 births in Canada, led by Huang et al. reported that low SES 
was independently associated with unexplained stillbirth (OR 1.59; 95%CI: 1.14-2.22)88. In this 
study, low SES was defined as public compared with private hospital service for birth data from the 
years 1961–1974, and as maternal schooling less than 13 years thereafter. A population-based 
cohort study led by Bilsteen et al. in Denmark reviewed all birth data from the national registries 
between 2000-2009 and found that maternal educational level was inversely associated with all 
adverse perinatal outcomes. Compared with mothers having attained vocational education, this 
study reported that mothers with more than 15 years of education had an adjusted risk ratio for 
stillbirth of 0.64 (95%CI: 0.56-0.72)89. 
A population-based individually-matched case-control study by Stephansson et al. investigated the 
association between low SES and risk of stillbirth and assessed whether any differences in risk were 
mediated by other maternal factors. Data were extracted from the Swedish Medical Birth Register 
matching primiparous women who had experienced a stillbirth between the years 1987-1996 with 
controls. The study reported a more than two-fold increase in risk of stillbirth for women with the 
lowest SES compared with the highest. Low SES was defined by “blue-collar” and “white-collar” 
employment. After controlling for a range of covariates including age, country of birth, BMI and 
smoking, authors still could not explain the increase in risk90. Study authors hypothesise that 
suboptimal perinatal outcomes may relate to the mother’s environmental circumstances and 
material deprivation, which could in turn reduce her levels of support, educational attainment and 
access to information, which could further impact perinatal health outcomes91.  
There is little information available in the published literature about whether or how socioeconomic 
disadvantage is associated with reporting of DFM, but limited investigations from high-income 
countries shows that women with socioeconomic disadvantage, or lower levels of educational 
attainment, may seek care less readily when experiencing DFM concerns. A 2014 study by Linde et 
al. of women birthing in Sweden investigated characteristics of women seeking consultation due to 
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DFM in late pregnancy or onset of labour, through a questionnaire sent to 2,683 women with DFM 
and 26,041 women in a control group. Women with low educational attainment of primary school 
or equivalent did not seek care to the same extent as women with a higher educational level 
(p < 0.001)92. These findings support the hypothesis put forward by Stephansson et al., that 
increased stillbirth risk among women of lower SES may be affected by reticence to seek care when 
facing DFM or other “signals of a pathological pregnancy”; or conversely, that the quality, quantity 
or content of medical care may be affected by SES90. These complex relationships would be worth 
exploring in more detail, particularly in relation to mobile app health interventions, where 
technological access or maternal levels of literacy may be associated with lower SES, in whatever 
way SES is defined by researchers.  
 DFM, stillbirth and adverse perinatal health outcomes 
Maternal perception of decreased fetal movement has clinical significance as a predictor of 
pregnancies at increased risk of adverse outcomes. Studies have reported associations between 
DFM and low birth weight93-101, low levels of amniotic fluid, preterm birth93,102, threatened preterm 
labour93, congenital malformations and chromosomal abnormalities103, feto-maternal transfusion104, 
perinatal brain injuries and disturbed neurodevelopment105,106, intrauterine infections107, low Apgar 
scores and acidemia95,97, hypoglycemia93, umbilical cord complications and placental 
insufficiencies94,100,108, emergency deliveries, inductions of labour and Caesarean sections, 
stillbirths and neonatal deaths31,38,109,110. In this section of the thesis, associations with selected 
adverse perinatal outcomes will be described, including gestational age at birth, baby birthweight, 
labour induction, and caesarean birth, as they serve as secondary outcomes for the systematic 
review presented in Chapter 3 and in the My Baby’s Movements case study analysed in Chapter 5.  
 Gestational age at birth, DFM and stillbirth 
The Australian Institute for Health and Welfare (AIHW) defines gestational age as duration of 
pregnancy in completed weeks, calculated from the date of the first day of a woman’s last menstrual 
period and her baby’s date of birth, or via ultrasound, or derived from clinical assessment during 
pregnancy or from examination of the baby after birth1. Birth at term is classified as occurring from 
37 to 41 weeks’ gestation. Infants born prior to 37 weeks’ gestation are considered preterm, though 
it is worth noting that this is not a homogenous group and there are significant differences in the 
outcomes of infants delivered within the interval of 20 to 36 weeks’ gestation111,112.  
In 2016 in Australia, 90.8% of babies were born at term. The average gestational age for all 
liveborn babies was 38.7 weeks, compared to 26.6 weeks’ gestation for stillborn babies; from a 
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different angle, most stillbirths were for preterm babies (85.8%), with 13.9% of stillbirths occurring 
at term1. In Queensland, 90.3% of babies were born at term, 9.3% were born preterm, and only 
0.4% of births were post-term at 42 weeks’ gestation or more44.  
 
Figure 2-6. Proportion of Australian births at term, by parity 
Source: Australian Institute of Health and Welfare. Perinatal data visualisations 2016. Canberra: AIHW; 2018. Data 
sourced from Table 17.  
Notes: Gestational age categories: Term=37-41 weeks. Preterm=20-36 weeks. Post-term=42 weeks or more. 
As further demonstrated in Figure 2-6, there is an association between gestational week of birth and 
maternal parity. Of all Australian births, 42.8% are among primiparous women birthing for the first 
time, and 90.9% of these women birth at term, between 37-41 weeks’ gestation. However, a higher 
proportion of preterm births (45.9%) and post-term births (59.5%) occur among primiparous 
women44.  
In addition to parity, advanced maternal age ≥ 35 years is also associated with stillbirth as 
gestational age progresses. A study by Reddy et al. analysed 5,458,735 singleton gestations without 
reported congenital anomalies, from the U.S. National Center for Health Statistics perinatal 
mortality and natality files from 2001-2002. Women of advanced maternal age were found to be at 
higher risk of stillbirth throughout pregnancy, with a peak risk period from 37-41 weeks’ 
gestation113.  
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In a retrospective cohort study of almost three million births in the United States recorded in 2005, 
Page et al. found that the risk of stillbirth was higher for older women birthing between 37 to 41 
gestational weeks, compared with women younger than 35 years of age114. For older women, risk of 
stillbirth doubled from 5.0 per 10,000 births (95%CI: 3.8-6.2) at 39 weeks’ gestation to 10.0 per 
10,000 births (95%CI: 8.0-12.0) at 40 weeks’ gestation. For younger women below 35 years of age, 
risk of stillbirth also increased with gestational age, but at a substantially lower rate. 
 
 
Maternal reporting of DFM has not been associated with earlier gestational age at birth in numerous 
studies. The Aviram et al. study in Israel reported that among women at term reporting to the 
hospital with spontaneous labour or induced labour, gestational age at birth was 39 weeks for 
women reporting DFM as well as women without such concerns, regardless of parity62.  
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Figure 2-7. Risk of stillbirth stratified by maternal age and gestational age 
Source: Page JM, Snowden JM, Cheng YW, Doss AE, Rosenstein MG, Caughey AB. The risk of stillbirth and infant 
death by each additional week of expectant management stratified by maternal age. AJOG 2013; 209(4): 375.e1-7. 
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 Birthweight, DFM and stillbirth 
Low birthweight, small for gestational age (SGA) birthweight and fetal growth restriction (FGR) 
are associated with increased risk of adverse outcomes in a significant number of pregnancies where 
DFM has been reported94,109,115-119. Fetal growth restriction refers to a fetus that has not reached its 
growth potential due to fetal, placental or maternal factors, with the most common sonography-
based definition of FGR is a weight below the 10th percentile for gestational age120. However, this 
definition is not resolute, because it does not make a distinction among babies who are 
constitutionally small, compared to those who are small due to a pathologic process that has 
hindered achievement of their genetic growth potential. For example, over 25,000 late preterm and 
term infants are born small in Australia every year, but many of these infants are small but 
healthy121. But among all the babies who are small-for-gestational-age, risk of perinatal death is 
four times their appropriately grown counterpart, and identifying the growth restricted among the 
small remains an obstetric priority in order to identify risk factors and minimise risk of stillbirth121. 
The appropriate reference standard for defining FGR is also controversial, with some hospitals 
using standards based on birth weights across gestation and others using customised standards that 
may incorporate fetal size with the status of placental health measured by maternal and fetal 
Doppler velocimetry and biomarkers, biophysical findings, and genetics122. A further refinement to 
customised fetal weight standards could include individualisation for maternal characteristics, such 
as height, weight, ethnicity, parity and fetal gender123. There is also no standard approach to the 
measurement of symphyseal-fundal height (SFH), and this may also affect FGR detection. 
FGR is considered the single biggest risk factor for stillbirth121 though it is frequently 
underdiagnosed50. A study by Gardosi et al. in the U.K. reported a stillbirth rate of 2.4 per 1000 
births in pregnancies without FGR, compared to a stillbirth rate of 9.7 per 1000 births in 
pregnancies with antenatally-detected FGR, increasing to 19.8 per 1000 when FGR was not 
detected60. Up to 75% of all growth-restricted babies remaining undetected antenatally124, thus 
detection and management of FGR remains a leading priority in the prevention of stillbirth. 
Improved identification of growth-restricted babies is an important benefit of assessment of 
pregnancies where there is a complaint about DFM9,125,126. 
In the Flenady et al. study of DFM reported at Queensland maternity hospitals, of pregnant women 
in the third trimester who reported DFM, 16% birthed a baby presenting with FGR41. Similarly, a 
case-control study from the UK reported that FGR was present in 11% of women with DFM 
compared with 0% in the control group125. A seminal study by Valentin et al. published in 1984 
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reported a statistically significant association between small-for-gestational age babies (p=0.04) and 
maternal consultation for decreased fetal movement, among a total sample of 1,914 women who 
had been advised to perform fetal movement counting during the final trimester of pregnancy93. 
Authors recommended that women reporting DFM should be carefully monitored as a higher risk 
group. 
Studies suggest that maternal perception of DFM may be strongly associated with fetal growth 
restriction and stillbirth through placental dysfunction108,127. Previous studies including Dutton et al. 
have reported altered placental structure and function among women reporting DFM, with increased 
infarction, increased density of syncytial knots, and reduced vascularity, trophoblast area, and 
nutrients exchange activity101. Warrander et al. reported evidence of abnormal placental 
morphology and function in women with DFM, supporting the proposition of a causal association 
between placental insufficiency and DFM128.  
A retrospective cohort study in the U.K. by Scala et al. of pregnancies referred for DFM to a tertiary 
fetal medicine unit from the years 2008 to 2014 concluded that women with repeated episodes of 
DFM had a significantly higher mean uterine artery pulsatility index in the second trimester. 
Authors recommended that women presenting with repeated episodes of DFM should be treated as 
being at high risk of placental dysfunction irrespective of the results of prenatal ultrasound and 
Doppler assessment129. Repeated episodes of DFM at term were also strongly associated with the 
birth of SGA infants, whereby 9.8% of women presenting with one episode of DFM had an SGA 
baby, compared to 44.2% of women presenting with repeated episodes of DFM (OR=7.3; 95%CI: 
5.1-10.4; p<0.05).  
 Labour induction, DFM and stillbirth 
Labour induction has been associated with DFM in numerous studies. In the absence of clear 
evidence, it is possible that rates of induction relate to hospital protocols of how and when to 
respond to women’s concerns about fetal movement, which may also be influenced by the types of 
diagnostic testing available, practitioners on staff, and adherence to clinical practice guidelines130.  
In Queensland in 2016, among 60,987 singleton births, 16,998 births (27.9%) were induced, 31,046 
were spontaneous (50.9%), and 12,943 births (21.2%) had no labour45. For births with induced 
labour (reported collectively for a total of 17,165 singleton and multiple births), the reason cited in 
the perinatal health record for the majority of inductions is prolonged pregnancy (15.5%), followed 
by psychosocial and other “administrative” circumstances (14.7%), and diabetes complicating 
pregnancy (14.0%); “other fetal problems” accounts for 4.8% of labour inductions and includes 
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“decreased fetal movement” among other unspecified issues. Given how this data is collected and 
reported, it is still unknown whether women with DFM have higher rates of induction in 
Queensland. The Queensland Clinical Guideline on Induction of labour specifies decreased fetal 
movement as one issue of concern for fetal wellbeing, which may result in the clinician 
recommending expectant management or induction of labour, with timing of birth dependent on 
factors such as gestational age, severity of concern and results of tests of fetal wellbeing131.  
A large cohort study led by McCarthy et al. in Cork, Ireland in 2013 compared women presenting 
with DFM at ≥ 28 weeks’ gestation to the emergency room of a large tertiary maternity hospital to a 
retrospectively collected control group delivering contemporaneously. There were 275 presentations 
analysed in the DFM group, compared with 264 in the control group; women presenting with DFM 
were more likely to have labour induction (p=0.001), with 42.4% of the DFM group induced, 
compared to only 27.9% of the control group. Gestational age across both cohorts was similar, at a 
mean age of 39 weeks + 4 days132. However, the stillbirth rate of the DFM group was 14.5 per 1000 
births, which was significantly higher than the hospital’s institutional stillbirth rate of 2.9 per 1000 
births during that period. Such a vast difference in stillbirth rates underscores the importance of 
educating women about DFM and encouraging their prompt action if concerned, though it is 
unclear whether any hospital intervention could have changed the stillbirth outcome.  
 Mode of birth, DFM and stillbirth 
Numerous studies have reported associations of caesarean delivery (CD) with DFM reporting. 
Similar to associations between DFM and labour induction, it is possible that hospital protocols 
influence clinical decision-making, and may lead to wide variability across maternity centres and 
health systems, even within the same state. In Queensland in 2016, among 60,987 singleton births, 
34,394 births (56.4%) were vaginal (non-instrumental), 6,405 births (10.5%) were vaginal (forceps 
or vacuum), and 20,188 births (33.1%) were delivered by caesarean45. Caesarean delivery rates in 
Queensland are similar to national rates, with 104,839 births (33.8%) by caesarean section, among 
310,247 Australian births in 20161. These perinatal data collections do not report on mode of birth 
related to DFM reporting. 
However, internationally, some studies have investigated such an association. The Aviram et al. 
prospective cohort study in Israel found that DFM was an independent and significant risk factor for 
caesarean birth among primiparous women, with the rate of CD higher in the DFM group than the 
non-DFM cohort, even after accounting for labour induction (aOR=1.3; 95% CI: 1.01–1.8). Rates 
of labour induction were much higher among the DFM cohort group (p< 0.001), with 20% of 
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primiparous women in the DFM group induced, compared to 8.1% of the non-DFM cohort62; 
however, the cohorts were stratified at the time when women presented to the hospital in labour, 
and this may have influenced clinical decision-making at the time of birth. Primiparous women with 
DFM in this study were at increased risk for CD and adverse perinatal outcomes including 
antepartum fetal death, low Apgar scores and neonatal seizures; however, for multiparous women, 
DFM was associated with increased risk for unscheduled CD, mostly as a result of 
intermediate/abnormal fetal heart rate tracing, with no immediate adverse perinatal outcome.  
A retrospective study by O’Sullivan et al. in a U.K. maternity hospital found that among 203 
women presenting to the obstetric triage unit with concerns of DFM, 26.6% of these women had a 
poor perinatal outcome (defined as stillbirth, small for gestational age, or preterm birth before 37 
weeks’ gestation40. Furthermore, women with DFM concerns, compared to the total hospital 
population during that period, with a statistically significant increase in stillbirths (15.1% versus 
5.1%; p=0.02) and a clinically significant increase in emergency caesarean delivery (15.7% versus 
11.9%; p=0.10).  
 Interventions targeting awareness of DFM 
The Lancet Stillbirth series identified awareness and timely evaluation of women reporting DFM as 
a stillbirth research priority133. A number of reviews and studies have analysed benefits of 
interventions for pregnant women that raise awareness about fetal movement and enhance clinical 
identification and management of maternal risk factors for adverse perinatal health outcomes. 
However, most of these studies focus on fetal movement counting as the intervention, either in 
contrast to no counting or to different methods of counting134. Fetal movement counting is a daily 
systematic record of the mother’s perception of her baby’s movement, typically recommending use 
of a kick chart.  
A 2015 systematic review by Winje et al analysed studies of interventions to enhance maternal 
awareness of DFM as a means to assess fetal well-being135. Within this review, eight studies 
specifically assessed the effect of interventions on stillbirth and perinatal death. Of these, three 
randomised controlled trials (RCTs) reviewed had differing results. The largest of these RCTs by 
Grant et al.136, with a sample size of 68,654 women, reported no stillbirth reduction within the 
intervention group. But within this study, the overall stillbirth rate of the intervention and control 
group, when combined, decreased by 4 per 1000 to 2.8 per 1000 births. It is postulated that this may 
be attributed to increased maternal awareness and vigilance toward DFM3,136.  
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Frøen’s review of this landmark study describes serious methodological flaws and biases3. Clinical 
practice has changed since those studies were conducted, with the introduction of clinical guidelines 
in many maternity facilities, new technologies for investigation of concerns and more sophisticated 
interventions to address maternal or fetal conditions suggesting fetal compromise. Further, these 
RCTs assess fetal movement counting on “kick charts” versus standard care; they did not test other 
forms of maternal and clinical education about fetal movement. Accounting for variability in 
educational content, these studies demonstrate the importance of educating pregnant women about 
fetal movement patterns, options for building awareness of fetal movement, and how to proceed if 
concerned.   
However, many women report not receiving adequate information about fetal movement from their 
care providers137,138. A study conducted by Pakenham et al. in a large, tertiary care centre in Canada 
found that only 58% had received timely information, and only one-third of those surveyed were 
informed and would have sought further investigation for decreased movement139. McArdle et al. at 
a large, metropolitan maternity hospital in Queensland found that more than one-third of women at 
34 weeks gestation or later did not recall receiving information about fetal movement from their 
healthcare provider8. Surveys administered to obstetricians and midwives in Australia revealed that 
while asking women about fetal movements was considered an important component of routine 
antenatal care, there was variability in definition of alarm limits and clinical assessment of concerns 
of women reporting DFM140,141. 
Antenatal education about fetal movement has shown to increase knowledge about DFM, reduce the 
time from maternal perception of DFM to health-seeking behaviour and further reduction in 
stillbirth rates9,142. A quality improvement study reported by Tveit et al. in Norway used a 
prospective “before- and-after” study design to evaluate the combined impact of providing women 
with information on DFM, and clinicians with clinical practice guidelines on DFM.  This combined 
intervention was associated with a reduction in stillbirth rates, giving an adjusted odds ratio (OR) of 
0.67 (95% CI: 0.49-0.94) in the overall study population and an adjusted OR of 0.51 (95% CI: 0.32-
0.81) in women with DFM28,143. Among women reporting DFM, stillbirth rates were lower in the 
post-intervention period compared to the pre-intervention period: 4.2% versus 2.4%9.  Furthermore, 
during the intervention period, among those with DFM, fewer women with a perceived absence of 
fetal movement waited more than 24 hours, or a perceived decrease in fetal movement for more 
than 48 hours, before contacting health-care professionals during the intervention. Notably, when 
comparing maternal demographics for women reporting DFM during the pre-intervention and 
intervention periods, there were no statistically significant differences reported for maternal age, 
BMI, parity or ethnicity.  
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More recently, the AFFIRM trial, a stepped-wedged randomised controlled trial enrolling 409,175 
women among 37 hospitals in the U.K. and Ireland, hypothesised that the incidence of stillbirth 
would be reduced by a care package for pregnant women and clinicians to increase women’s 
awareness of the need for prompt reporting of DFM and through standardised management, 
including timely birth144. During the intervention period, stillbirth rates at or beyond 24 weeks’ 
gestation were reduced to 4.06 per 1000 births, compared to 4.40 per 1000 births during the control 
period, but this reduction was not statistically significant (aOR=0.90, 95% CI: 0.75–1.07; p=0.23).  
Secondary outcomes reported by the AFFIRM trial demonstrated many statistically significant 
associations during the intervention period, including an increase in labour induction at ≥ 39 weeks’ 
gestation (aOR=1.08, 95% CI: 1.04-1.11; p˂0.0001), caesarean section births (aOR=1.09, 95% CI: 
1.06-1.12; p˂0.0001), and baby admissions to neonatal unit for ˃48 hours (aOR=1.12, 95% CI: 
1.06-1.18; p=0.0001). The trial also reported fewer small for gestational age babies delivered ≥ 40 
weeks’ gestation (aOR=0.86, 95% CI: 0.78-0.95; p=0.0009). In terms of absolute effect per 10,000 
pregnancies, there were 5 fewer stillbirths at ≥ 24 weeks’ gestation, 2 fewer stillbirths at ≥ 37 
weeks’ gestation in normally formed infants, 162 more caesarean sections, 165 more labour 
inductions at ≥ 39 weeks’ gestation, 256 fewer spontaneous vaginal deliveries, 34 more preterm 
births, and 68 more babies admitted to neonatal care unit for ˃ 48 hours (Figure 2-8).  
A commentary by Walker and Thornton accompanying the publication of results from this trial in 
the Lancet concluded that “encouraging awareness of fetal movements is harmful”, since stillbirth 
reduction was not statistically significant during the intervention period, and there was an increase 
in labour induction, preterm birth, caesarean sections, and admissions to the neonatal unit145. 
However, while the AFFIRM trial claims to be the largest fetal movement awareness trial to date, it 
did not actually measure awareness, or clinician uptake of the intervention, as described in another 
recent commentary about the trial, published by Flenady et al146. These authors emphasise the 
importance of determining the best approach to investigate and manage DFM presentations, 
improve induction protocols for women reporting DFM, and discuss risks and benefits of delivery, 
especially at earlier gestations, rather than discouraging discussion with women about fetal 
movements before term.  
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Figure 2-8. Effect of intervention on perinatal outcomes, AFFIRM trial  
Source: Norman JE, Heazell AEP, Rodriguez A, Weir CJ, Stock SJE, Calderwood CJ, et al. Awareness of fetal 
movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial. The 
Lancet. 2018;392(10158):1629-38. 
The My Baby’s Movements trial underway in Australia and New Zealand (detailed in Chapter 5) 
will also provide more results from a cluster-randomized controlled trial investigating effectiveness 
of an intervention to raise awareness of fetal movement, by pregnant women and their care 
providers. Chapter 5 also provides results from one of the hospitals participating in the trial as a 
case study, interrogating whether an association exists between app uptake or usage, increased 
obstetric intervention rates and associated improvement in maternal and perinatal outcome 
 Clinical practice guidelines for care of pregnant women with DFM 
Clinical practice guidelines provide a means of guiding patient education and clinical management. 
The NHMRC define clinical practice guidelines as “evidence-based statements that include 
recommendations intended to optimise patient care and assist health care practitioners to make 
decisions about appropriate health care for specific clinical circumstances. Clinical practice 
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guidelines should assist clinicians and patients in shared decision making.”147  This section 
describes the development, review and publication of Clinical practice guidelines on the care of 
women with decreased fetal movement17. Though written and published in Australia and New 
Zealand, these guidelines benefit from a global team of authors providing expertise in this field and 
drawing upon the international research literature. 
 Publication and endorsement 
The revised guideline was launched in October 2017 under the auspices of the Perinatal Society of 
Australia and New Zealand (PSANZ), and the NHMRC Centre for Research Excellence (CRE) in 
Stillbirth, with support from Mater Health Services and Stillbirth Foundation Australia, and 
endorsed by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists 
(RANZCOG); Australian College of Midwives (ACM); Stillbirth Foundation Australia; Australian 
National Council for Stillbirth and Neonatal Death Support (SANDS); Red Nose; and Still Aware. 
Additional review and support had been received from the Royal Australian College of General 
Practitioners (RACGP), New Zealand College of Midwives, PSANZ Policy Committee and 
Consumer Advisory Panel, and collaborators in the My Baby’s Movements clinical trial.  
The guidelines were published in full by PSANZ and the Stillbirth CRE17, and as a Short 
Communication in the Australian and New Zealand Journal of Obstetrics and Gynaecology 
(ANZJOG)16, to promote uptake among maternity units, obstetricians, midwives and GPs providing 
antenatal care. It is unknown how many hospitals, health systems or clinicians are using the 
guideline, or how it has influenced clinical practice or patient care, as these data are not currently 
collected. However, the published article has been downloaded extensively and ranks highly for 
attention measured by Altmetrics (top 2% of ANZJOG research outputs). Additional consumer 
resources have been developed as an adjunct to the guidelines to improve uptake, including patient 
information brochures endorsed by the International Stillbirth Alliance and available in multiple 
languages (https://sanda.psanz.com.au/resources/pregnancy/) (Appendix Q). A clinician eLearning 
module is available for enrolment at http://perinatal.matereducation.qld.edu.au. Program reports 
from 9 October 2018 showed that 1640 clinicians had accessed the elearning package. 
 Guideline aim and objectives 
This guideline targets health care professionals providing antenatal care in Australia and New 
Zealand, with the aim of improving the quality of care for women perceiving DFM, through six 
objectives: 
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▪ Provide an evidence-based approach to the management of women with DFM; 
▪ Improve consistency in the management of women with DFM; 
▪ Assist health care providers to counsel women with DFM; 
▪ Aid in the identification of women with higher-risk pregnancy  
▪ Reduce maternal anxiety about fetal activity and self-monitoring; and 
▪ Improve outcomes for women and their babies. 
Care of women with specific pregnancy conditions identified during the course of care, such as 
multiple pregnancy, fetal growth restriction, hypertension or diabetes, is beyond the scope of this 
guideline. Adoption of the guideline by clinicians and maternity hospitals could result in earlier 
identification of higher-risk pregnancies, improved perinatal health outcomes for women and their 
babies, and reduced stillbirth rates.   
 Methods 
The guidelines utilised the National Health and Medical Research Council (NHMRC) 
recommendations for the development of clinical practice guidelines148-150. A working party was 
assembled to review the literature, evidence and recommendations, and to update an existing 
guideline that had been developed in 2010 by the Australian and New Zealand Stillbirth Alliance. 
As detailed in Appendix C, a literature review was undertaken, and relevant studies were identified 
and classified according to level of evidence reported. Recommendations were prepared and graded. 
The guideline was finalised following circulation and feedback cycles with stakeholders, endorsing 
organisations and a consumer advisory panel. This updated guideline offers 12 recommendations 
and a suggested care pathway, with the aim of using an evidence-based approach to improve the 
quality of care for women reporting DFM. As this process did not involve human participants, no 
Human Research Ethics Committee (HREC) approval was required. 
 Key updates from the 2010 to the 2017 guideline 
From the original 2010 version, the guideline was updated with the following key changes: 
▪ Recommendations for fetal movement monitoring and investigations of fetal movement 
concerns remain largely unchanged. 
▪ A revised care pathway reflects updated evidence for investigation of decreased fetal 
movement and addition of clinical practice points. 
▪ Additional clinical resources highlighted, including patient information brochures and 
clinician eLearning module. 
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▪ The literature review was updated to include evidence published between May 2010 and 
July 2016. As such, 42 articles were added as key citations in this update. 
▪ Updated birth and perinatal mortality statistics for Australia and New Zealand  
▪ Evidence level and recommendation grade remained unchanged for the 13 
recommendations, alongside additional references to more recent studies.  
▪ Suggested investigations for women with DFM concerns at less than 28 weeks’ gestation, in 
the absence of sufficient evidence to inform management 
▪ A conflict of interest statement was added on behalf of the working group compiling the 
guideline, as per NHMRC recommendation. 
 
 Guideline recommendations 
The guideline offers 12 recommendations for fetal movement monitoring and clinical investigation, 
as described in Table 2-3. Evidence levels and Recommendation grades have been determined with 
guidance from the National Health and Medical Research Council (NHMRC) criteria, as detailed in 
Appendix C.  
Table 2-3. DFM Clinical practice guidelines recommendations  
Recommendations 
Evidence level & 
references  
Grade 
Recommendation 1 
a. All pregnant women should be routinely provided with verbal and 
written information regarding normal fetal movements during the 
antenatal period. This information should include a description of 
the changing patterns of movement as the fetus develops and normal 
wake/sleep cycles. 
III-3 
28,143 
C 
b. Clinicians should emphasise the importance of maternal 
awareness of fetal movements at each clinical visit. 
 √ 
Recommendation 2 
Women with a concern about decreased fetal movements should be 
advised to contact their health care provider immediately.  
III-3 
3,5,28 
C 
 
Recommendation 3 
a. Maternal concern of DFM overrides any definition of DFM based 
on numbers of fetal movements.  
III-3 
5,28,29 
√ 
b. The use of kick-charts is not currently recommended as part of 
routine antenatal care. 
I 
134 
B 
Recommendation 4 
a. When a woman reports DFM, assessment of the woman and her 
fetus should be undertaken as soon as possible. 
III-3 
28,94,143,151 
B 
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Recommendations 
Evidence level & 
references  
Grade 
b. This assessment should preferably be undertaken within 2 hours. 28 √ 
Recommendation 5 
a. Women who report DFM should be assessed for the presence of 
other risk factors associated with an increased risk of stillbirth. 
III-3 
3 
C 
 
b. Women with DFM in combination with other risk factors should 
be managed as a high-risk pregnancy. 
 √ 
Recommendation 6 
Clinical assessment of a woman with DFM should include review of 
symphysis-fundal height measurements. 
 √ 
Recommendation 7 
a. A CTG should be performed to exclude immediate fetal 
compromise. 
III-3 
28,94,152 
C 
 
b. Further evaluation is recommended for women with any 
abnormal CTG pattern. 
 √ 
Recommendation 8 
Ultrasound scan assessment for fetal biometry and amniotic fluid 
volume should be considered as part of the preliminary 
investigation of a woman reporting DFM. 
 III-3 
3,5,28,94,125,152 
B 
 
Recommendation 9 
Ultrasound scan assessment should include evaluation of fetal 
morphology if this has not already been performed. 
III-2 
28 
C 
Recommendation 10 
Where an ultrasound scan assessment for DFM is indicated, the 
timeframe to perform this investigation will be guided by the 
clinical circumstances and availability of appropriate expertise. 
 √ 
Recommendation 11 
Testing for fetal to maternal haemorrhage should be considered in 
the preliminary investigation of women with DFM. 
153 √ 
Recommendation 12 
In the presence of a normal clinical assessment (including a CTG 
and ultrasound), if maternal concern of DFM persists, specialist 
medical opinion should be sought and further management should 
be individualised. 
40 √ 
 
A revised care pathway (Figure 2-9) reflects updated evidence for investigation of DFM and clinical 
practice points (Figure 2-10). These are intended for general guidance only with the understanding 
that decision making is guided by a clinician’s expert judgement for an individual patient.   
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DFM ≥28 weeks 
Clinical history including risk 
factors for stillbirth 
Examination including  
symphyseal-fundal height (SFH) 
measurement & handheld Doppler 
Cardiotocography (CTG) 
Fetal to maternal haemorrhage 
(FMH) test  
Consider ultrasound  
If suspected fetal compromise on 
CTG, seek urgent medical review 
Kleihauer test or  
flow cytometry positive for FMH 
Yes 
No 
Abnormal ultrasound  
Seek specialist medical opinion 
and individualise management 
based on gestation and all clinical 
findings 
No fetal heart sounds detected  Ultrasound to evaluate if fetal 
death (FD) 
If FD then manage as per PSANZ 
Guidelines on Perinatal Mortality 
www.psanz.com.au 
Figure 2-9. Care pathway for women presenting with DFM from 28 weeks' gestation 
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Fetal to maternal haemorrhage  
• Perform Kleihauer test or flow cytometry test, where feasible  
• MCA Doppler assessment may be performed where expertise in 
ultrasonography is available 
Ultrasound 
• Consider ultrasound within 24 hours 
• Include fetal biometry, amniotic fluid volume, and morphology (if not 
already performed) 
• Placental and fetal Doppler assessment, as indicated 
• The timeframe to perform this investigation will depend on the clinical 
circumstances and availability of appropriate expertise 
CTG 
• Perform within 2 hours of presentation  
• Perform for at least 20 mins or until satisfactory 
• Use maternal fetal movement recorder during CTG 
Examination 
• Abdominal palpation to assess uterine tone & tenderness, fetal 
lie/presentation 
• Symphyseal-fundal height (SFH) to be measured in centimetres & 
plotted on growth chart 
• Handheld ultrasound Doppler is rec mmended, not auscultation with 
a stethoscope or Pinards 
• Record maternal pulse rate & confirm as different to fetal heart rate 
• Blood pressure and temperature 
Risk factors for stillbirth 
• Previous stillbirth 
• Fetal growth restriction and small for gestational age 
• Antepartum haemorrhage 
• Diabetes 
• Hypertension 
• Parity of 0 or >3 
• Advanced maternal age (>35 years) 
• IVF 
• Indigenous ethnicity 
• Maternal BMI >25 kg/m2 
• Smoking or illicit drug use 
• Low socioeconomic status 
Advice to pregnant women 
• Be aware of baby’s movements daily 
• Provide PSANZ patient information brochure 
(https://sanda.psanz.com.au/parent-centre/pregnancy/) 
• Women with concerns about decreased or absent fetal movements 
should be advised to contact their health care provider immediately 
• Women with concerns about decreased or absent fetal movements 
should be assessed by a health care provider immediately 
Figure 2-10. Clinical practice points for care of women with DFM 
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 Limitations 
Limited guidance exists on clinical management of pregnant women presenting with DFM, 
resulting in clinical variation and increasing the possibility of suboptimal care. This guideline was 
developed to promote clinical practice based on the best available international evidence, thereby 
improving information and guidance during the antenatal period. 
Guideline recommendations cover two key areas: 1) information for pregnant women about what 
constitutes normal fetal movements and advice about reporting DFM concerns to a health care 
provider; and 2) information for clinicians regarding management and investigation of women 
reporting DFM.  
In the absence of definitive clinical trials, the 12 key recommendations are largely based on 
consensus after careful consideration of available evidence. The working party emphasised the 
importance of rigorous research to develop and test screening tools which identify “at-risk” 
pregnancies on the basis of fetal movement. High-quality, randomised controlled trials are needed 
to determine appropriate intervention strategies for women with DFM. Trials should be adequately 
powered to examine effects on perinatal mortality and major neonatal morbidity, as well as 
maternal anxiety, health care utilisation and cost.  
The majority of women assessed for perceived DFM in their third trimester continue with 
uncomplicated pregnancies; so while maternal perception of DFM is recognised as an indicator of 
potential fetal compromise, its predictive value for adverse outcomes is low. Stillbirths preceded by 
a reported decrease in fetal activity form an important group on which to focus future research. 
 Health care-seeking behaviour of women through mobile applications 
For many women adjusting to pregnancy and preparing for motherhood, the antenatal period is 
characterised by information seeking and efforts to adopt healthy lifestyles for themselves and their 
babies154. Still, the large proportion of women expecting their first child lack previous pregnancy 
information to guide risk assessment, and adverse outcomes in these first pregnancies can be more 
difficult to predict or prevent57. Health communication methods such as face-to-face education, 
pamphlets, audio-visual training clips and mass media have been employed for decades to 
encourage healthy behaviours among pregnant women. However, women are increasingly turning 
to digital sources of information during pregnancy11, and may prefer these modalities over 
traditional, paper-based formats155. Public health programs seeking to engage women of 
childbearing age are increasingly interested in developing mobile applications to convey 
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information and impact behaviour during pregnancy, with an interest in whether these tools deliver 
significant benefits or whether there are associations with maternal anxiety or further obstetric 
interventions without benefit to mother or infant. 
 Emergence of mobile applications as part of health interventions 
Mobile phone ownership has become ubiquitous in Australia and around the world. In 2015, there 
were more than 7 billion mobile-cellular subscriptions worldwide, with close to 90 percent of the 
world’s population having access to mobile phones156. This level of ownership has opened the door 
for mobile health modalities to reach, teach, connect, motivate and empower individuals to address 
specific health concerns10. Mobile phone-based interventions represent a shift in health 
communication modalities to a dynamic, interactive environment that can include verbal, vocal and 
visual messages157. 
A mobile application is a computer 
program designed for use on a mobile 
digital device, commonly used on a 
smartphone or tablet computer158. Mobile 
applications are commonly called “apps”, 
such a popular term that the American 
Dialect Society acclaimed “app” as “word 
of the year” in 2010159. Though digital 
devices have incorporated computer 
software for user function or recreation 
for decades, the debut of 500 apps in the 
Apple App Store in 2008 signified a shift 
toward user-controlled, downloadable, 
accessible tools160. Apps are available 
through multiple avenues, but the 
majority of apps intended for public use 
are available to download from two web-
based app “stores”: Apple App store (for 
iOS products) and GooglePlay (for Android products). As of June 2015, 100 billion apps had been 
downloaded from the Apple App store. This growth is expected to continue; McKinsey Global 
Institute estimates that by 2025, the predicted economic impact for health and fitness applications 
will equal $1.6 trillion dollars per year161. 
Figure 2-11. Display of apps available on a 
smartphone. 
Source: https://pixabay.com/en/iphone-smartphone-apps-
apple-inc-410311/. Creative Commons CC0.  
LM Daly                                                     Page 41                                                                            
 
To date, most published mHealth studies, including a handful of Cochrane Reviews, have been 
relatively small-scale, analysing text messaging as the primary mode of health communication, as 
opposed to an interactive mobile application162,163. Free et al. conducted a systematic review to 
quantify the effectiveness of mobile technology-based interventions delivered to health care 
consumers for health behaviour change and management of diseases. Of the 26 interventions aimed 
at increasing healthy behaviours, most focused on text messaging. Of these, interventions for 
smoking cessation and adherence to antiretroviral therapy demonstrated effectiveness. However, 
authors concluded that high quality, adequately powered trials of optimised interventions were 
required to establish evidence of effect for other health issues and using other mobile 
technologies164. 
As one of the prominent behaviour change platforms of our decade, mobile health apps could 
potentially improve health outcomes in a myriad of ways, including helping people actively 
measure, monitor, and manage their health conditions165. Some mobile health interventions using 
apps have been specifically designed to facilitate healthy lifestyles and improve health outcomes for 
users. Mobile health interventions can include health information, motivational messages, 
monitoring and behaviour change tools, while also tailoring content by desired demographics such 
as age, health issues, known risk factors or lifestyle choices. Inherent to the design of mobile health 
interventions, economies of scale may also be achieved as large populations can be reached easily, 
consumer usage can be tracked, and materials can be updated or adapted with immediate 
transmission to users. 
 Health care-seeking behaviour and mobile health apps 
Mobile phone-based applications offer a new frontier to test theories of behaviour change, health 
promotion and health care-seeking behaviour among pregnant women. Health care-seeking is 
broadly defined as any action undertaken by individuals who perceive themselves to have a health 
problem, or to be ill, for the purpose of finding an appropriate remedy166. Two types of health care-
seeking behaviour studies have been described: the first analyses barriers to care that lie between 
patients and services, and the second investigates the process of health care seeking167.  
Reviews of mHealth globally have highlighted notable features of project implementation or 
process improvements, but the theoretical link to behaviour change or health outcomes has been 
less explicit168. In an evaluation of the U.S. perinatal health intervention Text4baby, Evans et al. 
describes four theories of behaviour change relevant to perinatal health promotion programs 
delivered through mobile applications (Table 2-4)169. 
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Table 2-4. Behaviour change theories relevant to perinatal health interventions using mobile apps 
Theory Description 
Socioecological model170 Mobile programs as a new layer of social influence beyond 
individual, interpersonal, community, institutional and systemic 
levels of influence on a person’s behaviour. 
Health belief model171 Mobile applications may serve as a cue to action and healthy 
behaviour change. 
Social cognitive theory172 Modelling healthy behaviours through mobile applications may 
promote self-efficacy and positive outcome expectations for 
behaviour adoption. 
Theory of planned 
behaviour173 
Mobile application users may change their beliefs and attitudes 
as a result of exposure at the point of decision-making. 
 
However, these theories base the determinants of health-seeking behaviour within the individual, 
when such behaviour can actually extend beyond personal factors to include complex relationships 
with community and health system factors167. Some have addressed this complexity by replacing 
the word “behaviour” with “strategy”, weighing up social, economic, practical, cultural and 
personal factors, as people engage in purposeful action in response to an illness event, rather than 
unreflecting, predetermined behavioural responses174.  
While these theories broadly influence development of mobile health apps, few evaluations of 
interventions specifically look at what aspects of behavioural theory influence outcomes169. These 
models are useful in describing the types of behavioural and cognitive changes required of users to 
reach clinical targets for improved outcomes, but they offer little information on how to design and 
implement effective, usable, technological interventions175. Further research and analysis is needed 
to determine which models might best influence maternal health care-seeking strategies when 
concerned about decreased fetal movement, and how models might be operationalised in 
developing mobile health tools for pregnant women. 
 Mobile application usage by pregnant women 
Mobile applications are an increasingly popular mode of accessing, storing and sharing health 
information among pregnant women.  In fact, there are currently over 40,000 medical apps, and 
more apps for pregnancy than any other medical topic176. Mobile apps are widely used among the 
childbearing population; 90% of Australians aged 18-34 years downloaded an app on a mobile 
phone in 2014, and adults aged 18-34 years use mobile phones to go online more than any other 
device (laptop, desktop or tablet)177. Features of mobile technologies that may make them 
LM Daly                                                     Page 43                                                                            
 
appropriate for providing individual level support to pregnant women relate to their popularity, 
mobility, technological capabilities and availability at a time most relevant to the user164. Mobile 
transmission can also be attractive for pregnant women who might be harder to reach due to remote 
geographical distance178, language or cultural affiliation179 or age. Recent studies have found that 
Australian pregnant women are seeking mobile apps to provide information, monitor fetal 
development and changes in their own bodies, and provide reassurance180. In their key findings, the 
Healthy You, Healthy Baby study in Western Australia reported that pregnant women want 
evidence-based information from trusted health professionals that are accessible online, allow self-
assessment and save personal data for ongoing tracking181.  
A study of pregnancy app usage by Lupton et al. among 410 Australian women who were pregnant, 
or had been within the past three years, found that almost three-quarters of respondents said that 
they had used a pregnancy app, with one-quarter of these using a pregnancy app daily, and one-
quarter using a pregnancy app a few times a week180. Further, the vast majority (92%) of these 
women found the apps useful. Respondents also answered questions about why they used the 
pregnancy apps. The most popular reasons cited were for information about fetal development (86% 
of respondents), information about changes in body in pregnancy (71%),  tracking information 
about bodily changes, such as weight gain or diet (33%), and tracking aspects of the baby, such as 
heartbeat (18%)180. In terms of user trust in the app developer and validity of information, 74% of 
respondents had not checked any source for content in the app, and how personal information could 
be used by app developers was seemingly not of great concern: only 9% of users were “very 
concerned”, and 19% were “somewhat concerned”182. Study authors suggest that mobile application 
usage is an integral part of the pregnancy experience for a significant proportion of Australian 
women.  
Of equal importance, policymakers and primary health care providers guiding development of these 
digital health resources also emphasise the need for “clinically-endorsed” information that GPs, 
obstetricians, midwives, child health nurses, and child care providers can confidently refer to 
women181. However, more research is required into whether disparities of access, language, or other 
factors affect app usage, health care-seeking behaviours or strategies, and related perinatal health 
outcomes. 
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 Conclusion 
This literature review has explored the relationship between decreased fetal movement, stillbirth, 
maternal characteristics. To translate this research into practice, an evidence-based clinical practice 
guideline was incorporated into this thesis research and is included in this chapter. Translating 
maternal knowledge and concern about DFM into health care-seeking behaviour remains a 
challenge. Investigation of the effectiveness of mobile apps for provision of perinatal health 
information, and their impact on maternal behaviour and associated perinatal outcomes, is 
particularly topical at the present time, as millions of pregnant women are using these resources. A 
rigorous review of evidence is warranted and timely. Health systems and maternity care facilities 
are questioning whether and how to integrate these patient support modalities to improve rates of 
perinatal mortality and morbidity. Decision-making must be guided by evidence supporting 
measured clinical improvements, cost-effectiveness and user satisfaction.  
 
  
LM Daly  Page 45                                                                            
 
Chapter 3. Systematic review: Effect of mobile app interventions on influencing 
healthy maternal behaviour and improving perinatal outcomes 
This chapter incorporates the following two 
publications:  
1. Published protocol 
Citation: Daly LM, Horey D, Middleton PF, 
Boyle FM, Flenady V. The effect of mobile 
application interventions on influencing healthy 
maternal behaviour and improving perinatal health 
outcomes: a systematic review protocol. Systematic 
Reviews. 2017;6(1):26. 
Altmetrics: Score of 2 as at 2 August 2019.  
Copyright information: As an open access article, 
copyright remains with the manuscript authors: “As 
authors of articles published in Systematic Reviews 
you are the copyright holders of your article and 
have granted to any third party, in advance and in perpetuity, the right to use, reproduce or 
disseminate your article, according to the BioMed Central license agreement.” 
(https://systematicreviewsjournal.biomedcentral.com/about). 
Author contributions and acknowledgments: Lisa Daly and Vicky Flenady conceptualised the 
review in consultation with the co-reviewers. Lisa Daly wrote the first draft of this protocol with 
substantial inputs from all authors. The Methods – Measures of Treatment Effect section of this 
protocol is based on a standard template used by Cochrane Pregnancy and Childbirth Review 
Group, with modification by review authors. No external sources of funding or support were 
provided for this review. 
Available for download (open access):  
https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-017-0424-8 
PRISMA-P checklist: Submitted for protocol publication, available in Appendix E.  
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2. Published systematic review  
Citation: Daly LM, Horey D, Middleton PF, 
Boyle FM, Flenady V. The effect of mobile 
application interventions on influencing healthy 
maternal behaviour and improving perinatal health 
outcomes: Systematic review. JMIR mHealth and 
uHealth 2018;6(8):e10012. DOI: 10.2196/10012. 
Altmetrics: Score of 12 (top 25% of all research 
outputs scored by Altmetric) as at 31 July 2019. 
Copyright information: As per the journal 
webpage with this article: “©Lisa M Daly, Dell 
Horey, Philippa F Middleton, Frances M Boyle, 
Vicki Flenady. Originally published in JMIR 
Mhealth and Uhealth (http://mhealth.jmir.org), 
09.08.2018. This is an open-access article 
distributed under the terms of the Creative 
Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work, first 
published in JMIR Mhealth and Uhealth, is properly cited. The complete bibliographic information, 
a link to the original publication on http://mhealth.jmir.org/, as well as this copyright and license 
information must be included.” The Methods – Measures of Treatment Effect section of this 
protocol is based on a standard template used by Cochrane Pregnancy and Childbirth Review 
Group, with modification by review authors. 
Author contributions and acknowledgments: Lisa Daly and Vicki Flenady conceptualised the 
review in consultation with the co-reviewers. Lisa Daly performed the literature search with a 
clinical librarian. All authors screened studies to determine inclusion. Lisa Daly and Vicki Flenady 
performed data collection, data extraction, and bias assessment. Lisa Daly wrote the manuscript, 
with review and input from all authors.  
Available for download (open access):  http://mhealth.jmir.org/2018/8/e10012/ 
PRISMA checklist: Submitted for manuscript publication, available in Appendix F.  
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 Review registration 
This systematic review was registered (CRD42016037344) with the University of York, 
International Prospective Register of Systematic Reviews (PROSPERO) database. PROSPERO is a 
repository of protocol details for systematic reviews relevant to health and social care, welfare, 
public health, education, crime, justice, and international development, where there is a health-
related outcome.  
 Background 
Adoption, practice, and maintenance of healthy behaviours during pregnancy can potentially 
improve maternal and child health. Adverse perinatal health outcomes such as emergency caesarean 
section, preterm birth, low birthweight, and stillbirth are associated with maternal risk factors that 
may be modifiable through changes in maternal behaviour54,183. During pregnancy and in 
preparation for motherhood, many women seek information and try to adopt a healthy lifestyle154. 
Pregnant women are increasingly using digital resources such as mobile applications (apps)—
computer programs designed to run on mobile devices such as mobile phones and tablet 
computers—to access information, monitor fetal development, track individual health indicators, 
and provide reassurance11,182,184-186. Collectively, pregnancy apps have been downloaded hundreds 
of millions of times and are an integral source of information for many pregnant women13. Pregnant 
women may feel heightened support for informed decision-making and a sense of control by using a 
familiar device to access, store, and share information186. 
In 2017, over 325,000 health and fitness and medical apps were available187; apps directed at 
pregnancy constitute a major genre188. These apps can include health information, motivational 
messages, monitoring, and behaviour change tools. The content of apps can be tailored by 
demographics such as gestational age, maternal age, language or risk factors. App developers may 
employ methods to engage users, such as “push communication,” including notifications designed 
to encourage users to follow a prompt (e.g., read, listen, view content or perform an activity). 
Pregnancy apps may also link to a device such as a camera, glucometer, fitness activity tracker, 
Kegel “exerciser,” fetal heartbeat “listener,” or other monitoring equipment. Some devices 
associated with an app are marketed directly to consumers and avoid regulatory scrutiny, while a 
woman’s health care provider may provide other devices as part of clinical care. 
From an institutional perspective, health systems and maternity care facilities are investigating 
whether and how to integrate digital support modalities into care and are seeking evidence to 
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support decision making. It has been hypothesized that mobile apps may improve perinatal 
outcomes by encouraging access to health information, modifying demand for services, and 
enabling provision of targeted care14. This systematic review aims to determine the effects of 
mobile app interventions during pregnancy on influencing healthy maternal behaviour and 
improving perinatal health outcomes, compared to interventions using other communication 
modalities or standard care. 
 Aim 
This review aims to assess the effects of mobile application interventions during pregnancy on 
influencing healthy maternal behaviour and improving perinatal health outcomes, compared to 
interventions using other communication modalities or standard care.  
 Methods   
 Protocol 
This systematic review protocol has been developed based on Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) guidelines for reporting systematic 
reviews evaluating health care interventions189,190.  
 Criteria for considering studies for this review 
3.4.2.1 Study design 
All randomized controlled trials (RCTs) and non-randomized studies including controlled before-
after studies, interrupted time-series studies, and prospective comparative cohort studies were 
considered for inclusion. Case-control studies and cross-sectional studies were excluded due to their 
retrospective design. Crossover trials were also excluded as they are considered most suitable for 
temporary effects and chronic conditions191. Women at any stage of pregnancy or labour were 
considered for participation. 
3.4.2.2 Interventions 
Studies assessing the effects of mobile app-based interventions designed to influence maternal 
knowledge or behaviour during pregnancy were considered for inclusion if they provided general 
information for pregnant women or focused on a specific maternal risk factor or perinatal outcome. 
There was no restriction on who sponsored the intervention or type of setting.  
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Studies were excluded if the intervention (1) did not utilize a mobile app, (2) used a mobile phone 
solely for telephone conversations or SMS (short message service) text messaging, (3) did not 
report on maternal or infant health outcomes, (4) did not target pregnant women (focus on 
clinicians, partners), and (5) focused on physical effects of mobile phone usage (such as radiation) 
during pregnancy. 
3.4.2.3 Comparators 
The following three comparisons were planned: 
1. Mobile health apps versus paper-based or SMS text messaging-based communications. 
2. Mobile health apps versus interpersonal communication modes (i.e., face-to-face or 
telephone conversation). 
3. Mobile health apps versus standard care or no specified intervention. 
3.4.2.4 Outcome measures 
The primary outcome measure was a change in maternal behaviours (as defined by trial authors), by 
intervention goals. Secondary outcomes addressed maternal and infant health outcomes, maternal 
experience with the intervention, and health service utilisation measures, as listed in Table 3-1. 
Table 3-1. Outcome measures 
Primary outcomes  
Maternal 
Change in maternal behaviours (as defined by trial authors), by intervention goals 
 
Secondary outcomes 
Maternal Infant 
▪ Major adverse maternal outcome (composite of death, 
admission to intensive care unit, or near-miss mortality as 
defined by World Health Organization) 
▪ Antepartum haemorrhage 
▪ Postpartum haemorrhage 
▪ Pre-eclampsia 
▪ Gestational diabetes mellitus (GDM) 
▪ Emergency caesarean birth 
▪ Successful initiation of breastfeeding  
▪ Maternal knowledge (about topic targeted by intervention) 
▪ Stillbirth 
▪ Neonatal death  
▪ Small for gestational age 
▪ Large for gestational age 
▪ Preterm birth, <32 
weeks’ gestation 
▪ Gestational age at birth 
▪ Caesarean section 
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Secondary outcomes 
Maternal Infant 
▪ Maternal general health (as defined by standardised 
measures such as general health questionnaires) 
▪ Maternal evaluation of the intervention (as reported by the 
trial) 
▪ Maternal psychosocial outcomes, such as satisfaction or 
anxiety (as measured by any validated, standard instrument)  
▪ Health service utilisation (antenatal care attendance, 
maternal antenatal admission, length of hospital stay of 
mother or infant)  
▪ Major neonatal 
morbidities (as defined 
by trial authors) 
 
 
 
 
 
 
 Search methods for identification of studies 
3.4.3.1 Sources 
Systematic searches were performed using seven electronic bibliographic databases: PubMed, 
Embase, The Cochrane Library, CINAHL, World Health Organization Global Health Library, 
POPLINE, and CABI Global Health. Handsearching of journals and conference proceedings from 
the reference lists of retrieved studies were also conducted. No language or date restrictions were 
applied. Abstracts and full-length articles were obtained for each citation, where available.  
3.4.3.2 Search strategy 
The specific search strategies were developed by the primary author (LD) and an experienced 
clinical research librarian, with input from all authors. Electronic searches using subject headings 
and all fields for keywords were conducted to avoid missing non-indexed concepts. Search terms 
and returns by the database and handsearching are presented in Appendix G. Articles published in 
non-peer reviewed publications were excluded, as per the review protocol. Remaining citations and 
abstracts were uploaded to the Web-based software platform Covidence192. Throughout the review 
process, authors were not blinded to journal titles, study authors or institutions. If it was unclear 
whether studies met inclusion criteria, study authors were contacted up to two times by email to 
request further information. 
LM Daly  Page 51                                                                            
 
3.4.3.3 Study selection 
Abstracts of articles retrieved through the search strategy were independently screened by 2 review 
authors to determine if inclusion and exclusion criteria were met. A third author addressed any 
concerns about inclusion. If necessary, additional information was sought from study authors to 
resolve eligibility queries. For selected studies, full-text articles were obtained and read by 2 authors 
to confirm that they met inclusion criteria.  
3.4.3.4 Bias assessment 
Studies were assessed for quality by 2 reviewers independently (LD, VF), according to the 
guidelines in the Cochrane Handbook for Systematic Reviews of Interventions193, by 6 domains: (1) 
selection bias, (2) performance bias, (3) detection bias, (4) attrition bias, (5) reporting bias, and (6) 
any other possible bias. All included studies were assessed on the risk of bias, likely magnitude, and 
potential impact on findings. 
 
 Data collection and analysis 
3.4.4.1 Data extraction and management 
Once the studies were selected, using standardized forms, 2 reviewers (LD, VF) independently 
extracted data including study objective, study design, inclusion and exclusion criteria, data sources, 
study period, methodology, sample size, intervention details and effects, and outcomes. Due to the 
complexity of the interventions found, a post-hoc decision was taken to collect data on the 
interventions based on the Template for Intervention Description and Replication (TIDieR) 
checklist194,195.  
3.4.4.2 Synthesis of results 
As described in the review protocol196, we set out to synthesize data and present measures of 
treatment effects including summary risk ratios for dichotomous outcomes and mean difference for 
continuous data and subgroup analysis. Due to the considerable heterogeneity of participant 
characteristics, intervention features, and reported outcomes, it was decided that meta-analysis 
could not be performed, and results were summarized in a narrative synthesis. 
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 Results 
 Description of studies 
3.5.1.1 Included studies 
The search strategy for this review has been consolidated into a Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis (PRISMA) diagram (Figure 3-1), summarising inclusion 
and exclusion of studies197. For database screening, one author (LD) searched the databases on 15-
16 February 2017, with a yield of 5,089 articles. After initial screening to remove duplicates and 
articles from non-peer reviewed journals, the titles and abstracts of 2,241 articles were reviewed by 
2 authors independently (among LD, VF, DH, PM, and FB). Title and abstract screening of 1,091 
additional articles identified through handsearching was performed by 2 reviewers (LD and VF); 
however, no additional studies were identified. Full-text screening of 69 articles was performed by 
2 review authors (among LD, VF, PM, and DH). At all stages, disagreements between authors were 
resolved by consultation with a third reviewer. Reasons were recorded for excluding studies 
(Appendix H). Several articles had multiple reasons for exclusion, although each was allocated to a 
single category. A total of 4 trials met the inclusion criteria. 
The characteristics of included studies are presented in Table 3-2. Though not specified as a 
requirement for inclusion, all studies that met inclusion criteria used RCT designs and involved 
pregnant women in high-income countries. Three trials were based in hospital settings, comparing 
women using mobile apps with standard antenatal care. One community-based trial gave all 
participants a device to promote physical activity; participants in the intervention arm were also 
given a mobile app. 
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Figure 3-1. PRISMA diagram summarising inclusion of studies 
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Table 3-2. Characteristics of included studies 
Study 
characteristics 
Study 
 Ainscough et 
al198  
Choi et al199 Ledford et al157 Zairina et al200 
Country Ireland United States United States Australia 
Year 2016 2016 2016 2016 
Design Randomized 
controlled trial 
Randomized 
controlled trial 
Randomized 
controlled trial 
Randomized 
controlled trial 
Aim To investigate 
the influence of a 
mobile phone 
app-supported 
antenatal healthy 
lifestyle 
intervention on 
the behavioural 
stage of change 
among 
overweight and 
obese pregnant 
women. 
To examine the 
feasibility of 
subject 
recruitment, 
randomization, 
intervention, and 
efficacy of an 
mHealth physical 
activity program 
for physically 
inactive pregnant 
women. 
To compare the 
effectiveness of a 
mobile application 
with a spiral-
notebook guide in 
prenatal care. 
To evaluate the 
efficacy of a 
telehealth program 
supported by a 
handheld 
respiratory device 
in improving 
asthma control 
during pregnancy. 
Participants 
(Risk 
category) 
204 pregnant 
women with 
body mass 
index≥25 and<40 
kg/m2a 
(Moderate) 
30 pregnant 
women with a 
sedentary lifestyle 
and intent to be 
physically active 
(Low) 
150 low-risk 
obstetrics 
participants 
following standard 
care pathway (Low) 
72 pregnant 
women with 
asthma (Moderate) 
Control group 
(n) 
Standard care: no 
consistent diet or 
lifestyle advice 
offered (98) 
Recommendations 
for gestational 
weight gain and 
safety instruction 
for promoting 
physical activity 
during pregnancy, 
and an 
accelerometer 
(Fitbit Ultra) (15) 
Standard care: a 
spiral notebook 
designed to educate 
participants about 
pregnancy and 
enable recording of 
pregnancy 
experiences (78) 
Standard care 
through a 
participant 
information 
brochure (36) 
Intervention 
group (n) 
A “healthy 
lifestyle 
package” of 
individualized 
nutrition 
counselling and 
exercise advice, 
supported by a 
mobile phone 
app. (106) 
The same 
information and an 
accelerometer as 
women in the 
control group plus 
a mobile phone 
application, a daily 
message, activity 
diary, and 
feedback graphs of 
personal data. (15) 
The standard care 
spiral notebook 
replaced with a 
mobile app with 
identical content. 
(72) 
In addition to 
standard care, 
participants were 
given a mobile app 
to record data, a 
COPD-6b to 
measure lung 
function and a 
written asthma 
action plan. (36) 
Notes: akg/m2: kilogram per square meter. bCOPD-6: A proprietary medical device intended for measuring lung 
function. 
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3.5.1.2 Bias assessment of included studies 
Objective assessments and validated data collection tools were employed in all included studies. 
Studies performed generally well regarding the risk of bias in random sequence generation; 3 
studies were low risk and one study was unclear, as it was not described. High risk of performance 
bias was shared across all studies. Due to the nature of mobile app interventions, blinding 
participants is difficult, and did not occur in any of the included studies. Blinding health care 
providers can also be difficult and occurred in only one study. Most studies had a low risk of 
attrition bias, with low rates of withdrawal, drop-out or loss to follow-up. Reporting biases were 
also low, with all studies reporting results for their respective primary outcomes. The overall risk 
assessment is presented in Table 3-3 and Table 3-4.  
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Table 3-3. Systematic review: Bias assessment 
   
  
  
  
  
  
Study Author (Year) 
  
Ainscough (2016)198 Choi (2016)199 Ledford (2016)157 Zairina (2016)200 
Bias Risk Support Risk Support Risk Support Risk Support 
Random 
sequence 
generation  
(selection bias) 
Unclear Not described. Low Computer-generated 
randomisation, stratified 
by self-reported pre-
pregnancy BMI 
category. 
Low Pre-assigned block 
randomisation (each 
block n=40). 
Low Computer-generated allocation in 
a ratio of 1:1 for intervention or 
controls, in random blocks of four 
and six. 
Allocation 
concealment  
(selection bias) 
Unclear Not described. Low Allocation concealed in 
opaque envelopes. 
Unclear Not described if those 
assigning participants 
to intervention groups 
were blinded. 
Low Allocation concealed in opaque 
envelopes.  
Blinding of 
participants and 
personnel 
(performance 
bias) 
High Participants not 
blinded to 
intervention. 
Unknown whether 
researchers 
blinded. 
High Blinding participants 
and research staff was 
not possible due to 
nature of the 
intervention. 
High Providers blinded to 
patient participation in 
study. Impossible to 
blind participants to 
intervention group. 
High Blinding participants and research 
staff was not possible due to 
nature of the intervention. 
Blinding of 
outcome 
assessors  
(detection bias) 
Unclear Not described. High Participants and 
researchers aware of 
group assignment. 
Unclear Data were analysed 
separately to data 
collection. Blinding 
not specified. 
Low Outcome assessments performed 
by research assistants masked to 
group allocation. 
Incomplete 
outcome data  
(attrition bias) 
Unclear Not described.  Low Low dropout rate in 
intervention group; 
reasons not stated. 
Low No significant group 
differences detected. 
Reasons reported for 
attrition and 
exclusions. 
Low Intervention had 3 
withdrawals/loss to follow-up 
from 3 months. Controls had 1 
withdrawal at 6-month follow-up. 
Selective 
reporting 
(reporting bias) 
Unclear Not fully described. 
Abstract reports on 
one primary 
outcome. 
Low Authors reported results 
of primary and 
secondary outcomes. 
Low Authors reported 
outcomes of 3 primary 
hypotheses. 
Low Authors reported results of 
primary and secondary outcomes. 
Other sources of 
bias 
Unclear Not described. Unclear Not described. Unclear Not described. Unclear Acknowledgements include in-
kind support from Vitalograph 
Inc, manufacturers of COPD-6. 
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Table 3-4. Systematic review: Risk assessment 
Study (publication year) Random 
sequence 
generation 
Allocation 
concealment 
Blinding of 
participants 
& personnel 
Blinding of 
outcome 
assessors 
Incomplete 
outcome 
data 
Selective 
reporting 
Other bias 
 Risk assessment 
Ainscough et al. (2016)198 Unclear Unclear High Unclear Unclear Unclear Unclear 
Choi et al. (2016)199 Low Low High High Low Low Unclear 
Ledford et al. (2016)157 Low Unclear High Unclear Low Low Unclear 
Zairina et al. (2016)200  Low Low High Low Low Low Unclear 
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 Description of participants 
Overall, 456 pregnant women participated in the four included trials, with 180 women categorized 
as low risk in two trials and 276 as moderate risk in two trials. Of these, one trial included pregnant 
women with asthma and another recruited pregnant women classified as overweight or obese. All 
trials recruited women prior to 20 weeks gestation. Table 3-5 shows the participant characteristics 
reported by each study. 
Table 3-5. Participant characteristics 
Study characteristics Study 
Ainscough        
et al198 
Choi               
et al199 
Ledford et 
al157 
Zairina et 
al200 
Participant risk category Moderate Low Low Moderate 
Total number of participants (N) 204 30 150 72 
 Control (n) 98 15 78 36 
 Intervention (n) 106 15 72 36 
Inclusion characteristic among pregnant women Body mass 
index≥25 
and<40 kg/m2 
Desire to 
increase 
physical 
activity  
Low-risk Asthma 
Group differences No No No No 
Age (years), mean (SD) —a 33.7 (2.6) 28.91 (5.03) 31.45 (4.5) 
Gestation age at recruitment (weeks), mean (SD) 15 17.2 (3.4) 10-12b 16.35 (2.9) 
Primiparous, (% N) — 56.7 — 43.1 
Marriedc, (% N) — 96.7 92.4 75 
Body mass index (kg/m2)d, mean (SD) — 27.7 (3.7) — 28.5 (5.7) 
Race/ethnicitye (% N)     
 White — 43.3 69.4 83 
 Asian — 40 5.6 8 
 Black/African-American — 6.7 9.7 — 
 Hispanic/Latina — 10 10.4 — 
 Other — — 4.7 8 
Education (% N)     
 High school graduate — 20 34 12.5 
 University graduate — 80 61.3 62.5 
Ability to communicate in English — Yes — Yes 
Notes: aDashes indicate unreported values. bStandard deviation not reported. cStudies reporting data used the term 
“married,” except the Choi et al study, with response category “married/cohabitating.” dChoi et al reported pre-
pregnancy body mass index. Zairina et al reported study baseline. eResponse categories as described by study authors.  
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 Description of interventions 
All interventions used mobile apps specifically designed for the study, rather than apps available 
through commercial “app stores.” None of the included studies reported if modification of the 
intervention occurred during the trial or described a cost-benefit analysis or compared cost of the 
app to other communication modalities. To motivate users to engage with the content, 2 studies 
developed apps utilising “push” communication strategies. These same interventions also included a 
device available through a “plug-in”199,200. Three studies allowed users to record and track personal 
data within the app and provided individualised information198-200. None of the studies reported that 
their apps included shared participant “chat” spaces. Intervention features are described using the 
TIDieR checklist194,195 presented in Table 3-6. Additional information about intervention 
characteristics—including user experience, content, patient-provider communication, functionality, 
and data tracking—was also collected by one reviewer (LD) using a customised form (Appendix I). 
Table 3-6. Intervention features by the TIDieR checklist 
Study characteristics Study 
 Ainscough et al198 Choi et al199 Ledford et al157 Zairina et al200 
Brief name (trial 
registration) 
Pears (Pregnancy, 
exercise, and 
nutrition research 
study with mobile 
phone app support 
study) 
(ICTRN29316280) 
MOTHER 
(Mobile 
Technologies to 
Help Enhancing 
Regular Physical 
Activity) Trial 
for Pregnant 
Women (NCT 
01461707) 
Mobile app as a 
prenatal 
education and 
engagement tool 
(No registration 
provided) 
MASTERY 
(Management of 
Asthma with Supportive 
Telehealth of 
Respiratory function in 
Pregnancy Telehealth to 
improve asthma control 
in pregnancy) study 
(ACTRN 
12613000800729) 
Why  Investigate the 
influence of mobile 
app-supported 
antenatal healthy 
lifestyle 
intervention on the 
behavioural stage 
of change 
Examine the 
feasibility of an 
mHealth physical 
activity program  
Compare the 
effectiveness of a 
mobile app with a 
spiral-notebook 
guide in prenatal 
care 
Evaluate the efficacy of 
a telehealth program 
supported by a 
handheld respiratory 
device in improving 
asthma control during 
pregnancy 
What (materials) Mobile app Mobile app, 
accelerometer 
Mobile app  Mobile app, COPD-6a, 
individualized written 
asthma action plan 
(WAAP)  
What (procedures) Participants 
received 
individualized 
nutrition 
counseling and 
exercise advice, 
and mobile app. 
Participants 
provided with a 
mobile app, 
accelerometer, 
and goal-setting 
session at 
baseline. Data 
Participants 
provided with a 
mobile app. 
Paper-based 
surveys 
completed at 
each prenatal 
Participants received a 
COPD-6a, mobile app, 
and individualized 
WAAPb. Data 
transmitted 
automatically to a 
server accessed by 
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Study characteristics Study 
 Ainscough et al198 Choi et al199 Ledford et al157 Zairina et al200 
Behavioural stage-
of-change score 
measured at 
baseline and late 
pregnancy  
remotely 
monitored and 
extracted  
appointment. 
App use assessed. 
Outcomes 
reported from 
health record at 
birth  
researchers, 
participants, and 
clinicians. Data 
collected at 3 and 6 
months from baseline, 
and after birth 
Who provided Not described Research staff Antenatal care 
providers, 
researchers 
Antenatal care 
providers, researchers 
How Mobile app Mobile app Mobile app Mobile app 
Where Not described. 
Study authors 
based in Dublin, 
Ireland 
Not described. 
Participants 
recruited by 
obstetricians, 
prenatal clinics, 
and communities 
(San Francisco, 
United States) 
Community 
hospital in 
women’s health 
and family 
medicine 
departments 
(Maryland, 
United States) 
Antenatal clinics of two 
large maternity 
hospitals (Melbourne, 
Australia) 
When and how much From [mean of] 15 
weeks’ gestation to 
28 weeks’ 
gestation 
From 10-20 
weeks’ gestation, 
continuing for 12 
weeks 
From 8-10 
weeks’ gestation, 
continuing 
throughout 
pregnancy 
From [mean of] 16.7 
weeks’ gestation, 
continuing throughout 
pregnancy 
Tailoring  Individualized 
nutrition and 
exercise advice 
Individualized 
prescheduled 
weekly step goals  
Not described  Individualized WAAPb 
and weekly feedback 
messages 
Modification of 
intervention during 
trial 
Not described Not described Not described Not described 
Strategies to improve 
or maintain 
intervention fidelity 
Not described Feedback offered 
on user progress, 
based on 
uploaded activity 
diaries  
Not described Feedback based on 
individualized WAAPb, 
lung function and 
asthma symptoms 
Extent of intervention 
fidelity 
Retention and 
adherence rates not 
reported  
29/30 (97%) 
participants 
retained during 
the intervention. 
Adherence by 
intervention 
group waned 
over the study 
period 
127/173 (73%) 
participants 
retained during 
the intervention. 
Change mainly 
due to 
miscarriage and 
elevation to high-
risk care 
69/72 (96%) 
participants retained 
during the intervention 
Notes: aCOPD-6: A proprietary medical device intended for measuring lung function. bWAAP: Written asthma action 
plan. cTIDieR: Template for Intervention Description and Replication. 
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 Effects of interventions 
The included trials reported different maternal and infant health outcomes such that meta-analysis 
or subgroup analysis was not possible. 
3.5.4.1 Primary outcomes  
The primary outcome of interest was a change in maternal behaviours (as defined by trial authors), 
by intervention goals. All studies reported some type of behaviour change and better results for the 
intervention group than controls for their respective primary outcomes (Table 3-7). Inventories and 
data collection tools used in the included studies are listed in Appendix J.  The Ainscough et al 
study198 concluded that a significantly higher proportion of the intervention group had transitioned 
to a “maintenance stage” of healthy lifestyle behaviours by 28 weeks’ gestation, compared to the 
control group (52.8% versus 32.7%, p=0.004). The primary outcome measure for the Choi et al 
study199 of physical activity was weekly mean steps, and intervention participants had a greater 
increase in daily steps at 12 weeks with 1096 (SD 1898) steps, compared with 259 (SD 1604) steps 
among control participants (p=0.13). The change between groups reported across the 12-week study 
period was not statistically significant (p=0.38). The Ledford et al study157 found that by 32 weeks’ 
gestation, participants using a mobile app recorded information more frequently than the control 
group, and that they had developed greater “patient activation” than the control group 
(F(1127)=4.99, p≥0.05, n2=.04, marginal mean of 79.88 versus 74.81). The Zairina et al study200 
reported that the intervention group had a higher proportion of participants with well-controlled 
asthma than the control group (82% versus 58%, p=0.03) at 6 months from baseline.  
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Table 3-7. Primary maternal outcomes: Change in maternal behaviours by intervention goals 
Study Study results 
 Primary maternal outcome Results 
Ainscough et al198 Shift in the stage-of-change 
score (transitioning from 
contemplation/preparation to 
maintenance stage of healthy 
lifestyle behaviours in 
pregnancy): Baseline to 28 
weeks 
Mean score showing a shift in stage-of-change 
score distribution observed for both groups. 
Change reported as more significant for the 
intervention group (p<0.001 versus p=0.032). 
The proportion in each group achieving 
change not reported. 
Study participants at 
Maintenance stage (stage 5). 
At 28 weeks, a higher proportion of 
intervention group at stage 5 (52.8%) 
compared with the control group (32.7%), 
(χ2=8.4, p=0.004).  
Choi et al199 Physical activity: change in 
mean steps per day. 
Intervention participants had a greater 
increase in daily steps at 12 weeks with 1096 
(SD 1898) steps, compared with 259 (SD 
1604) steps among control participants 
(p=0.13).  
Ledford et al157 Patient use of a tool to find 
information about pregnancy 
(information-seeking). 
No significant difference detected between the 
2 groups (data not provided). 
Patient use of tool to record 
information about pregnancy 
(information-recording). 
Across all time points, intervention group 
recorded more frequent use of information 
source than the control group (F(1118)=4.10, 
p≥0.05, ɳ2=.03) 
Patient activation at 32 
weeks’ gestation (use of a 
tool). 
The intervention group activation score was 
greater than controls (patient activation score 
marginal mean 79.88 versus 74.81 
(F(1127)=4.99, p≥0.05, ɳ2=.04). 
Zairina et al200 Asthma control (ACQ) 6 
months from baseline. 
Mean difference between groups was 
significant (–0.36 (SD 0.15), p=0.02). The 
intervention group had higher proportion of 
participants with well-controlled asthma than 
the control group (82% versus 58%, p=0.03).  
3.5.4.2 Secondary outcomes 
Of the 4 studies in this review, 2 studies199,200 report maternal secondary outcomes relevant to this 
review, as further detailed in Appendix K. One study of asthma control reports a clinically 
significant improvement in the asthma-related quality of life among the intervention group 
compared with usual care at 6 months from baseline, but the mean change was not statistically 
significant200. Another study of physical activity during pregnancy reported reduced barriers such as 
lack of energy, time, and willpower among the intervention group, and decreased severity of 
pregnancy symptoms199. No studies reported data on major adverse maternal outcome, maternal 
knowledge about the targeted health topic, maternal evaluation of the intervention, or successful 
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initiation of breastfeeding. Furthermore, none of the trials report statistically significant differences 
in neonatal outcomes between intervention and control groups. 
 Discussion 
 Principal findings 
Despite the broad search criteria used, this systematic review identified only 4 studies for inclusion. 
This was an unexpected outcome of the review given the expanding use of mobile applications in 
maternity care. All studies included in the review reported on the primary outcome, “change in 
maternal behaviours by intervention goals,” but the specific outcomes reported varied by 
intervention. None of the studies included in this review reported statistically significant differences 
between intervention and control groups for neonatal outcomes, mode of birth or pregnancy 
complications. As advocated through the Core Outcomes in Women’s and Newborn Health 
initiative, a standard set of perinatal outcome measures, reported alongside those appropriate to 
specific health conditions or interventions, would enhance comparability201,202. A standardised 
approach using reliable and valid methods to analyse participant usage, navigation, adherence, and 
satisfaction would also improve comparability further and inform the design of future interventions. 
Further areas for research include investigation of which intervention features yield the desired 
results, for example, to establish if it is an individualised clinical care plan or the advice supported 
by a mobile app that makes a difference. Future studies could also explore how technology can 
support individualized patient care plans, and if technology can be used for data tracking or 
streamlined reporting of symptoms to automatically prompt closer clinical scrutiny. A more in-
depth exploration of the theories of behaviour change underpinning study results could also add an 
important dimension to understand how mobile interventions influence behaviour and improved 
perinatal outcomes. 
None of the studies were designed to gauge the longitudinal benefit of mobile app interventions 
commenced during the perinatal period. This would be another important avenue to understand 
longer-term benefits, potential diminishing effects, data tracking and patient engagement 
opportunities offered by interventions commenced during pregnancy. Qualitative research or 
follow-up surveys of interventions could provide insight into users’ experiences of these 
interventions, including how such apps are used, and if they augment or affect perceptions of care. 
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Hundreds of pregnancy apps are available to the public, yet all the studies in this review developed 
their own mobile apps. Researchers may find it easier to guide content, facilitate communication, 
track data and assure user privacy with their own apps. The potential commercialisation of 
successful interventions that could generate income for research programs could also be a 
consideration. However, bespoke models are likely to require more investment in development, 
testing, maintenance, and marketing than existing apps. 
Despite creating their own apps, reviewed studies did not report extensively on their development, 
testing or architecture, or whether modifications were required, which would assist replication 
efforts. Further, none of the included studies reported an economic analysis, comparing the cost of 
the intervention with standard care or comparators. Policymakers and those guiding educational or 
clinical interventions during pregnancy would likely require such information to gauge investment 
alongside projected perinatal health benefits.  
 Strengths and limitations 
There are several important strengths and limitations in our review. To the best of our knowledge, 
this systematic review is the first to assess the effects of mobile app interventions during pregnancy 
on influencing healthy maternal behaviour and improving perinatal outcomes. This review followed 
an established methodology for the conduct of systematic reviews193,195 and used a highly sensitive 
search strategy with no language or date restrictions to identify as many relevant studies as possible. 
Two authors completed the review process and extracted data independently at all stages based on 
prespecified criteria, and a third author participated when required to achieve consensus. Included 
studies were limited to those which provided comparators between mobile applications and any 
other intervention, including standard care, so that the role of the communication modality on 
intervention effects could be analyzed. 
This review may have some methodological limitations. Findings are limited by the few studies that 
met inclusion criteria, and the small sample sizes involved in each study. Although search criteria 
and the databases searched were comprehensive, it is possible that relevant articles were missed. 
Only articles published in peer-reviewed journals were included, which may have left out some 
studies. Over 3,000 published study abstracts were assessed, and it was unexpected that only 4 
studies would meet inclusion criteria. The heterogeneity of outcome measures further hampered the 
ability to meta-analyse data as originally intended, or to explore impact. Future updates of this 
review could search additional databases and expand the inclusion criteria to enable the analyses 
originally intended by the authors.  
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 Conclusions 
As an increasing number of pregnant women use mobile apps, further research on intervention 
components, usage, and associated perinatal health outcomes should influence content, features, and 
quality of interventions. The effect of mobile app interventions on maternal knowledge, behaviour, 
and perinatal outcomes is still largely underreported, as evidenced by the few studies that met 
inclusion criteria for this review, and the minimal significant impact reported on perinatal health 
outcomes. Results of this systematic review may contribute to decision making by health systems, 
hospitals, and clinicians about the integration of mobile applications into clinical care. Emerging 
evidence from future trials should help to make firmer conclusions about the effectiveness of 
mobile app interventions during pregnancy on primary and secondary outcomes, compared to other 
communication modes.  
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 Introduction 
Maternal perception of fetal movement has long been used as an indicator of fetal wellbeing and 
vitality18, while a perceived decrease in fetal movement (DFM) has clinical significance as a 
predictor of pregnancies at risk of adverse outcomes. Studies have reported associations between 
DFM and adverse perinatal health outcomes, including low birth weight, preterm birth, umbilical 
cord complications, placental insufficiencies, emergency deliveries and stillbirth3,5,37,38,40,41,101,108. 
Pregnant women who receive information about fetal movement from their clinicians demonstrate 
improved ability to describe healthy fetal movement patterns203, reduced time from maternal 
perception of DFM to presenting at hospital9, and reduced stillbirth rates126,143. A prospective cohort 
study implementing clinical practice guidelines for management of DFM and uniform information 
to pregnant women about fetal activity reported that stillbirth rates were almost halved during the 
intervention period among those who presented with DFM (4.2% vs. 2.4%)9. Further, studies have 
shown that fetal movements do not decrease at term in normal pregnancies23,204. 
A recent systematic review of 16 studies analysing interventions to enhance maternal awareness of 
DFM found no clear evidence that interventions offered benefit or harm205. Authors presented 
indirect evidence associating interventions with improved pregnancy and birth outcomes and 
recommended that women receive information about the importance of fetal movement for fetal 
health. Most studies included in the review focused on fetal movement counting, or “kick 
counting”, a daily systematic record of the mother’s perception of her baby’s movement. A 
Cochrane review of fetal movement counting for assessment of fetal wellbeing also concluded that 
there was not sufficient evidence to influence practice134 in this area.  
Clinical practice guidelines exist in some countries to guide the education provided about fetal 
movement by midwives and other health care providers. Guidelines published by the Perinatal 
Society of Australia and New Zealand (PSANZ) and National Health and Medical Research 
Council (NHMRC) Centre for Research Excellence in Stillbirth, and endorsed by the Australian 
College of Midwives, suggest that clinicians advise pregnant women experiencing DFM to 
investigate concerns without delay; kick counting, kick charts, and counting protocols are not 
recommended16. The Royal College of Obstetricians and Gynaecologists in the UK conclude in 
their guideline on reduced fetal movements that “there is insufficient evidence to recommend 
formal fetal movement counting using specified alarm limits206.” The American College of 
Obstetricians and Gynecologists acknowledges that although several counting protocols have been 
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used, neither the optimal number of movements nor the ideal duration for counting movements has 
been defined207.  
 
 
 
 
 
 
 
 
Increasingly, women preparing for motherhood are turning to digital sources of 
information11,155,188,208 for antenatal education and to query signs and symptoms of risk and 
disease208. Over 325,000 health & fitness and medical apps were available in 2017, with an 
estimated 3.7 billion app downloads187; apps directed at pregnancy constitute a major genre188. 
Pregnant women may use apps on smartphones or tablet computers to access information, monitor 
fetal development, understand changes in their own bodies and seek reassurance for concerns176,182. 
Pregnancy apps may also link to a device such as a camera, fitness activity tracker, Kegel 
“exerciser”, fetal heartbeat “listener”, or other monitoring equipment that allow users to track and 
share their own data. However, little is known about the effect on maternal behaviour or perinatal 
health outcomes of health interventions using mobile apps209. Midwives and other clinicians 
regularly engage with pregnant women who download and access apps, but little research exists on 
app quality, content, maternal usage or optimal ways to integrate apps into routine antenatal 
education or care210.   
Pregnancy apps advise users about how to address their perceptions of decreased fetal movement. 
But the content, or evidence base, of their recommendations has not been analysed. Innovative 
mobile apps may contribute to reducing perinatal mortality and morbidity through heightening 
maternal awareness of DFM; but app impact could be influenced by accuracy of information, 
Figure 4-1. A sample of popular pregnancy apps 
Source: Screen pages of commercially-available mobile applications are used under the Fair Use 
Doctrine of the Copyright Act (U.S. Copyright Office). 
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features to guide women in monitoring fetal movement, and promotion of prompt health care-
seeking behaviour. 
 Objective 
This review explores how mobile apps inform women about DFM during pregnancy and encourage 
them to monitor fetal movement. This review did not seek to compare pregnancy apps more 
generally on overall functionality, aesthetics, user engagement or information quality about topics 
other than fetal movement.  
 Methods   
 Study design 
This study is a review and a content analysis of the most popular, publicly available pregnancy apps 
available through the largest app platform, GooglePlay. The Quality and Risk of Bias Checklist for 
Studies That Review Smartphone Applications was used to ensure adequate description of 
methods211 and is available in Appendix L. 
 Search and screening strategy 
This review included mobile apps intended for use by women during pregnancy. GooglePlay was 
used as a platform to generate the study sample, because it is the largest platform for accessing 
mobile health apps187 and provides metrics about user downloads that other platforms do not. As 
detailed in Table 4-1, for the purposes of generating a study sample, a set of inclusion and exclusion 
criteria was developed around four domains:  
(1) Accessibility, including apps available for download through GooglePlay, in English and at no 
cost to the user.  
(2) Reach of over 100,000 installations. GooglePlay data includes the number of downloads to date 
per app (within a range).  
(3) Relevance, for apps intended to provide information to pregnant women. GooglePlay was 
searched using the Medical Subject Heading “pregnan*”. 
(4) Quality, through an app having attained more than 1,000 user reviews, with 80% of those 
reviews rating the app at “4 stars” or higher.  
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Table 4-1. Eligibility criteria for study sample 
Domain Item Inclusion 
criteria 
Exclusion criteria 
Accessibility App platform Downloadable 
through 
GooglePlay 
Not available through GooglePlay 
Language English Other than English 
Cost Free Payment required to download 
Reach Installations >100,000  <100,000 
Relevance Keyword Pregnan*  
Audience Pregnant 
women 
▪ Care providers 
▪ Partners 
▪ Specific information for twin or 
multiple pregnancy 
Content Pregnancy 
information  
▪ Menstruation calendars 
▪ Fertility trackers 
▪ Pranks, jokes 
▪ Baby or parenting apps 
▪ Games, cartoons 
▪ Pregnancy nutrition only 
▪ Pregnancy due date calculator only 
▪ Pregnancy music or relaxation only 
▪ Pregnancy fitness only 
▪ Contraction timer 
▪ Shopping only 
Quality Total user reviews > 1,000 
reviews  
< 1,000 reviews 
User ratings ▪ 4 or 5 stars  
▪ 80% of 
reviewers 
rate app at ≥ 
4 stars 
≤ 3 stars 
 
The GooglePlay site was accessed once during a 24-hour period (21-22 December 2016) to 
generate the sample. The reviewers and technology used for this review were based in Australia. 
The search returned 250 app descriptions which were screened by one reviewer (LD), by the 
inclusion criteria. Information relevant to each of the four domains was entered into a spreadsheet 
and sorted to determine the study sample.  
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 Data extraction and analysis 
To enable download of identified apps, study authors created one “user identity” reflecting maternal 
characteristics at low-moderate risk of adverse perinatal outcomes: Married woman, 30 years of 
age, expecting a first child (male), pre-pregnancy BMI of 21 (“normal” range), unassisted 
conception, at 20 weeks’ gestation. Once eligible mobile apps were identified and downloaded onto 
Android tablets, two reviewers (among LD, HL and JR) independently extracted data from each app 
during a four-week period (27 Dec 2016 - 23 Jan 2017). Once complete, reviewers compared data 
collected; any differences were discussed, the app content was consulted again for accuracy or 
interpretation, and when necessary, a third reviewer (VF) was included to achieve consensus. 
The data extraction form was created using examples from other systematic reviews of mobile 
health interventions, as well as documents guiding “best practice” in development of mobile apps 
for health211-213. The form had 34 items organised into five sections: (1) Information about 
decreased fetal movement; (2) Fetal movement monitoring; (3) “Kick counting”; (4) Information 
about the app developer; (5) Privacy, security and data sharing features (Supplementary File 2). 
To collect data from text describing decreased fetal movement, data were extracted from the main 
content pages of each app, including the gestational week-by-week pages that structure most 
pregnancy apps. These pages provide information about fetal development and what the mother 
may experience at that stage of pregnancy. To identify any information that might have been 
missed, if a “search” function was available in the app, a search was also performed with the key 
word “movement”. If multiple results were returned, the first 500 results were scanned by title for 
relevance. To allow authors to identify illustrative examples for analysis, one reviewer (LD) 
exported app content about DFM to a separate document and used Nvivo 11 Pro for Windows214 to 
organise and code content. Information posted through message boards, chat spaces, videos, links to 
third-party websites, or polls was not collected.  
To evaluate the guidance and tools provided to pregnant women about monitoring their own fetal 
movement, data were collected for (1) text encouraging women to be aware of fetal movement, (2) 
functions allowing users to set reminders about being aware of fetal movement, (3) features for 
women to write or record their experiences of fetal movement, (4) in-app or plug-in devices or 
diagnostic tools, (5) information about “kick counting”, timer features or data tracking options, and 
(6) referencing to clinical practice guidelines for any information about monitoring fetal movement.  
Further, reviewers recorded whether there was any guidance provided to users about how or when 
to proceed if perceiving DFM, and potential clinical investigations that a health care professional 
LM Daly   Page 72                   
 
might perform if a woman reported DFM. Data were also collected on whether a specific number of 
movements perceived over a duration of time was described as a “threshold” for when users should 
seek further care for concerns, and how this guidance compared to clinical practice guideline 
recommendations. Finally, data were extracted on other descriptive characteristics of the apps, such 
as user ratings, downloads, and user privacy policies.  
 Results 
 Search results 
The search strategy resulted in 250 mobile app descriptions, and all were screened for inclusion 
through the app store GooglePlay. A Preferred Reporting Items for Systematic Reviews and Meta-
analyses (PRISMA) flow-diagram215 was created to summarise the inclusion and exclusion of apps 
in the study sample (Figure 4-2):  
 
Figure 4-2. PRISMA (modified) diagram of app sample 
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Characteristics of the 24 apps that met inclusion criteria are provided in Table 4-2; apps screened 
but excluded from this review are catalogued in Appendix N. Precise download numbers are not 
published, but based on the range provided, the apps in this study sample have been collectively 
downloaded through GooglePlay from 24.6 million at the minimum end of the range, to 100.5 
million times at the maximum end of the range. Pseudonyms were assigned to each app for the 
purposes of analysis and reporting. 
Table 4-2. Study sample characteristics 
# Installations 
(GooglePlay) 
App name App 
codea  
User 
review 
scoreb 
Total 
user 
reviews 
Developer 
location 
10-50 million BabyCenter My Pregnancy & Baby Today A1 0.93 371,106 U.S.A. 
5-10 million Pregnancy + B1 0.88 99,772 U.K. 
1-5 million Ovia Pregnancy Tracker C1 0.96 51,102 U.S.A. 
1-5 million BabyBump Pregnancy Pro C2 0.93 22,483 U.S.A. 
1-5 million Pregnancy Calendar C3 0.92 20,919 Unknown 
1-5 million What to Expect - Pregnancy Tracker C4 0.90 37,332 U.S.A. 
1-5 million Happy Pregnancy Ticker C5 0.87 8381 India 
1-5 million I'm Pregnant / Pregnancy App C6 0.87 21,669 Ukraine 
500,000-1 million Pregnancy Tracker D1 0.92 7795 Turkey 
500,000-1 million Sprout Pregnancy D2 0.87 15,790 U.S.A. 
500,000-1 million Pregnancy Assistant D3 0.84 5550 Poland 
500,000-1 million The Bump Pregnancy Tracker D4 0.83 7912 U.S.A. 
500,000-1 million Pregnancy week by week D5 0.82 2098 Russia 
100,000-500,000 Pregnancy Week by Week E1 0.97 9048 Unknown 
100,000-500,000 280days: Pregnancy Diary E2 0.94 6964 Japan 
100,000-500,000 Pregnancy Tracker Glow Nurture E3 0.94 14,199 U.S.A. 
100,000-500,000 Pregnancy Calculator E4 0.92 2657 Belarus 
100,000-500,000 Mom Life, Chat & Pregnancy Tracker E5 0.83 21,054 U.S.A. 
100,000-500,000 Bounty pregnancy, birth & baby E6 0.82 2373 U.K. 
100,000-500,000 First Time Pregnancy E7 0.82 3468 Australia 
100,000-500,000 Pregnancy App Expertli E8 0.82 2419 U.S.A. 
100,000-500,000 Pregly Pregnancy Ticker E9 0.81 2055 U.S.A. 
100,000-500,000 Pregnancy Week by Week E10 0.81 2029 India 
100,000-500,000 Fetal Pregnancy app E11 0.80 1324 Unknown 
Notes: Data collected during a 24-hour snapshot period, 21-22 December 2016. aApp code assigned by reviewer. bUser 
review score is derived by dividing total number of user reviews by the total number of reviews scoring above 4 stars. 
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 Information about decreased fetal movement 
All 24 mobile apps in the sample mentioned DFM, as detailed in Figure 4-3. The majority of apps 
provide information to women about changes in fetal movement that occur as the baby grows, 
offering different explanations of why perceptions of altered fetal activity may occur, such as 
changes in sleep and wake cycles, space limitations in the womb, and amniotic fluid levels. Table 
4-3 provides illustrative examples of how changes in fetal movement are described in gestational 
week-by-week content pages during weeks 32-40 of pregnancy. Some apps correctly suggest that 
fetal movements remain steady up to term and labour; others incorrectly counsel women that 
decreased vigour or frequency of fetal movements is normal and no cause for alarm.  
Table 4-3. Illustrative examples of mobile app content and DFM advice 
 Gestation week 
C
o
n
te
n
t 
32-34 35-37 38-40+ 
"Kicks are, of course, still on 
the daily schedule, but they 
are less frequent and less 
violent. At this stage, in 32nd 
week this is perfectly 
normal." (D3) 
"Given the crowded 
conditions inside your 
uterus, you may feel fewer 
of your baby's movements 
this week." (C6). 
"You may notice that your 
baby moves less due to tight 
space." (E7) 
"Your baby is sleeping like a 
baby - with regular sleep and 
wake cycles (which would 
also account for the decrease 
in movement you're likely 
feeling these days.)" (C4) 
"His/her movements will be 
reduced…Call your doctor 
immediately if he/she is 
barely kicking or have not 
moved for a while." (D1) 
"Inevitably, there is less 
fetal movement, but the 
baby does move the hands 
and feet until just before it is 
born." (E2) 
"You might not be feeling it 
move much these days and 
this is normal as it doesn't 
have ample room to move 
inside the womb now!" (C5) 
"Your baby will continue to 
grow and the amniotic fluid 
that surrounds him or her 
will actually decrease a 
bit…this might also cause 
you to notice smaller fetal 
movement." (C2) 
"It's normal for the vigour 
of your baby's activities to 
decrease somewhat during 
the last few days before 
birth. But generally, the 
number of movements 
shouldn't drop a great 
deal." (C6) 
"Despite their obviously 
increasing strength, your 
bigger-by-the-day baby will 
actually start dropping 
their rate of movement in 
the last few weeks, no 
thanks to their restricted 
womb space." (E1) 
"Your baby may be moving 
a little less now as there is 
less space to move and 
instead of whole body 
movements, you may only 
notice jabs from their foot or 
knee.” (E9) 
"He feels really tight in his 
mommy's womb and his 
movements are completely 
constrained and barely 
felt." (E5) 
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Despite evidence linking DFM to adverse perinatal outcomes such as stillbirth, preterm birth, low 
birthweight, emergency delivery and neonatal death, 17 of the 24 apps in the sample do not describe 
associations of DFM with specific adverse perinatal outcomes. Five apps provide information 
linking DFM to stillbirth. Fewer apps link DFM to preterm birth (3), low birthweight (2), 
emergency delivery (2), or neonatal death (0). 
 
 Tools to assist women with monitoring fetal movement  
Clinical practice guidelines emphasise the importance of encouraging women to be aware of fetal 
movement and lay out recommendations for fetal movement monitoring16, as presented in Table 
2-3. Only five apps in the sample cited clinical practice guidelines or other specific evidence-based 
sources in recommendations around fetal movement monitoring. None of the apps in the sample 
refer to endorsement of app content by an external, independent medical college, association or 
independent body of experts.  
 
Figure 4-3. Mobile app attributes related to fetal movement awareness and monitoring 
 
As illustrated in Figure 4-3, two-thirds of the sample offer guidance on “kick counting” for self-
assessment. One-third of apps incorporate a “kick counter” feature, and all of these allow for the 
user to track her own data within the app. Guidance about “normal” fetal movement varies across 
the sample, with the majority (42%) guiding women that “10 kicks felt over a 2-hour period” should 
be reassuring. Other apps suggest that 10 movements experienced over 12 hours (8%), or one hour 
(17%) are in the normal range (Figure 4-4). One-third of the apps in the sample do not provide any 
quantitative guidance around kick counting in terms of numbers of kicks over a duration of time.  
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Another 12% of apps in the sample have a documentation feature, such as a diary or journal, where 
a user can record experiences of fetal movement. This narrative approach may encourage women to 
consider not just the frequency of movement, but also changes to movement quality or strength. 
Three apps have options for users to set reminders for fetal movement monitoring, such that a 
“push” communication can be provided. None of the apps in the sample provided “plug-ins” or 
other devices to assist women to monitor fetal movement.  
 
In addition to “kick counting”, if concerned about DFM, users are guided to perform a number of 
actions. Within the sample, 38% of apps encourage women to stimulate fetal movement through 
consumption of food or drink, and 25% of apps encourage listening to music, even though neither 
of these methods have proven efficacy and are discouraged in clinical practice guidelines for the 
care of women with DFM16,216.  
 Discussion 
 Principal findings 
Information about fetal movement is a cornerstone of antenatal education provided by popular 
pregnancy apps. All 24 apps in this study sample provide information to users about DFM, and 
most encourage women to be aware of their fetal movement. Some apps offer descriptive language 
about fetal movement, including quality, strength, fluidity and change; however, many focus on 
“counting kicks” despite inconclusive evidence to support such recommendations. The substantial 
variability of guidance for fetal movement stimulation and monitoring may influence the behaviour 
of women with DFM concerns.  
It is unknown whether app developers formally integrate health behaviour theory into the crafting of 
app content and features. However, if a theoretical framework is applied to findings, one could 
hypothesise that some users will be misguided about how to appropriately act upon fetal movement 
concerns. The Health Belief model proposes that in order for someone to perform a recommended 
health behaviour, she must first believe that she is at risk of a serious negative health outcome217. 
Protection Motivation Theory similarly proposes that people protect themselves based on perceived 
severity of and vulnerability to a threatening event, efficacy of the recommended preventive 
behaviour, and self-efficacy to perform that behaviour218.  
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Figure 4-4. Variability of guidance on “kick counting” by mobile pregnancy apps 
Note: App code after each quotation links to app names in Table 4-2. 
Figure 1. Guidance on "kick counting" by mobile pregnancy apps, with illustrative examples 
“Movements of at least 10 times a day should continue in the same familiar 
pattern and are a reassuring sign of a healthy baby.” (E3). 
“If you record at least 10 kicks in 12 hours this is considered normal. (D2) 
“A healthy baby should have 10 movements in less than 2 hours” (D5) 
“If your baby is moving regularly and then ceases to do so for a day or 
two, you may want to contact your doctor.” (C2). 
"Pregnant moms should call their healthcare provider about Baby's 
inactivity if they notice…failure to detect 10 kicks in 2 hours multiple 
times in a given day” (C1). 
“Number of perturbations at least 10 in two hours should be considered 
as an indication of violation condition of the fetus and conduct additional 
research.” (C3) 
“If you’re worried, try counting kicks over the course of a few days; 
ideally, you should feel at least 10 within 2 hours…Don’t expect the 
same pattern every time you count. Remember, you are looking for 
significant deviations over the course of a couple of days.” (D4) 
“It is perfect if you can feel about 10 per hour. But remember that every 
child is different" (D3). 
"Baby's movements can vary from 4 to 100 every hour. Instead it's more 
about knowing what's normal for your little one...You'll probably start to 
notice a pattern and this is what you should be counting.” (E6). 
“You should be able to count 10 movements within two hours” (B1) 
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These theories of health behaviour provide a backdrop for how women might use mobile app 
content to guide their monitoring of fetal movement. All apps studied offer content about DFM, but 
within the gestation week-by-week format that structure most pregnancy apps, users will not see 
explicit information about adverse outcomes associated with DFM. This mirrors findings from a 
study conducted in the U.S. reporting that antenatal care providers rarely mentioned stillbirth as a 
possibility to pregnant women during antenatal visits219. If a pregnant woman is unaware of the 
specific association between DFM and stillbirth, preterm birth, emergency delivery or having a low-
birthweight baby, she may not perceive a serious threat to her pregnancy.  
If an app user is concerned about DFM and understands that her baby could be in danger of an 
adverse outcome, she may have self-efficacy to perform behaviours to address her concerns. But 
many apps recommend behaviours to stimulate fetal movement that are lacking in evidence, such as 
kick counting, eating, drinking, or playing loud music. Most apps recommend that women contact a 
healthcare provider if concerns abide, but if recommendations for stimulating fetal movement or 
kick counting are followed, a critical window of opportunity could be missed for prompt, 
appropriate action to avert an adverse outcome such as stillbirth. Future research on the “user 
journey” would also be highly beneficial, to understand which app content pages or tools women 
access and how they integrate information into decision-making. 
Antenatal education, whether delivered through publicly-available mobile apps or routine clinical 
care, should reflect information from evidence-based sources or updated, endorsed clinical practice 
guidelines wherever possible, to ensure accuracy and to mitigate potential harm. Midwives and 
health care providers should emphasise the importance of women contacting them directly with any 
fetal movement concerns, rather than solely relying on information within commercial apps. An 
opportunity exists for industry, clinicians and healthcare systems to collaborate on developing 
quality content presented in an engaging way through mobile apps.  
 Limitations 
This study may be limited by a number of factors. The majority of apps are accessed through two 
“app stores”; users of Android phones and tablets download apps through GooglePlay, and users of 
iOS products utilise Apple App Stores. No methods currently exist for searching all app stores 
together220. Once an app store is searched for key terms, a confidential algorithm indexes results 
and presentation order. The study sample was generated from internet connections and users 
registered in Australia. This may have affected the algorithm used by GooglePlay to generate the 
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results and presentation order of the apps, as well as content. We may also have missed some 
popular apps only presented to iOS users. 
Another possible limitation is a rapid rate of change of app content or features. Data were collected 
during a “snapshot” period in December 2016-January 2017; app rankings, reviews, and content 
may differ by the time of publication. Development of the study sample may also have been 
affected by app reviews and ratings, which may in turn be influenced by demographic factors of 
users. Mobile apps more recently launched may also be less likely to meet eligibility criteria for 
review. Some mobile apps invest in strategies, such as purchasing a set number of app downloads 
and reviews from independent vendors221, which may inflate rankings and affect algorithms in the 
app store marketplace. Developers may also tailor functionality or content of apps to specific user 
information222. Thus while the 24 apps that met inclusion criteria for this review provide useful 
data, there may be others that did not come up in the search that could have also been eligible. 
Valid methods to systematically evaluate content and quality of commercial health apps is limited 
in the academic literature, despite the explosion of apps available to the public; challenges to 
analysing content of commercial apps have been identified, including the subjectivity and discretion 
of researchers211,220,223. It is possible that app content may have been misidentified during data 
collection; this risk was limited by having two researchers use standardised forms and extract data 
independently from each app before reviewing data together to ensure consistency. This review also 
focused on cataloguing features available within the app that could be assessed with a minimum of 
reviewer discretion, to ensure reliability. 
 Conclusion 
Millions of women download and use mobile applications during pregnancy. This review assessed 
the information women receive about decreased fetal movement through publicly-available apps. 
While all apps in the sample provided information about DFM, few explicitly informed users of 
linkages to specific adverse outcomes. Guidance on fetal movement monitoring was variable, with 
most apps providing advice about stimulating fetal movement and “kick counting” parameters that 
are unsupported by clinical practice guidelines.  
The lack of cited references or content endorsement makes it challenging for users, midwives or 
other clinicians to assess app quality independently. Opportunities are ripe for partnership between 
industry, researchers and healthcare organisations to develop quality content that provides accurate 
information about healthy fetal movement and encourages users to act promptly when concerned. 
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This review may also help inform establishment of guidelines and quality frameworks for 
implementing evidence into antenatal health information. Finally, though outside the scope of this 
review, few studies evaluate impact of mobile app content or usage during pregnancy on maternal 
behaviour and health outcomes. Rigorous studies in this area would assist in understanding where 
investments by developers and healthcare organisations would yield benefits for key perinatal 
health outcomes, including reduction of stillbirth. 
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Chapter 5. My Baby’s Movements (MBM): A prospective cohort study 
 Introduction 
The risk of dying on the day of birth exceeds that of any other average day of life until the 92nd 
year224. Stillbirth remains the most common cause of infant death, accounting for 70% of all 
perinatal deaths and affecting over 2.64 million families worldwide annually2. Half of all stillbirths 
are preceded by maternal perception of decreased fetal movement (DFM)3,4. At least 40 percent of 
pregnant women become concerned about DFM during pregnancy7, and up to 15 percent of 
pregnant women in the third trimester contact their care provider due to persistent DFM9. However, 
despite such high rates of concern and clinical investigation, a recent study found that 40 percent of 
pregnant women were unable to recall receiving information from their healthcare provider about 
fetal movements8.  
Health interventions using mobile apps have been suggested as a direct, inexpensive medium to 
increase maternal awareness of fetal movement among Australian women. Mobile apps are widely 
used among Australian adults. At June 2017, 81% of Australian adults owned a smartphone, and 
79% used a mobile phone multiple times per day to access the internet; 88% of these online 
Australians used an app to communicate via either messages or voice/video calls177. Pregnant 
women may feel heightened sense of control and support for informed decision-making by using a 
familiar device to access, store, and share information186. 
The My Baby’s Movements (MBM) trial aims to reduce stillbirth rates in Australia through an 
interactive mobile app for use by pregnant women, to educate them about fetal movement and 
prompt them to act if concerns arise. As a large-scale, cluster-randomised control study across 27 
maternity facilities in Australia and New Zealand, 256,770 total births are anticipated over three 
years. In this section of the thesis, data were analysed from one hospital participating in the study, 
from the first cluster to roll out the intervention.  
 Study aims  
This study aimed to understand 1) uptake of a mobile app intended to raise awareness of healthy 
fetal movement; 2) associations between app usage and maternal demographics, knowledge, 
attitudes and behaviour; and 3) effects of app usage on perinatal health outcomes. 
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 The My Baby’s Movements trial 
This study analysed data from Gold Coast University 
Hospital and was embedded in a larger trial led by 
Mater Research Institute – The University of 
Queensland, and the NHMRC Centre for Research 
Excellence in Stillbirth, titled “My Baby’s Movements: 
a stepped wedge cluster randomised controlled trial to 
raise maternal awareness of fetal movements during 
pregnancy.”  
According to the study protocol, the trial aims to test 
the impact of a package of interventions on the 
following perinatal health outcomes: 1) stillbirth at 28 
weeks’ gestation or more, 2) neonatal morbidity, 3) 
maternal psychosocial outcomes and health service 
utilisation, 4) women’s knowledge and perception of 
fetal movements and acceptability of DFM, and 5) 
cost.  
The interventions include: 1) a mobile phone 
application and SMS program designed to increase 
maternal awareness of fetal movements and reduce 
delay in reporting of DFM; and 2) an education program for clinicians around use of MBM and the 
PSANZ clinical practice guidelines on care for women presenting with DFM.  
The trial has been conducted across 27 maternity facilities in Australia and New Zealand, and the 
facilities have been randomly assigned to eight clusters. Gold Coast University Hospital was 
amongst the hospitals in the first cluster to roll out the intervention. At the time of writing this 
thesis, the trial is ongoing and data collection should be complete by mid-2019. Objectives and 
hypotheses of the larger MBM trial are presented in Appendix P.  
 Study outcome measures and hypotheses 
 Outcome measures 
This study will analyse MBM uptake and associations with the following maternal characteristics 
and perinatal outcomes: 
Figure 5-1. MBM app Welcome page 
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Table 5-1. MBM study - Outcome measures 
Maternal characteristics Perinatal outcomes 
Primary 
Primigravidity Reported DFM concerns 
Primiparity Stillbirth rates 
Previous pregnancy loss  
Previous stillbirth  
Secondary 
Maternal ethnicity Gestational age at birth  
Maternal region of birth Labour induction rates 
Socioeconomic disadvantage Mode of birth 
Maternal age  
 
 Hypotheses 
This study proposed a primary and secondary hypothesis, comparing characteristics and outcomes 
of women who downloaded MBM in the “user” cohort with women who did not download MBM in 
the “non-user” cohort.  
Table 5-2. MBM study - Primary hypothesis  
Primary hypothesis: Uptake of the MBM mobile application is associated with maternal 
characteristics of primigravidity, primiparity, previous pregnancy loss or stillbirth. 
Maternal factor Outcome Comparison group  
Primiparous women 
Are more likely to 
download the MBM app 
than 
Multiparous women 
Primigravid women Multigravid women 
Women who have experienced 
previous pregnancy loss  
Women who have not 
experienced previous pregnancy 
loss  
Women who have experienced 
previous stillbirth 
Women who have not 
experienced previous stillbirth 
 
The secondary hypothesis of this study is that selected perinatal health outcomes of women who use 
the MBM mobile application will be better than for women who do not use MBM (Table 5-3). 
LM Daly                           Page 84                                                                            
 
Table 5-3. MBM study - Secondary hypothesis 
Secondary hypothesis: Perinatal health outcomes of women who use the MBM mobile 
application will be better than women who do not use MBM. 
Outcome Range Comparison group  
Reported DFM concerns Will be higher among 
the MBM user cohort  
Compared to women who do not 
use MBM. 
Stillbirth rates Will be lower among 
the MBM user cohort  
Compared to women who do not 
use MBM. 
Labour induction rates 
Will be the same 
Across user cohorts. 
Vaginal birth rates Across user cohorts 
Gestational age at birth Across user cohorts. 
 
Further analysis was performed within the MBM user cohort to better understand how this exposed 
group accessed the app, frequency of usage, features accessed, and associations with additional 
selected maternal demographics and outcomes. 
 Ethics approval 
Ethics approval has been granted for this study by the UQ School of Public Health, approval 
number LMD05022015. Ethics approval for the MBM study has also been received from the 
University of Queensland (approval #: 2014001655) and the Mater HREC for all Queensland sites 
(reference #: HREC/14/MHS/141). Appendix A provides the ethics approval letter from The 
University of Queensland. 
 Methodology 
 Design  
This prospective cohort study is embedded in a larger trial led by the Mater Research Institute 
– The University of Queensland, titled “My Baby’s Movements: a stepped wedge cluster 
randomised controlled trial to raise maternal awareness of fetal movements during pregnancy.”  
This study design was selected as it allowed for comparison between a group of individuals 
“exposed” to the MBM intervention, and a group of individuals who were “unexposed” to the 
intervention. This latter group were enrolled into the trial and were provided the opportunity to 
participate in the intervention but chose not to. All participants were then followed during their 
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pregnancy and birth to track usage of the MBM app and perinatal health outcomes.  For this 
thesis, data were analysed from one hospital in the first cluster to roll out the intervention, 
during its first 12 months of implementation.  
 
 Description of the intervention 
5.6.2.1 App development 
The intervention was conceptualised in 2014, with successful 
funding proposals submitted to the NHMRC and the Stillbirth 
Foundation in 2015. The study protocol was drafted to guide the 
MBM trial, and individual applications were made for ethics 
clearance for each hospital participating in the trial, including Gold 
Coast University Hospital. Content for the app was adapted from 
PSANZ Clinical Practice Guidelines on Care for Women 
Reporting Fetal Movement Concerns16 (Table 2-3). A digital 
innovation company was hired to create the app and the 
participant registration database, and the information technology 
(IT) unit of Mater Mothers’ Hospitals in Brisbane was contracted 
to manage reporting from the app server, collate app usage data 
and create a private portal for researcher access to the data. 
The app development process included a series of feedback cycles 
to ensure that the design and development of the tool progressed 
according to project scope. The research team periodically consulted all study investigators, 
representatives from each of the study sites, and various subject matter experts. A newsletter 
was also circulated regularly to update these stakeholders on the status of app development and 
to share developments. Perhaps most importantly, a series of focus groups were held to garner 
feedback from clinicians and pregnant women.  
With Aboriginal and Torres Strait Islander women experiencing higher rates of stillbirth than 
non-Indigenous Australians, study investigators recognised an opportunity to use innovative 
methods to reach Indigenous women225. An Indigenous Reference Group was convened, 
comprised of Aboriginal and Torres Strait Islander researchers, clinicians and community 
representatives with an interest in maternal health. Consultations also took place with staff 
Figure 5-2. MBM app with 
Indigenous theme 
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from the Mater Hospital Birthing in our Community initiative, clinicians attending a 
community-controlled health service workshop, and Indigenous women attending an Institute 
for Urban Indigenous Health community event. These consultations provided invaluable 
feedback that resulted in a fetal movement information pamphlet tailored to Indigenous 
women, and modifications to the MBM app such that women can choose a visual setting that 
has Indigenous artwork and slight language modifications (for example, “baby” is referred to 
as “bubba”). 
5.6.2.2 App content 
The mobile application has nine sections that users can access from the home screen (Table 5-4). 
The version of the app is provided on the “About this app” page (Version 1.6.190), and the last 
update of each page is listed at the bottom of the page. Information about fetal movement and 
recommendations for users are referenced from peer-reviewed publications such clinical practice 
guidelines16, where appropriate. 
Table 5-4. App content: Sections and subsections 
App section Subsections Format Notes 
About this 
app 
What can this app do 
for me? 
Text  
Who created this app? Text Information about content authors, affiliated 
research organisations, funders, and artists 
associated with the MBM app. 
Help/How to use this 
app 
Text Overview of content, features and 
recommendations for user navigation. 
Disclaimer Text  
Information 
about 
movements 
What is my baby 
doing in there? 
Text and 
links 
Text and links to three sub-pages with further 
text: 
▪ Type of movement 
▪ Strength of movement 
▪ Frequency of movement 
Knowing my baby’s 
movement patterns 
Text  
Activities for bonding 
with my baby 
Text and 
links 
Includes sub-pages: 
▪ The music test 
▪ My baby the bookworm 
▪ Whereabouts are you in there? 
What if I am 
concerned about my 
baby’s movements? 
Text Recommendations for what to do if concerned 
about DFM, including using the “movement 
counter” and “movement strength recorder” 
functions of the app. 
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App section Subsections Format Notes 
What happens at 
hospital? 
Text Information about diagnostic testing for DFM 
concerns. 
Suggested questions to 
ask my care providers 
Text Questions to ask a care provider (a) anytime; 
and (b) if concerned about DFM. 
Movement 
check 
Are you happy with 
your baby’s 
movements today? 
Question 
Y or N 
If No, “If you are concerned about your baby’s 
movements, please contact your care provider”. 
Also provides button for “movement recorder 
tools”. 
Movement 
counter 
Instruction for using 
the “kick counter”. 
Text “Start” button allows for user to perform kick 
counting, with a 2-hour timer pre-programmed 
and an “I felt something!” button. 
Movement 
strength 
recorder 
My baby’s strength of 
movements 
Slidebar Allows user to gauge strength of movement 
from weak to strong and submit for data 
tracking. 
My Diary  Calendar Calendar uses happy or sad face to demonstrate 
when user has said “happy” or “sad” with 
movements on a given date. Includes link 
button to Movement Check Chart. 
Settings Theme selection Drop-
down 
menu 
Allows user to change theme (artwork) 
between Community, Indigenous, Bubbles, 
Ocean or Paisley. 
Reminder time Clock 
menu 
Allows user to choose what time to receive 
movement reminders. 
Reminder frequency Drop-
down 
menu 
Allows user to choose when to receive 
reminders: daily, every second day, three times 
per week, twice per week, weekly. 
Due date Calendar Allows user to change due date. 
Record baby birth Button Allows user to record baby birth. 
Sign out Button Allows user to sign out of the app and remove 
data from phone. 
I’ve had my 
baby! 
Congratulations! Calendar Record baby birth. 
Survey  Survey 12-item survey about MBM app usage. 
 
App content was written to be understood by a diverse audience, with simple, direct language. Prior 
to app launch, text was analysed using the Flesch Reading Ease test, and received a score of 60.8, 
indicating that the text can be easily understood by readers 13 to 15 years of age. 
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 Study population 
The study population was defined as per the MBM study protocol226.  
Inclusion criteria: Women with a singleton pregnancy for whom routinely-collected perinatal 
health data is available. 
Exclusion criteria: Pregnant women with a lethal fetal congenital abnormality at 24-28 weeks' 
gestation. Women who do not have a mobile phone.  
 Study site 
This study analysed data from Gold Coast University Hospital (GCUH), a tertiary referral hospital 
and the third largest maternity hospital in Queensland, with 4,569 babies born at the hospital and 
483 born in its birthing centre in 2016, accounting for 
8.1% of total births registered in Queensland45. 
Pregnancy care services are offered at the hospital, at 
community locations or in the home, through a 
variety of channels including:  
▪ General Practitioner (GP) shared care – women 
with a low-risk pregnancy attend pregnancy 
appointments through their GP. 
▪ Eligible Privately Practicing Midwives – a 
private arrangement between a midwife in private 
practice and her/his individual patients.  
▪ Midwifery-led care –women with a low-risk 
pregnancy are cared for by midwives and with 
minimal intervention or use of drugs.  
▪ Midwifery Group Practice – women are 
allocated a midwife who is on call to attend the birth and work collaboratively with obstetricians 
to provide care in hospital and at home. 
▪ Obstetrician-led care – if the pregnancy is deemed at risk of developing complications, an 
obstetrician is identified to be the lead carer for the pregnancy and birth, including liaising with 
doctors and midwives during antenatal appointments. 
Figure 5-3. Map of Gold Coast HHS 
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Regardless of where antenatal care is provided and the health professional designated to guide that 
care, all babies are scheduled to be born at the Gold Coast University Hospital, located in 
Southport, Queensland. 
 
 Allocation of groups 
This study utilises the data generated by the MBM trial, extracting data for trial participants 
and births enrolled during the first year of the intervention period at Gold Coast University 
Hospital, one of the 27 hospitals participating in the trial. All women registered to birth at the 
hospital were automatically enrolled by the hospital study coordinator into the MBM study 
database, and were invited, by an automated text message sent to their mobile phone from 27 
weeks’ gestation, to download the MBM app. This study allocated groups such that women 
who downloaded the app were considered “users”, and women who did not download the app 
were considered “non-users”. 
 
 Procedure  
Eight weeks prior to the beginning of the intervention, study procedures were established and 
MBM was introduced to staff by the site coordinators and MBM trial investigators. In addition 
to standard care, hospitals were encouraged to adopt recommendations and the clinical care 
pathway published in the PSANZ Clinical Practice Guidelines on Care for Women Reporting 
Fetal Movement Concerns16 (Table 2-3). Staff, alongside midwifery and obstetric educators, 
were also provided access to in-service education through a free eLearning package based on 
these clinical practice guidelines (available at http://perinatal.matereducation.qld.edu.au). At 
Gold Coast University Hospital, according to reporting from the course administrator, 32 
clinicians had accessed the online education, and 15 had completed it, as of 8 October 2018. 
All women deemed eligible for the study and registered to birth at the hospital were enrolled 
onto the MBM database and assigned a unique study identification (ID) number. The study ID 
number was also placed in the woman’s hospital file, to facilitate data linkage. A text message 
was sent to her mobile phone when she reached 27 weeks’ gestation, providing a passcode and 
encouraging her to download and use the app. Maternity care staff at the hospital were 
encouraged to enquire about the use of MBM at antenatal appointments and reinforce the 
importance of being aware of fetal movement and to contact the hospital if concerned. Various 
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items were developed to encourage this awareness by clinicians and staff, including pos ters, 
brochures, stickers for files, mugs and pens (Figure 5-4). Upon the birth of the baby, women 
could deactivate the MBM app by entering the baby’s date of birth and answering brief survey 
questions about the experience of using the app. 
 
 Materials development and appropriateness 
The materials forming the foundation of the MBM trial were developed in consultation with 
site investigators and member organisations of the Australian and New Zealand Stillbirth 
Alliance (ANZSA) (now Stillbirth CRE) and the Perinatal Society of Australia and New 
Zealand (PSANZ)-Stillbirth and Neonatal Death Alliance (SANDA). A deliberative approach 
to consumer engagement, and consultation with key informants representing groups at higher 
risk of stillbirth, such as Indigenous health services and minority groups, was conducted prior 
to program launch. This process aimed to ensure appropriateness for culture, literacy, patient 
beliefs and perceptions. The app is user-controlled and provides information about fetal 
movement, how fetal movement changes as pregnancy progresses, and encouragement to 
promptly act upon any fetal movement concerns.  
  
Figure 5-4. MBM promotional materials 
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 Data collection tools  
Among the multiple data collection tools 
developed for the trial, three tools are 
analysed for this study: 
a) Routinely collected electronic perinatal 
data (RCD) provided by the hospital 
directly.  
b) Data on MBM app usage: patterns of 
use, features accessed, notifications 
requested, and frequency of use.  
c) Usage survey of MBM app users to 
evaluate satisfaction, correlations 
between usage, behaviour, and 
communication with care providers. 
Data linkage was possible through the unique study identification number assigned to each 
participant. Data collection tools and specific questions analysed for this study are presented in  
Appendix O. Due to the sample size of the larger MBM trial, seeking individual women’s 
consent to access routinely collected or clinical audit data were not feasible. However, consent 
was sought for surveys and access to Medicare data. Consent to track app usage data and 
survey responses was agreed by app users upon initial login. All participant consent was 
recorded and securely filed. This approach to attaining patient consent was approved by the 
HRECs overseeing all study sites involved in the MBM trial.  
 
  Data collection timeline 
The intervention enrolment period for this sub-study lasted 12 months, from 12 December 2016 to 
12 December 2017. During this time, all registered participants were offered the opportunity to 
participate from 27 weeks’ gestation. Routinely-collected data were obtained for the period of 12 
December 2016 to 31 March 2018, to ensure complete birth outcome data for women enrolled in 
the trial during the 12-month intervention period. Data from the Usage Survey was collected up 
until 13 July 2018, as a participant may have chosen to complete the survey and remove the app 
from her phone months after birthing.  
 
Figure 5-5. MBM data collection tools 
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   Data management 
Due to the multiple streams of data managed for this trial, from participant enrolment to tracking 
perinatal health outcomes, the data management system had several components. First, a purpose-
built online database was created to manage participant enrolment in the trial. Study site 
coordinators were able to log in, enrol or cancel participants for their site and access enrolment 
information at any time. 
MBM app usage and the Usage Survey were compiled through a purpose-built repository managed 
by the Information Technology (IT) department at Mater Health Services. Study administrators with 
permission to access this data, including this thesis author, could download reports by logging on 
with an approved ID number and password, and this author downloaded reports directly. Separately, 
routinely-collected perinatal data were submitted electronically from the data custodian at Gold 
Coast University Hospital to the MBM Data Manager at Mater Research, where it was placed into a 
password-protected Excel spreadsheet with data linkage through the unique participant Study ID 
number. This thesis author submitted a request to the MBM Data Manager at Mater Research 
specifying which data were required for this study and received a spreadsheet with the data. At all 
times, data were maintained in a secure, password-protected environment. 
   Data analysis  
The initial analysis examined baseline characteristics of all women in the two intervention groups, 
as an indication of comparability. Data analysis to determine the overall effectiveness of the 
intervention involved comparison of the data points among women using the mobile app with those 
who did not use the app. Data were analysed using IBM SPSS Statistics for Windows, Version 
22.0227. In order to describe study participants who downloaded the app, descriptive statistics, 
including mean and standard deviation (SD) (or median and interquartile range (IQR) where 
continuous variables were not normally distributed), minimum and maximum values were used for 
continuous variables, and numbers and percentages were used for categorical variables.  
To understand usage of the app, cohort analysis techniques specific to mobile app usage were 
employed to allow for “a deep dive” into groups of user behaviours. These methods are primarily 
used by app developers and companies looking to retain clients and generate revenue228 through 
mobile app usage, but they are useful techniques for this analysis. Cohort analysis is used “to 
identify behavioural patterns or trends within a predefined period of time, starting from the first user 
event and analysing the actions that follow”229. For this thesis, cohort analysis catalogues the 
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number of downloads, pages opened, user journeys and user retention over the duration of 
pregnancy, analysed by selected maternal characteristics and perinatal health outcomes.  
 Results 
 Study sample 
Gold Coast University Hospital used a “bulk enrolment” procedure to enrol all women registered to 
birth at their hospital into the trial. Participation in the actual app intervention was self-selected, in 
that all women enrolled in the database received a text message at 27 weeks’ gestation inviting them 
to download the MBM app. Some women chose to participate, and some women chose not to 
participate.  
The study sample comprises women eligible for 
enrolment, with singleton pregnancies at 27 weeks’ 
gestation or more, during the one-year study period of 
12 December 2016 to 11 December 2017. To be 
included in this sample and enable data linkage, 
routinely-collected data had to be available.  
The MBM Data Manager provided data for all births 
with routinely-collected data at GCUH for the period of 
12 December 2016 to 31 March 2018. Thus it is 
unknown whether there was loss to follow-up, as data 
were provided only for women who had given birth 
during this time period, rather than at patient 
registration. Data were filtered by inclusion criteria for 
this sub-study (Figure 5-6). 
Of the 4,315 women meeting these criteria, 660 women 
(15.3%) downloaded the app and were exposed to the 
intervention as the MBM “user” cohort. The “non-user”, 
unexposed cohort totalled 3,655 women (84.7%). 
Maternal characteristics by cohort groups are presented 
in Section 5.7.2.1 below. 
 
 
Original dataset  
N=5,215 
Plurality ≠ 1 
(excluded, n=28) 
EDC minus 13 weeks  
 ≠ 6/12/2016-12/12/2017 
(excluded, n=872) 
Study sample 
N=4,315 
Figure 5-6. Study sample determination 
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 Primary hypothesis 
The primary hypothesis of this study is that uptake of the MBM mobile application is associated 
with maternal characteristics of primigravidity, primiparity, previous pregnancy loss or previous 
stillbirth.  
5.7.2.1 App uptake by maternal characteristics 
5.7.2.1.1 Gravidity, parity, previous pregnancy loss, previous stillbirth 
As illustrated by data in Table 5-5, the intervention was embraced by women pregnant for the first 
time, expecting their first child, and those who had experienced previous pregnancy loss or previous 
stillbirth. The association between MBM app download and primigravidity and primiparity was 
particularly strong (p<0.001), with 59.4% of MBM users as primiparous, expecting a first child 
during the time of app usage, compared to 40.9% of non-users. Similarly, 42.3% of MBM users 
were pregnant for the first time, compared to 27.4% of non-users. Within the MBM user cohort, 
38.0% had experienced a previous pregnancy loss, and 1.2% had a previous stillbirth. 
Table 5-5. Maternal characteristics by cohort groups: Gravidity, parity, previous pregnancy loss 
and previous stillbirth 
Maternal characteristic Cohort group  
 
MBM users 
(N=660) 
Non-users 
(N=3655) 
Total 
(N=4315) 
p-valueb 
Primigravidity, n (%) 279 (42.3%) 1003 (27.4%) 1282 (29.7%) <0.001 
Parity, n (%) <0.001 
     0 (primiparous, expecting first child) 392 (59.4%) 1495 (40.9%) 1887 (43.7%)  
1  165 (25.0%) 1307 (35.8%) 1472 (34.1%)  
2 67 (10.2%) 514 (14.1%) 581 (13.5%)  
3 25 (3.8%) 210 (5.7%) 235 (5.4%)  
4 or more previous births 11 (1.7%) 129 (3.5%) 140 (3.2%)  
Previous pregnancy lossa, n (%) 251 (38.0%) 1485 (40.6%) 1736 (40.2%) 0.23 
Previous stillbirth, n (%) 8 (1.2%) 31 (0.8%) 39 (0.9%) 0.37 
Notes: aPrevious pregnancy loss may include previous abortions, miscarriages, or hydatidiform mole. bp-values were 
calculated using Fisher’s exact test (two-sided). 
 
5.7.2.1.2 Maternal age, ethnicity, region of birth, socioeconomic disadvantage  
In addition to the primary outcome – maternal characteristics of interest related to previous 
pregnancy and childbirth experience – cohort group data were collected and analysed by secondary 
outcomes of maternal age, ethnicity, region of birth, and socioeconomic disadvantage (Table 5-6). 
A null hypothesis that the mean maternal age at the baby’s birth would be the same across MBM 
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cohort groups was rejected through a t-test, with the mean age for MBM users at 29.6 years (± 5.4 
years), compared to 30.3 years (± 5.4 years) for non-users (p=0.002).  
Table 5-6. Maternal characteristics by cohort groups: Age, ethnicity, region of birth, SES 
 Cohort group  
Maternal characteristic 
MBM users 
(N=660) 
Non-users 
(N=3655) 
All 
(N=4315) p-valued 
Maternal age at birth (years) 0.002 
Mean* (± SD) 29.56 ± 5.39 30.28 ± 5.41 30.17 ± 5.41  
Under 20 13 (2.0%) 52 (1.4%) 65 (1.5%)  
20-24 114 (17.3%) 519 (14.2%) 633 (14.7%)  
25-29 203 (30.8%) 1072 (29.3%) 1275 (29.5%)  
30-34 206 (31.2%) 1202 (32.9%) 1408 (32.6%)  
35-39 101 (15.3%) 645 (17.6%) 746 (17.3%)  
40 and over 23 (3.5%) 165 (4.5%) 188 (4.4%)  
Maternal Indigenous ethnicitya 0.385 
Aboriginal or Torres Strait Islander 12 (1.8%) 72 (2.0%) 84 (1.9%)  
Caucasian/European 503 (76.2%) 2692 (73.7%) 3195 (74.0%)  
Other 145 (22.0%) 891 (24.4%) 1036 (24.0%)  
Maternal region of birthb 0.29 
Oceania and Antarctica 496 (75.2%) 2744 (75.1%) 3240 (75.1%)  
   Australia 420 (63.6%) 2260 (61.8%) 2680 (62.1%)  
   New Zealand 72 (10.9%) 456 (12.5%) 528 (12.2%)  
Northwest Europe 38 (5.8%) 212 (5.8%) 250 (5.8%)  
Southern & Eastern Europe 13 (2.0%) 70 (1.9%) 83 (1.9%)  
North Africa & Middle East 4 (0.6%) 29 (0.8%) 33 (0.8%)  
Southeast Asia 16 (2.4%) 108 (3.0%) 124 (2.9%)  
Northeast Asia 22 (3.3%) 207 (5.7%) 229 (5.3%)  
Southern & Central Asia 31 (4.7%) 112 (3.1%) 143 (3.3%)  
Americas 24 (3.6%) 80 (2.2%) 104 (2.4%)  
Sub-Saharan Africa 13 (2.0%) 72 (2.0%) 85 (2.0%)  
Not stated 3 (0.5%) 21 (0.6%) 24 (0.6%)  
Index of Relative Socio-economic Disadvantage (IRSD) quintilec 0.23 
Quintile 1 (most disadvantaged) 7 (1.1%) 22 (0.6%) 29 (0.7%)  
Quintile 2 89 (13.5%) 409 (11.2%) 498 (11.5%)  
Quintile 3 138 (20.9%) 821 (22.5%) 959 (22.2%)  
Quintile 4 395 (59.8%) 2254 (61.7%) 2649 (61.4%)  
Quintile 5 (least disadvantaged) 31 (4.7%) 144 (3.9%) 175 (4.1%)  
Not reported 0 (0.0%) 5 (0.1%) 5 (0.1%)  
Notes: *Mean presented in years ± standard deviation. aMaternal Indigenous ethnicity as reported by routinely collected 
data. For women reporting mixed ethnicity, if any identification as Aboriginal or Torres Strait Islander, counted as such. 
bPer Australian Bureau of Statistics, Standard Australian Classification of Countries, Major groups, 2016. cData is 
derived from the Australian Bureau of Statistics, 2016, Relative Socio-Economic Indexes for Areas (SEIFA), by 
postcode. SD=standard deviation. dp-values were calculated using t-tests for continuous measures and chi-square for 
categorical variables. 
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Uptake rates among women identifying as Aboriginal and/or Torres Strait Islander were similar to 
the overall population (14.3% compared to 15.3%, respectively), with maternal age associated with 
higher rates of app uptake among these women identifying as Indigenous.  When analysed 
alongside maternal age, the mean difference of age between Aboriginal and Torres Strait Islander 
women in the app cohort (mean age of 25.2 ± 4.57 years) compared to the non-user cohort (mean 
age of 27.6 ± 5.30 years) was 2.4 years, signifying that Indigenous women who used the app tended 
to be younger than Indigenous women who did not use the app.  
Among maternal region of birth categories, coded according to the Australian Bureau of Statistics, 
2016 Standard Australian Classification of Countries230, uptake was highest among women born in 
the Americas (23.1%) and Southern and Central Asia (21.7%). Women born in Australia (15.7%), 
Northwest Europe (15.2%), Southern and Eastern Europe (15.7%) and Sub-Saharan Africa (15.3%) 
had similar rates of uptake to the overall rate of 15.3%. Uptake was lowest among women born in 
Northeast Asia (9.6%), North Africa and the Middle East (12.1%), and Southeast Asia (12.9%). 
However, the association between maternal region of birth and uptake was not statistically 
significant (p=0.29). 
No statistically significant association was evident between MBM uptake and socioeconomic 
disadvantage (p=0.23). The majority of women using MBM (64.5%) reside in the least 
disadvantaged postcodes (quintiles 4 and 5), compared to 65.6% of non-users. 
 
5.7.2.2 App usage 
5.7.2.2.1 App usage by week of gestation and selected maternal characteristics  
It was hypothesised that app uptake would be higher among women pregnant for the first time 
(primigravid), expecting a first child (primiparous), and women with previous pregnancy loss or 
stillbirth, and the data presented in Table 5-5 demonstrates that this hypothesis was valid for 
primigravid and primiparous women. Beyond uptake of the app and aggregated usage patterns, 
usage by gestational week and maternal characteristics was also explored.  
Data were analysed to gauge whether the app was opened during each week of gestation, by each 
unique user. Users were only counted as eligible for this analysis if they were still pregnant during 
that gestational week, and they were only compared to other eligible women who were still 
pregnant. Once a woman birthed her baby, she was not counted as eligible for this analysis for 
subsequent weeks. For example, if a woman birthed in gestational week 38 but opened the app 
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during gestational week 40 to complete the survey, this final usage was not counted, as she was no 
longer pregnant. As presented in Figure 5-7, data were then further analysed by maternal 
characteristics.  
The week of gestation with the highest app usage for all users was week 27 of pregnancy, when all 
users received a text message inviting them to download the app; 63% of all users used the app 
during this week of gestation. Usage then plateaued to a range between 50-57% of eligible users 
(those who were still pregnant) using the app between 28 to 36 weeks of pregnancy. After that 
point, the trend of usage takes a downward turn, dropping off to 32% of eligible users using the app 
during gestational week 40. 
 
Figure 5-7. App usage by maternal characteristics and week of gestation 
 
Trends in app usage are not remarkably dissimilar between these groups, except for usage by the 
eight women in the MBM user cohort who had experienced a previous stillbirth. Among these 
women, usage was higher than the average, with 75% of these users opening the app during week 
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27 of pregnancy, and half of these women using the app until birth by gestational week 39, by 
which time all but one of these women had given birth, and she did not use the app further.  
5.7.2.2.2 App usage by week of gestation and reporting of DFM 
Further analysis was performed on whether the experience of DFM at any point during pregnancy 
was associated with use of the app across weeks of gestation. Due to the way DFM is recorded in 
the perinatal health record, it is unknown when during the pregnancy women reported DFM, and 
whether there was a spike in an individual woman’s usage before or after reporting such an event or 
seeking care. Among the MBM cohort, 108 (16.4%) women reported DFM to their care provider. 
Of these, 38 (35.2%) were primigravid, 52 (48.2%) were primiparous, 46 (42.6%) had experienced 
previous pregnancy loss, and 2 (0.02%) had a previous stillbirth. 
 
Figure 5-8. App usage by DFM reporting and week of gestation 
 
As shown in Figure 5-8, among women in the MBM cohort, usage was highest during the first week 
of access to the app (27 weeks’ gestation), with 62.6% of women using the app. However, of the 
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women who reported DFM at any point during pregnancy, 55.6% used the app during gestational 
week 27, compared to 63.9% of women who did not report DFM during pregnancy. From 35 
weeks’ gestation, however, among women reporting DFM, 54.6% used the app, compared to 52.7% 
among women not reporting DFM. By 40 weeks’ gestation, 36.7% of women reporting DFM used 
the app, compared to 20.5% of women not reporting DFM. For women past term at 41 weeks, 
among the 9 women in this group who had reported DFM, 42.9% used the app, compared to 60 
women in the group who had not reported DFM, of whom only 10.9% used the app.  
When analysed by week of gestation, reporting of DFM and maternal characteristics of 
primigravidity, primiparity, previous pregnancy loss and stillbirth experienced during a previous 
pregnancy, it is clear that MBM was utilised by women reporting DFM at latter stages of 
pregnancy, particularly primiparous women. This analysis represents data as a percentage of the 
total among MBM users, per user category who are eligible (have not yet birthed by 
commencement of gestational week). Usage was counted as any app usage during the week 
(frequency ≥1).  As described in Table 5-7, at gestational week 38, 55% of primiparous women who 
had reported DFM during pregnancy accessed the app at least once, compared to 40% of 
primiparous women who had not reported DFM.  
Table 5-7. App usage by week of gestation and maternal characteristics 
 
Week of gestation (% of eligible users using app) 
User category 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 
Total sample 63 57 52 50 51 53 53 55 54 53 46 42 34 32 26 14 
Primigravid 62 56 54 50 53 55 55 57 55 54 47 43 35 34 26 14 
Primiparous 63 57 52 51 53 54 55 56 55 54 46 42 36 31 26 10 
Previous preg loss 65 59 49 51 51 50 51 53 51 50 42 38 34 28 24 17 
Previous stillbirth 75 63 50 63 50 50 43 57 57 57 50 50 50 0 0 0 
Reporting DFM (Total) 
Primigravid 50 53 34 37 42 47 45 53 53 53 58 54 39 43 42 0 
Primiparous 52 52 38 44 48 54 46 52 54 54 52 55 42 41 44 0 
Previous preg loss 57 46 41 48 48 57 48 54 54 58 38 44 35 40 33 0 
Previous stillbirth 50 100 50 100 50 100 50 50 50 50 50 0 0 0 0 0 
Not reporting DFM (Total) 
Primigravid 63 56 57 52 55 56 57 57 56 54 45 41 34 32 23 14 
Primiparous 64 58 54 52 53 54 56 57 56 54 45 40 35 29 22 10 
Previous preg loss 66 61 50 52 52 48 52 53 51 49 43 36 34 27 23 17 
Previous stillbirth 83 50 50 50 50 33 40 60 60 60 50 67 50 0 0 0 
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5.7.2.2.3 App usage by page and sub-pages 
The MBM app has seven distinct sections or “lead pages” that are accessible through the app 
“dashboard”, or welcoming page. Usage of each lead page and sub-page was analysed to understand 
which pages were most popular among the user cohort. Frequency of use was calculated as per total 
number of page visits, number of unique users viewing the page, frequency of use among all app 
users, and frequency of use among only those app users who had opened the specific page or sub-
page (Table 5-8).  
Table 5-8. MBM frequency of use per app section, by unique users 
App page namea 
Total 
page 
visits 
(n)b 
Unique users 
viewing page 
Usage 
frequency 
among all 
usersc 
Usage 
frequency 
among 
users 
accessing 
paged 
 n n 
% of 
totale  
Median 
(IQR)f 
Median  
(IQR)f 
About this app 1278 423 64.1% 2 (0-3) 3 (2-4) 
What can this app do for me? 322 287 43.5% 0 (0-1) 1 (1-1) 
Who created this app? 131 118 17.9% 0 (0-0) 1 (1-1) 
Help/How to use this app 239 205 31.1% 0 (0-1) 1 (1-1) 
Disclaimer 44 43 6.5% 0 (0-0) 1 (1-1) 
Information about movements 2720 486 73.6% 3 (0-7) 5 (3-7) 
What is my baby doing in there? 1413 361 54.7% 1 (0-4) 4 (3-5) 
▪ Type of movement 383 310 47.0% 0 (0-1) 1 (1-1) 
▪ Strength of movement 281 251 38.0% 0 (0-1) 1 (1-1) 
▪ Frequency of movement 265 231 35.0% 0 (0-1) 1 (1-1) 
Knowing my baby’s movement patterns 327 253 38.3% 0 (0-1) 1 (1-1) 
Activities for bonding with my baby 1234 305 46.2% 0 (0-4) 4 (3-4) 
▪ The music test 304 262 39.7% 0 (0-1) 1 (1-1) 
▪ My baby the bookworm 254 235 35.6% 0 (0-1) 1 (1-1) 
▪ Whereabouts are you in there? 293 257 38.9% 0 (0-1) 1 (1-1) 
What if concerned about baby’s movements? 196 161 24.4% 0 (0-0) 1 (1-1) 
What happens at hospital? 328 266 40.3% 0 (0-1) 1 (1-1) 
Suggested questions to ask my care providers 191 161 24.4% 0 (0-0) 1 (1-1) 
Movement check 599 262 39.7% 0 (0-1) 2 (1-3) 
Movement counter 16675 637 96.5% 12 (3-44) 13 (3-45) 
Movement strength recorder 3218 527 79.8% 2 (1-4) 2 (1-4) 
My Diary 2754 486 73.6% 2 (0-5) 3 (1-6) 
Settings 684 335 50.8% 1 (0-2) 2 (1-3) 
Notes: aDescriptions of content for each app page is provided in Table 5-4. bTotal page visits is an aggregate of all 
“hits” to that app page, by any of the app users, N=660. cMedian is presented from calculation of all app users for 
number of times page accessed. dMedian usage is also provided only for those users who opened each page, to 
demonstrate the popularity of each page among those who used it. ePercentage calculated from the total N=660, among 
all MBM users. fInterquartile range (IQR) is presented for 25th and 75th centiles. 
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Using data presented in Table 5-8, Figure 5-9 presents the proportion of all unique users who 
opened each page and sub-page. Of the 660 women in the MBM cohort group, 423 users (64.1%) 
accessed About this app, and 486 users (73.6%) accessed Information about movements. These lead 
pages were accessed more frequently than their sub-pages, as users could only navigate from one 
sub-page to another via the lead page. Usage rates for sub-pages in these sections decreased the 
further down on screen that the sub-page was listed. Among those users opening the lead page 
“About this app”, it was opened a median of 3 times (IQR=2-4), while its 3 sub-pages were opened 
a median of 1 time (IQR=1-1 for all). Similarly, among those users opening the lead page 
“Information about movements”, it was opened a median of 5 times (IQR=3-7), its sub-pages were 
opened a median of 4 times (IQR=3-5) and further sub-pages were opened a median of 1 time 
(IQR=1-1 for all). This usage pattern demonstrates that information pages in the app were largely 
accessed once by those users who engaged with them, unless they were an “access point” to reach 
further sub-pages. 
The app section with the least usage included the “About” section, particularly the two least-visited 
pages of the app: Disclaimer with only 43 unique users (6.5%), and Who created this app? with 118 
unique users (17.9%) among the total MBM user sample. About half of all users accessed 
information about What is my baby doing in there? (55% of all users) and Activities for bonding 
with baby (46% of all users), but far fewer accessed information about What if I am concerned 
about baby’s movements or Suggested questions to ask my care providers (each accessed by 24% of 
all users).  
However, a deviation from this pattern occurred for app pages that offered an interactive feature, 
and these feature pages had the highest proportion of user access and frequency. The Movement 
“kick” counter received the highest frequency of usage, with 637 users (96.5%) accessing the page 
and median access of 13 times (IQR=3-45) per user. Usage of this feature is explored further in 
Section 5.7.2.2.4. The next most popular page accessed was the Movement strength recorder, which 
allowed users to move a slider bar to record the strength of a baby’s movements. Among all users, 
79.8% of users viewed this page at least once, with median access of 2 episodes of use (IQR=1-4). 
Data were saved into the Diary, which was accessed by 73.6% of users, a median of 2 times 
(IQR=0-5). 
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Notes: The seven main app sections are presented in bold colours. Their corresponding sub-sections are presented 
beneath them in related muted tones. 
Figure 5-9. Unique MBM users and app pages accessed 
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5.7.2.2.4 Movement “kick” counter usage 
Of the 660 MBM app users, 637 (96.5%) women opened the movement “kick” counter, a 
cumulative total of 16,675 times. However, not all app users who opened the kick counter page 
actually used the feature. For the analysis presented in this section, criteria were developed to count 
as a “user” only those women who interacted with this feature, rather than women who just opened 
and closed the page without any use. Thus a “kick counter user” is defined as someone who:  
▪ opened the kick counter and recorded ≥1 movements in a session, OR 
▪ opened the kick counter, did not record any movements, but marked a positive or negative 
response for “happy with movements today” after use. 
After excluding user events that did not meet the criteria above, analysis was performed on 1,727 
user events, among 320 kick counter users. Observed values are shown in Table 5-9.  
Table 5-9. Kick counter usage and maternal characteristics  
Maternal characteristic Cohort   
 
Kick counter used 
(N=320) 
Kick counter not used 
(N=340) 
Total 
(N=660) p-valuea 
Gravidity 0.01 
Primigravida 152 (47.5%) 127 (37.3%) 279 (42%)  
Multigravida 168 (52.5%) 213 (62.7%) 381 (58%)  
Parity 0.07 
Primiparous 202 (63.1%) 190 (55.9%) 392 (59%)  
Multiparous 118 (36.9%) 150 (44.1%) 268 (41%)  
Previous pregnancy loss 0.07 
Previous loss 110 (44.0%) 141 (41.5%) 251 (38%)  
No previous loss 210 (34.4%) 199 (58.5%) 409 (62%)  
Previous stillbirth 0.73 
Previous stillbirth 3 (0.9%) 5 (1.5%) 8 (0.9%)  
No previous stillbirth 317 (99.1%) 335 (98.5%) 652 (98.8%)  
Note: ap-values were calculated using Fisher’s exact test, two-sided. 
Fisher’s exact test was performed to examine the association between these maternal characteristics 
and kick counter usage. A significant association was observed between kick counter usage and 
primigravidity (p=0.01), but not observed for primiparity (p=0.07), previous pregnancy loss 
(p=0.07), or previous stillbirth (p=0.73). The kick counter was used a median of 2 times per user 
(IQR=2-2). Similar to the primary hypothesis, it was hypothesised that an association exists 
between kick counter usage and selected maternal characteristics.  
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 Secondary hypothesis 
The secondary hypothesis of this study is that selected perinatal health outcomes of women who use 
the MBM mobile application will be better than for women who do not use MBM.  
Data presented in Table 5-10 demonstrate few statistically significant associations between 
perinatal health outcome and MBM user cohort group. The primary outcome of reported DFM was 
not significantly associated with whether or not the woman was in the MBM user group (p=0.17), 
with 16.4% of all MBM users, and 14.3% of non-users, reporting DFM to care providers. Data 
related to this outcome is further explored in Section 5.7.3.1. Similarly, the primary outcome of 
stillbirth rates did not show an association (p=0.68) with participation in the MBM user group.  
Table 5-10. Perinatal health outcomes by MBM user cohort 
 Cohort group  
Perinatal health outcome 
MBM users 
(N=660) 
Non-users 
(N=3655) 
Total 
(N=4315) p-valuea 
Decreased fetal movement  
DFM reported in health 
record 108 (16.4%) 522 (14.3%) 630 (14.6%) 
0.17 
Induction of labour  
Induced labour 246 (37.3%) 1348 (36.9%) 1594 (36.9%) 0.86 
DFM cited as reason for 
induction 43 (6.5%) 212 (5.8%) 255 (5.9%) 
0.47 
Mode of birth 0.42 
Vaginalb 489 (74.1%) 2651 (72.6%) 3140 (72.8%)  
Caesarean section 171 (25.9%) 1004 (27.5%) 1175 (27.2%)  
Gestational age at birth (weeks)  
Median (IQR) 39 (2) 39 (2) 39 (2) 0.57 
28-31 0 (0.0%) 11 (0.3%) 11 (0.3%)  
32-34 14 (2.1%) 47 (1.3%) 61 (1.4%)  
35-36 21 (3.2%) 111 (3.0%) 132 (3.1%)  
37-38 151 (22.9%) 793 (21.7%) 944 (21.9%)  
39-40 336 (50.9%) 2041 (55.8%) 2377 (55.1%)  
41-42 138 (20.9%) 652 (17.8%) 790 (18.3 %)  
Preterm birth  
Birth <37 weeks (preterm) 35 (5.3%) 169 (4.6%) 204 (4.7%) 0.43 
Preterm births reporting 
DFM 
6 (0.9%) 17 (0.5%) 23 (0.5%) 
0.24 
Birthweight (grams)  
Median (IQR) 3420 (621) 3433 (625) 3430 (628) 0.17 
Less than 1,500 1 (0.2%) 11 (0.3%) 12 (0.3%)  
1,500-1,999 7 (1.1%) 27 (0.7%) 34 (0.8%)  
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 Cohort group  
Perinatal health outcome 
MBM users 
(N=660) 
Non-users 
(N=3655) 
Total 
(N=4315) p-valuea 
2,000-2,499 16 (2.4%) 111 (3.0%) 127 (2.9%)  
2,500-2,999 99 (15.0%) 499 (13.7%) 598 (13.9%)  
3,000-3,499 306 (46.4%) 1355 (37.1%) 1661 (38.5%)  
3,500-3,999 209 (31.7%) 1198 (32.8%) 1407 (32.6%)  
4,000-4,499 60 (9.1%) 359 (9.8%) 419 (9.7%)  
4,500 or more 7 (1.1%) 48 (1.3%) 55 (1.3%)  
Infant nursery admission 0.03 
Infant admitted to care 
nursery 
134 (20.3%) 617 (16.9%) 751 (17.4%) 
 
Birth outcome 0.68 
Livebirth 658 (99.7%) 3645 (99.7%) 4304 (99.7%)  
Stillbirth 2 (0.30%) 9 (0.25%) 11 (0.3%)  
Neonatal death 0 (0.0%) 0 (0.0%) 0 (0.0%)  
Notes: ap-values were calculated using Fisher’s exact test (two-sided) for categorical variables, or the Independent 
Samples Mann-Whitney U Test for continuous variables. SD=standard deviation. bVaginal birth includes non-
instrumental and instrumental birth (forceps or vacuum). 
 
Secondary outcomes such as induction of labour (p=0.86), mode of birth (p=0.42) and gestational 
age at birth (p=0.57) also did not demonstrate a statistically significant association with DFM 
reporting. Of the outcomes measured, there was a significant association observed between MBM 
user cohort group and baby admission to a care nursery (p=0.03). While reasons for baby admission 
to care nursery were not detailed in the dataset provided, there was a slightly greater proportion of 
MBM users with preterm birth (5.3%) compared to non-users (4.6%), though this association was 
not statistically significant (p=0.43). Overall, 195 (95.6%) of the 204 infants born preterm were 
transferred to the care nursery and among the 9 infants born preterm who were not admitted to the 
care nursery, 5 infants (55.6%) were stillborn. 
 
5.7.3.1 Birth outcome: Reported decreased fetal movement  
5.7.3.1.1 Reported DFM and maternal characteristics 
One of the primary objectives of the larger MBM trial is “to assess the effects of MBM on reporting 
DFM, stillbirth, and other important pregnancy outcomes using routinely collected perinatal data.” 
As presented in Table 5-11, there was no significant association observed between whether a 
woman had downloaded MBM and reporting of DFM (p=0.17). 
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Table 5-11. MBM cohort, maternal characteristics and reported DFM 
 Cohort group  
Maternal characteristic DFM 
reported 
(N=630) 
No DFM 
reported 
(N=3685) 
Total 
(N=4315) 
p-valuea 
MBM cohort    0.17 
MBM user 108 (17.1%) 552 (15.0%) 660 (15.3%)  
Non-user 522 (82.9%) 3133 (85.0%) 3655 (84.7%)  
Gravidity 0.89 
Primigravid 189 (30.0%) 1093 (29.7%) 1282 (29.7%)  
Multigravid 441 (70.0%) 2592 (70.3%) 3033 (70.3%)  
Parity 0.70 
Primiparous 280 (44.4%) 1607 (43.6%) 1887 (43.7%)  
Multiparous 350 (55.6%) 2078 (56.4%) 2428 (56.3%)  
Previous pregnancy loss 0.01 
Previous loss 282 (44.8%) 1454 (39.5%) 1736 (40.2%)  
No previous loss 348 (55.2%) 2231 (60.5%) 2579 (59.8%)  
Previous stillbirth 0.99 
Previous stillbirth 5 (0.8%) 34 (0.9%) 39 (0.9%)  
No previous stillbirth 625 (99.2%) 3651 (99.1%) 4276 (99.1%)  
Notes: ap-values were calculated using Fisher’s exact test (two-sided). 
Nor was a significant association observed for either cohort between reporting of DFM and 
gravidity, parity, or previous stillbirth. A significant association was found between reporting of 
DFM and previous pregnancy loss (p=0.01), with 44.8% of women reporting DFM having 
experienced a previous pregnancy loss, compared to 39.5% of women who did not report DFM.  
5.7.3.1.2 Reported DFM and app pages accessed  
With reporting of DFM a primary outcome of this study, analysis was performed on the number of 
unique users accessing each page and feature of the app and refined to look at usage by MBM users 
reporting DFM. As demonstrated by data presented in sections 5.7.2.2.3 and 5.7.2.2.4 and Table 
5-12, among the 660 women who downloaded the MBM app, interactive features to track fetal 
movement were the most popular, with 96.4% unique users accessing the Movement “kick” 
counter, 79.7% accessing the Movement strength recorder, and 73.5% accessing the Diary. A 
further 73.5% of unique users accessed the Information about movements page. However, the 
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further along information was presented within sub-pages of the app, the fewer unique users who 
accessed the information. 
Table 5-12. DFM reporting among MBM user cohort, by app pages accessed by unique users 
 Unique users DFM reported 
App page 
Total 
(n) 
% 
among 
all app 
users 
(N=660) 
DFM 
reported 
(N=108) 
% 
among 
all app 
users 
(N=660) 
% among 
unique 
users 
accessing 
page 
% 
among 
users 
reporting 
DFM 
(N=108) 
About this app 422 63.9% 64 9.7% 15.2% 59.3% 
What can this app do for me? 286 43.3% 42 6.4% 14.7% 38.9% 
Who created this app? 117 17.7% 14 2.1% 12.0% 13.0% 
Help/How to use this app 204 30.9% 24 3.6% 11.8% 22.2% 
Disclaimer 42 6.4% 5 0.8% 11.9% 4.6% 
Information about movements 485 73.5% 77 11.7% 15.9% 71.3% 
What is my baby doing in 
there? 
360 54.5% 56 8.5% 15.6% 51.9% 
Type of movement 309 46.8% 47 7.1% 15.2% 43.5% 
Strength of movement 250 37.9% 34 5.2% 13.6% 31.5% 
Frequency of movement 230 34.8% 34 5.2% 14.8% 31.5% 
Knowing my baby’s movement 
patterns 
252 38.2% 38 5.8% 15.1% 35.2% 
Activities for bonding with my 
baby 
304 46.1% 42 6.4% 13.8% 38.9% 
The music test 261 39.5% 35 5.3% 13.4% 32.4% 
My baby the bookworm 234 35.5% 32 4.8% 13.7% 29.6% 
Whereabouts are you in 
there? 
256 38.8% 33 5.0% 12.9% 30.6% 
Concerned about baby’s 
movements? 
160 24.2% 23 3.5% 14.4% 21.3% 
What happens at hospital? 265 40.2% 44 6.7% 16.6% 40.7% 
Suggested questions for care 
providers 
160 24.2% 26 3.9% 16.3% 24.1% 
Movement check 261 39.5% 41 6.2% 15.7% 38.0% 
Movement counter 636 96.4% 103 15.6% 16.2% 95.4% 
Movement strength recorder 526 79.7% 81 12.3% 15.4% 75.0% 
My Diary 485 73.5% 80 12.1% 16.5% 74.1% 
Settings 334 50.6% 61 9.2% 18.3% 56.5% 
 
App usage was further analysed by whether there was an association between ever accessing a page 
and reporting of DFM, using a chi-square test. Two sub-pages were associated with reporting of 
DFM when analysed by ever having been opened.   
▪ About – Who created this app? This sub-page was accessed by 17.7% of all app users, 
including 14 (13.0%) of women who reported DFM, and 103 (18.7%) of women who did not 
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report DFM. While there was a significant association between ever accessing the page and 
reporting of DFM (p=0.05), distribution of number of times the user opened this sub-page was 
not statistically significant (p=0.17). 
▪ Information – concerned about baby’s movements? This sub-page was accessed by 24.2% of 
all app users, including 23 (21.3%) of women who reported DFM, and 137 (24.8%) of women 
who did not report DFM. There was a statistically significant association between DFM 
reporting and number of times users accessed this page, with women reporting DFM less 
likely to open the page (p=0.02). 
Despite popularity among all MBM users, and potential as interactive features to help women 
consider changes in their fetal movement, there was no association observed between DFM 
reporting and access of the movement kick counter (p=0.68) or movement strength recorder 
(p=0.94).  
Among women using the MBM app, hypothesis testing was also performed to understand whether 
there was an association between frequency of accessing app pages and reporting of DFM. Using 
the Mann-Whitney Independent Samples test, this hypothesis was rejected for most of the pages 
assessed in this analysis, including the sub-pages above, with no statistically significant association 
observed. However, there were two notable exceptions: 
▪ Information – whereabouts are you in there? This sub-page was opened by 38.8% of all app 
users, including 33 (30.6%) of women who reported DFM, and 223 (40.4%) of women who 
did not report DFM. There was a statistically significant association between DFM reporting 
and number of times users accessed this page, with women reporting DFM less likely to open 
the page (p=0.05). 
▪ About – Help / How to use this app. This sub-page was opened by 30.9% of all app users, 
including 24 (22.2%) of women who reported DFM, and 180 (32.6%) of women who did not 
report DFM. There was a statistically significant association between DFM reporting and 
number of times users accessed this page, with women reporting DFM less likely to open the 
page (p=0.04). 
In conclusion, the study’s secondary hypothesis asserted that a higher proportion of MBM users 
would report DFM concerns compared to non-users, but this association was not found to be 
statistically significant. Among MBM users, analysis of DFM reporting associated with specific app 
page and sub-page use demonstrated few significant associations, and in all cases the proportion of 
non-users accessing the sub-page was higher than the MBM user group. Most notably, there was no 
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statistically significant association observed between DFM reporting and movement kick counter or 
strength recorder use. 
5.7.3.1.3 Reported DFM and other perinatal health outcomes 
Associations were observed between reporting of DFM and induction of labour (p<0.000), as 
presented in Table 5-13. Within the whole cohort of women, among the 630 women reporting DFM 
at some point during pregnancy, 381 women were induced (60.5%), compared to induction 
performed for 1213 (32.9%) of women who had no documented reporting of DFM.  
Table 5-13. Perinatal health outcomes and reported DFM 
Perinatal health outcome 
No DFM 
reported 
(N=3685) 
DFM 
reported 
(N=630) 
Total 
(N=4315) p-valuea 
Induction of labour <0.000 
Labour induced 1213 (32.9%) 381 (60.5%) 1594 (36.9%)  
Mode of birth 0.11 
Vaginal 2663 (72.3%) 477 (75.7%) 3140 (72.8%)  
Caesarean section 1022 (27.7%) 153 (24.3%) 1175 (27.2%)  
Gestational age at birth (weeks)  
Gestational age at birth 39 (2) 39 (2) 39 (2) 0.81 
Preterm birth (<37 weeks) 181 (4.9%) 23 (3.7%) 204 (4.7%) 0.19 
Birthweight (grams) 0.69 
Birthweight 3434 (630) 3419 (606) 3430 (628)  
Infant nursery admission    0.73 
Infant admitted to care 
nursery 
646 (17.5%) 105 (16.7%) 751 (17.4%)  
Birth outcome 0.21 
Livebirth 3677 (99.8%) 627 (99.5%) 4304 (99.8%)  
Stillbirth 8 (0.2%) 3 (0.5%) 11 (0.2%)  
Notes: Data presented include number and percentage of total or median with interquartile range (IQR). ap-values were 
calculated using Fisher’s exact test (two-sided) for categorical variables, or the Independent Samples Mann-Whitney U 
Test for continuous variables. 
However, MBM uptake seemed to have no significant association with labour induction (p=0.86) or 
labour induction with DFM cited as a reason in the perinatal health record (p=0.47). Among 246 
women who used MBM whose labour was induced, 61 women (24.8%) reported DFM. However, 
this was comparable to the proportion for women who did not use MBM, among whom 1348 
women were induced, and of these, 320 (23.7%) reported DFM. No significant associations were 
LM Daly                           Page 110                                                                            
 
observed between reporting of DFM and other perinatal health outcomes analysed, including mode 
of birth, gestational age at birth, preterm birth, birthweight, infant nursery admission or birth 
outcome. 
5.7.3.2 Birth outcome: Gestational age at birth 
Affiliation with the MBM user group or non-user group was not significantly associated with 
gestational age at birth, with a similar distribution across both cohorts (p=0.57) as calculated 
through an independent samples Mann-Whitney U test. The median gestational age at birth was 39 
weeks (IQR=2) for both MBM users and non-users reporting DFM.  
Table 5-14. Maternal characteristics, MBM cohort group and gestational age at birth 
 
Gestational age at birth (weeks) 
Maternal characteristic MBM user 
(N=660) 
Non-user 
(N=3655) 
Total 
(N=4315) 
 n Median 
(IQR) 
n Median 
(IQR) 
n Median 
(IQR) 
DFM during pregnancy 
DFM reported 108 39 (2) 522 39 (2) 630 39 (2) 
No DFM reported 552 39 (2) 3133 39 (2) 3685 39 (2) 
Labour induction 
Labour induction 246 39 (3) 1348 39 (2) 1594 39 (1) 
No labour induction 414 39 (2) 2307 39 (1) 2721 39 (2) 
Gravidity 
Primigravidity 279 40 (2) 1003 40 (1) 1282 40 (1) 
Multigravidity 381 39 (2) 2652 39 (2) 3033 39 (2) 
Parity 
Primiparous 392 40 (2) 1495 40 (1) 1887 40 (1) 
Multiparous 268 39 (2) 2160 39 (2) 2428 39 (2) 
Previous pregnancy loss 
Previous pregnancy loss 251 39 (2) 1485 39 (2) 1736 39 (2) 
No previous pregnancy loss 409 40 (1) 2170 39 (1) 2579 39 (1) 
Previous stillbirth 
Previous stillbirth 8 38 (3) 31 38 (3) 39 38 (2) 
No previous stillbirth 652 39 (2) 3624 39 (2) 4276 39 (2) 
Notes: Data presented includes medians and interquartile range (IQR; Q3-Q1).  
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When analysed by maternal characteristics, only women with previous experiences of stillbirth had 
a median gestational age at birth below 39 weeks, at 38 weeks. There was not a statistically 
significant association between previous stillbirth and caesarean birth (p=0.07) or induction 
(p=0.87). Of the 39 women in the sample with a previous stillbirth, 16 of them (41.0%) had a 
caesarean birth, compared to 639 of 2389 multiparous women (26.7%) in the sample who had not 
had a previous stillbirth. Of the 23 women with a previous stillbirth who had a vaginal birth, 13 of 
them (56.5%) were induced. For the women in the sample who had a previous stillbirth, gestational 
age may be affected by clinical decision-making around induction, birth mode and timing of birth. 
Further analysis of maternal characteristics, gestational age at birth, DFM reporting and app usage 
is provided in sections 5.7.2.2.1 and 5.7.2.2.2.  
5.7.3.3 Birth outcome: Stillbirth 
There was no significant association observed between stillbirth as the birth outcome and MBM 
cohort (p=0.68), or DFM reported during the pregnancy (p=0.21). Among the total sample, 11 
participants experienced a stillbirth. Of these, five women were primiparous, and six had previous 
livebirths. None had had a stillbirth during a previous pregnancy, though 6 had experienced a 
previous pregnancy loss. Three of the women experiencing stillbirth had reported concerns of 
decreased fetal movement, as documented in the routinely-collected data.  
Of the 11 women experiencing a stillbirth, two women had used MBM during their pregnancy. The 
stillbirth occurred for both women at 37 weeks’ gestation, and neither had documentation of fetal 
movement concerns in routinely-collected data. Data visualisation of the user journey for these two 
MBM users is presented in Figure 5-10, to depict how each user interacted with the app during the 
perinatal period. 
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Figure 5-10. User journey of MBM users with birth outcome of stillbirth 
 
 User 1. 38 years old, 3 previous pregnancies, 2 previous births.  
                
                
                
                
                
                
Week of 
gestation 
27 28 29 30 31 32 33 34 35 36 37a 38 39 40 41b 42 
                 
                
                
                
                
                
User 2. 28 years old, 3 previous pregnancies, no previous births. 
 
Key to app sections accessed: 
About   Information  Diary   Happy with movements today Not happy with movements today  Movement strength recorder  Movement “kick” counter 
 
Notes: Both users received the invitation text message at 27 weeks’ gestation and downloaded the app immediately. aBoth users experienced stillbirth at 37 
weeks’ gestation, with stillbirth occurring before labour and labour induction performed. Neither woman had DFM recorded in health record. However, both 
users had recorded “not happy with movements today” at least one time during pregnancy. bAt 41 weeks’ gestation, User 1 opened the app and spent one minute 
on it. She looked at the Diary, Movement “kick” counter, marked that she was “unhappy with movements today”, and used the Movement strength recorder to 
mark a “1”, the lowest possible rating.  
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 User evaluation of the MBM app 
5.7.4.1 Characteristics of survey participants 
Of the 660 MBM users in the study, 138 (20.9%) responded to a survey after birth of the baby. 
Analysis was performed to measure group differences between MBM users completing the survey, 
and those who chose not to complete the survey, as described in Table 5-15. There were no group 
differences based on tested maternal characteristics or perinatal health outcomes. Among app users, 
neither of the women who experienced a stillbirth responded to the survey. Significant associations 
were observed between frequency of app usage overall and survey completion (p<0.01). A 
significant association was also observed between survey completion and whether the user had ever 
used the app kick counter (p=0.02).  
Table 5-15. App survey respondents by maternal characteristics, selected outcomes, app usage 
Maternal characteristic or perinatal 
health outcome 
Survey completed 
Total 
(N=660) 
p-
valueb 
Yes 
(N=138) 
No 
(N=522) 
Maternal characteristic 
Gravidity 0.99 
Primigravida 58 (42.0%) 221 (42.3%) 279 (42.3%)  
Multigravida 80 (58.0%) 301 (57.7%) 381 (57.7%)  
Parity 0.28 
Primiparous 76 (55.1%) 316 (60.5%) 392 (59.4%)  
Multiparous 62 (44.9%) 206 (39.5%) 268 (40.6%)  
Previous pregnancy loss 0.69 
Previous loss 50 (36.2%) 201 (38.5%) 251 (38.0%)  
No previous loss 88 (63.8%) 321 (61.5%) 409 (62.0%)  
Previous stillbirth 0.37 
Previous stillbirth 3 (2.2%) 5 (0.9%) 8 (1.2%)  
No previous stillbirth 135 (97.8%) 517 (99.0%) 652 (98.8%)  
Maternal age (years) 29 (7) 29 (8) 29 (8) 0.27 
Perinatal health outcome 
DFM reported during pregnancy 0.52 
DFM reported 25 (18.1%) 83 (15.9%) 108 (16.4%)  
No DFM reported 113 (81.9%) 439 (84.1%) 552 (83.6%)  
Labour induction 0.20 
Labour induced 58 (42.0%) 188 (36.0%) 246 (37.3%)  
Labour not induced 80 (58.0%) 334 (64.0%) 414 (62.7%)  
Mode of birth    0.66 
Vaginal 100 (72.5%) 389 (74.5%) 489 (74.1%)  
Caesarean 38 (27.5%) 133 (25.5%) 171 (25.9%)  
Birth outcome 0.99 
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Maternal characteristic or perinatal 
health outcome 
Survey completed 
Total 
(N=660) 
p-
valueb 
Yes 
(N=138) 
No 
(N=522) 
Maternal characteristic 
Livebirth 138 (100.0%) 520 (99.6%) 658 (99.9%)  
Stillbirth 0 (0.0%) 2 (0.4%) 2 (0.3%)  
Baby gestational age at birth (weeks)  39 (2) 39 (2) 39 (2) 0.09 
Baby birthweight (grams) 3445 (772) 3434 (561) 3436 (636) 0.54 
App usage 
Number of days: invitation text message 
to app download by user 
1 (13) 1 (13) 1 (13) 0.86 
Number of times app opened 63 (45) 18 (45) 28 (55) <0.01 
App kick counter used 0.02 
App kick counter used 79 (57.3%) 241 (46.2%) 320 (48.5%)  
Kick counter not used 59 (42.8%) 281 (53.8%) 340 (51.5%)  
Number of times kick counter ever used 2 (5) 1 (2) 2 (3) 0.10 
Number of days between last kick counter 
use and baby birth 
44 (54) 66 (55) 62 (56) <0.01 
Notes: Maternal characteristics or perinatal health outcome reporting includes number and percentage of the total or 
median with interquartile range. bTests of association and significance were calculated using Fisher’s exact test (two-
sided) for categorical variables, or the Mann-Whitney test for independent samples for continuous variables.  
5.7.4.2 MBM app user satisfaction 
Of the 138 MBM users who responded to the usage survey after birth of the baby, 69.6% agreed 
and 24.6% somewhat agreed that the app increased awareness of fetal movements and provided 
trustworthy information (Table 5-16). Similarly, over 90% of respondents agreed or agreed 
somewhat that reminders about being aware of fetal movement were useful, and that they would 
recommend the app to others during pregnancy.  
In terms of information provided by the MBM app compared to information received through 
antenatal care, two-thirds of respondents (65.9%) agreed or agreed somewhat that MBM provided 
“information about my baby’s movements that I did not receive through my antenatal care.” It is 
unknown what information users found most useful or complementary to that provided through 
their antenatal care, or whether users compare this to information provided by their healthcare 
providers, through written materials or other mobile apps accessed during the antenatal period. It is 
also unknown which features or components of the app they felt provided this information to fill 
that “gap.” 
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Table 5-16. Survey responses querying MBM user experiences  
Notes: Data presented includes number of respondents providing each response, with corresponding percentage of the 
total respondents to the survey (N=138). Percentages may not equal 100% due to rounding. 
5.7.4.3 App usage and healthcare-seeking behaviour related to DFM  
Of the 138 women who responded to the survey about their experiences with MBM app usage, 49 
users (35.5%) answered “yes” to “were you ever concerned about your baby’s movements during 
the last 12 weeks of pregnancy?” As detailed in Table 5-17, of these 49 users, 67.4% of these 
women used the MBM app based on their concerns, and 71.4% of these women sought care, based 
on their concerns. In terms of use as a communication or documentation device during discussions 
with care providers, 30.6% of these women discussed the MBM app with their care provider when 
concerned about fetal movement.  
The MBM app was also cited as a behavioural prompt by women experiencing DFM. Among these 
MBM users responding to the survey who experienced DFM during the last 12 weeks of pregnancy, 
30.6% felt that use of the app prompted them to seek care when concerned about fetal movement. It 
is unknown whether this group of users might have sought care without the app providing 
information or encouragement. It is also unknown what association the health care-seeking 
behaviour of these users has to their perinatal health outcomes.  
 
 Response 
Item  Agree 
Agree 
somewhat 
Disagree 
somewhat Disagree Don’t know 
MBM increased my awareness 
of fetal movements. 
96 (69.6%) 34 (24.6%) 4 (2.9%) 4 (2.9%) 0 (0%) 
MBM provided me with 
trustworthy information. 
99 (71.7%) 26 (18.8%) 4 (2.9%) 2 (1.5%) 7 (5.1%) 
MBM provided me with 
information about my baby’s 
movements that I did not 
receive through my antenatal 
care. 
45 (32.6%) 46 (33.3%) 15 (10.9%) 15 (10.9%) 17 (12.3%) 
I found reminders about being 
aware of my baby’s movements 
useful. 
102 (73.9%) 23 (16.7%) 7 (5.1%) 1 (0.7%) 5 (3.6%) 
I would recommend the MBM 
app to a friend or family.  
98 (71.0%) 27 (19.6%) 3 (2.2%) 4 (2.9%) 6 (4.4%) 
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Table 5-17. Responses to user evaluation querying MBM impact on behaviour 
 Response (N=49) 
Item Yes No 
Did you use the MBM app, based on concern for your baby’s movements? 33 (67.4%) 16 (32.6%) 
Did you go to hospital or your care provider during your pregnancy, based on 
concern for your baby’s movements? 
35 (71.4%) 14 (28.6%) 
Did use of the MBM app prompt you to go to hospital or your care provider 
when you felt concern about your baby’s movements? 
15 (30.6%) 34 (69.4%) 
Did you discuss the MBM app with hospital staff or your care provider at any 
time you felt concern about your baby’s movements? 
15 (30.6%) 34 (69.4%) 
Notes: Data presented includes number of respondents providing each response, with corresponding percentage of the 
respondents who responded that they had been concerned about fetal movement in the latter stages of pregnancy 
(N=49). Percentages may not equal 100% due to rounding. 
Fisher’s exact test was used to analyse perinatal health outcomes, comparing the 49 women 
responding to the survey who cited DFM concerns to the 89 women who did not cite DFM. No 
statistically significant associations were observed with DFM documented in their health records 
(p=0.07), caesarean birth (p=0.43), or stillbirth (none in this group).  However, a statistically 
significant association was observed for labour induction (p=0.03), whereby among this sample of 
49 women citing DFM concerns, 27 had labour induced (55.1%), and 22 were not induced (44.9%). 
Analysis of maternal characteristics among this same population found no statistically significant 
associations between citing DFM concerns and primigravidity (p=0.21), primiparity (p=0.59), or 
previous pregnancy loss (p=0.07). The sample size for respondents who had a previous stillbirth 
was too small to analyse, but of the 3 women in this group, 2 cited DFM concerns in the survey. 
 Discussion 
This sub-study is part of a clinical trial that is breaking new ground in analysing the impact of a 
mobile application intervention for fetal movement awareness on perinatal health outcomes. The 
primary hypothesis of this study was that uptake of the app would be associated with 
primigravidity, primiparity, and previous experiences of pregnancy loss and stillbirth. Because no 
other studies have been conducted on this topic, hypotheses were exploratory, asserting whether 
associations were anticipated, rather than magnitude of that association. Thus no estimate was 
specified for number of users anticipated. However, because mobile apps are popular information 
LM Daly                           Page 117                                                                            
 
sources among pregnant women, the designers of this intervention supported testing this modality 
to complement existing educational tools such as pamphlets, posters and patient education.  
This study reviewed the data from one hospital enrolled in the trial, Gold Coast University Hospital, 
during one year of the intervention. It was not anticipated that such a low proportion (15.3%) of 
women invited to access the app would download it. Among women who accessed the app, there 
was a statistically significant association between uptake and the maternal characteristics of 
primigravidity and primiparity. Among primigravid women, 21.8% used the app, and among 
primiparous women, 20.8% used the app. Across the sample, primiparity is associated with younger 
maternal age, with the mean age of primiparous women at 28.6 ± 5.35 years, compared to 31.4 ± 
5.13 years for multiparous women. Therefore, the significance of maternal age on app download is 
not surprising. Though no data were collected in the study to explore the motivation of women with 
these characteristics, it is plausible that women who are experiencing their first pregnancy, 
anticipating their first birth experience or feeling fetal movement for the first time may seek 
information to understand this nascent experience.  
Surprisingly, while women with a previous pregnancy loss comprise 40.2% of the total sample, 
only 14.5% of these women downloaded the app. This proportion contrasts to women in the sample 
who had experienced a previous stillbirth, among whom 20.5% downloaded the app. Neither of 
these associations was statistically significant, but the findings are useful for clinicians and hospitals 
considering support for women who may have experienced significant loss in previous pregnancies 
or stillbirth. 
App uptake rates among women identifying with Aboriginal and Torres Strait Islander ethnicity 
(14.8%) were close to the total sample population (15.3%). Additional measures were in place to 
recruit Indigenous participants, including inputs from an Indigenous cultural reference group, 
patient brochures with Indigenous representation, and app settings that specifically include artwork 
by an Aboriginal artist, as well as slight language modifications, such as changing the word “baby” 
to “bubba” throughout the app. However, it is unknown whether these measures, or which of these 
measures, may have impacted app uptake; this should be explored further. On the other hand, Māori 
women downloaded the app at a rate far below (9.0%) the total sample population. MBM trial 
partners based in New Zealand have developed recruitment tools to encourage Māori participation, 
but these were not available at the time of project launch at Gold Coast University Hospital. It is 
unknown whether additional, tailored efforts might have been effective in encouraging uptake, but 
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further study on the efficacy of these materials on encouraging Māori participation in New Zealand 
could assist Australian hospitals with a sizeable Māori population. 
Among all women registered into the trial, when analysed by maternal region of birth category, the 
proportion of uptake was highest among women born in the Americas (23.1%) and Southern and 
Central Asia (21.7%), compared to women born in Australia (15.7%). On the other hand, women 
born in Southeast Asia had the lowest rates of uptake (12.9%). During the app development phase, 
trial investigators had considered translating the app into other languages spoken in Australia, but 
this was not possible due to cost constraints. Nonetheless, it was the intention of investigators that 
the resource would be available to all women regardless of native language or proficiency in 
English. Pamphlets were made available in multiple languages, though uptake of these has not been 
measured in this analysis.  Further analysis of usage by maternal ethnicity and region of birth could 
yield insights into implementing effective digital health interventions, particularly for those groups 
at increased risk of stillbirth. 
During trial development, questions arose about whether women from socioeconomically 
disadvantaged backgrounds would be further disadvantaged from accessing information if it was 
provided through a technological device, such as an app through a mobile phone. This query was 
explored through analysing MBM app uptake by maternal postcodes, which were coded by quintiles 
of socioeconomic disadvantage. While there was no statistically significant association between 
uptake and socioeconomic disadvantage broadly, among the 29 women residing in the most 
disadvantaged quintile of postcodes, 7 (24.1%) used MBM, compared to 15.3% within the total 
sample. Thus mobile app interventions may be an attractive communication option for engaging 
women representing this demographic.  
Among MBM app users, the majority (51.1%) downloaded the app within one day of receiving the 
invitation text message at 27 weeks’ gestation, and 63% of all users used the tool within that week. 
Usage plateaued until 36 weeks of pregnancy and then dropped for each gestational week until 42 
weeks’ gestation, adjusting for births at each week. Among women who had experienced a previous 
stillbirth and used the app, usage remained constant throughout the pregnancy, signalling that 
women with a subsequent pregnancy may be receptive to similar interventions focused on 
mitigating risk of adverse outcomes through mobile technologies. More research is needed to 
explore this finding. 
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App pages with high traffic by unique users include Information about movements (74% of sample), 
My Diary (74%), Movement strength recorder (80%), and Movement counter (97%). Use of the 
movement “kick” counter was not associated with primigravidity, primiparity, previous pregnancy 
loss or previous stillbirth. On pages where there was a list of sub-pages to click on for more 
information, usage was highest at the top of the list, and dwindled toward the end of the list. It is 
recommended that future mobile app interventions present the most important information in the 
app pages that are first to view or easiest to access, rather than buried in layers of “sub-pages.” 
These sub-pages receive less traffic and may not be accessed by the majority of users. 
The secondary hypothesis of this study was that selected perinatal health outcomes would be better 
for MBM users. Perinatal outcomes are likely to be significantly influenced by clinical decision-
making about the patient and other risk factors that are not part of this analysis, so while data is 
reported, assumptions about impact of the MBM app on perinatal health outcomes is limited. There 
were few statistically significant associations observed between perinatal health outcomes of 
interest and MBM cohort groups. It was hypothesised that for MBM users, compared to non-users, 
DFM concerns would be reported at a higher rate, gestational week at birth and labour induction 
rates would be the same, and stillbirth rates would be lower.  
There was not a statistically significant association between MBM app uptake and the perinatal 
health outcome of DFM reporting, with 16.4% of users reporting DFM, compared to 14.3% of non-
users. However, among MBM users, there was a different pattern of usage among women reporting 
DFM, compared to women who did not report DFM. A higher proportion of women who reported 
DFM used the app from 35 weeks’ gestation compared to women who did not report DFM. For 
example, at 40 weeks’ gestation, 37% of women reporting DFM used the app, compared to 20% 
among the women not reporting DFM. By 41 weeks’ gestation, the difference between groups had 
risen to 43% of women who had reported DFM using the app, compared to 11% of women who had 
not reported DFM using the app. One possible conclusion is that uptake of the app is not associated 
with reporting of DFM; but for women experiencing DFM, MBM has been used steadily as a 
resource, particularly toward the end of pregnancy. 
There was no significant association found between MBM uptake and gestational age at birth, with 
both groups birthing at a median gestational age of 39 weeks. There was also no significant 
association found between MBM uptake and perinatal health outcomes of labour induction, 
caesarean birth or stillbirth. A statistically significant association between MBM uptake and infant 
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admission to special care nursery was observed, which may have been related to slightly higher 
rates of preterm birth among MBM users (5.3%) compared to non-users (4.6%).  
Among all women in the sample reporting DFM, there was an association with labour induction. Of 
the 630 women in the sample reporting DFM, more than half (60.5%) had induced labour, 
compared to one-third (32.9%) of women who did not report DFM. Thus it seems that the MBM 
intervention had no significant effect on either reporting of DFM or labour induction; but within the 
hospital setting, clinical practice leans toward higher rates of labour induction of women reporting 
DFM. These findings should be explored further to ensure that appropriate diagnostic tests are 
performed and that such an outcome is appropriate for the woman. 
In addition to uptake and association with perinatal health outcomes, a user survey measured 
satisfaction with the intervention and explored potential impact on health care-seeking behaviour. 
Among the 20.9% of app users who completed the survey after the birth of the baby, usage of the 
app was reported to be positive and met the intervention goal of raising users’ awareness of fetal 
movement: over 90% of these women responded that the app increased their awareness of fetal 
movements, provided trustworthy information and would be worth recommending to other women 
during pregnancy. Among respondents, two-thirds (66%) felt that MBM provided them with 
information about fetal movements that was not received through antenatal care. The app provided 
extensive, detailed information about fetal movement and interactive features to assist women to 
become more mindful of their fetal movement and to act promptly if concerned. It is encouraging 
that respondents felt that the MBM app provided them with information in addition to what 
clinicians provided; further research is needed on ways clinicians can quickly and accurately 
convey this information such that all women are empowered with this information, not just the 
15.3% who downloaded the app. 
Among these respondents to this post-intervention survey, 36% stated that they had felt concern 
about fetal movements during the last 12 weeks of pregnancy. Of these, two-thirds (66%) stated that 
they had used the app based on these concerns, and 31% said they had discussed the MBM app with 
their care provider when concerned about fetal movement. These results indicate that for some 
women, access to information through a mobile app may be helpful to providing knowledge and 
may serve as a prompt for engaging in communication with a health care provider, or in health care-
seeking behaviour. It is not known whether app uptake was related to experiencing DFM, or 
whether users were more aware of fetal movement and therefore acted on their concerns when 
experiencing DFM. 
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An association was observed between MBM users choosing to complete the post-intervention 
survey and frequency of app usage, as well as whether they used the movement “kick” counter. It is 
possible that women who engaged more frequently with the app through an interactive feature felt 
more “invested” in the tool, and therefore were willing to engage further in a brief survey. Or, it is 
possible that users who interact with a tool have a specific characteristic for participation that would 
lend itself to completion of a survey. Either way, the inputs of users from this survey were 
invaluable for exploring impact of usage on health care-seeking behaviour. 
 Conclusion 
The MBM trial offers an array of data on how women use a mobile app during pregnancy, how they 
engage with information about decreased fetal movement, and how this usage is associated with 
maternal characteristics and related perinatal health outcomes. By analysing data from one hospital 
during its first year of promoting the app to all pregnant women at 28 weeks’ gestation and beyond, 
it was found that mobile app interventions are likely to be popular among women of younger 
maternal age and women expecting their first child. Exploratory analysis also found rates of uptake 
higher than the general sample for women born in regions other than Australia, of non-
Caucasian/European ethnicity and those residing in areas recognised as socioeconomically 
disadvantaged. Usage was not associated with a difference across groups for the perinatal health 
outcomes of DFM reporting, labour induction, gestational age at birth or stillbirth. Users reported 
high rates of satisfaction with the app and felt that it was a useful complement to antenatal care. 
However, study findings may have been more conclusive if the download rate were higher than 
15.3% of the total sample. For future digital health interventions, user engagement may benefit 
from investment in recruitment efforts, timed reminders (both electronically and verbally by 
antenatal care providers) and by encouraging users to track data with the app’s interactive features.  
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Chapter 6. Conclusion and translational significance 
Throughout the writing of this thesis, questions were frequently posed at conferences and symposia 
about whether the technology revolution, particularly in relation to mobile health apps, was helpful 
or harmful to women during pregnancy. Could mobile apps offer an innovative, effective platform 
for women to engage with information, learn about pregnancy risk factors, record data, and 
encourage prompt action when concerned about fetal movement? What could the opportunities and 
risks be of this emerging digital health tool in perinatal care, particularly since hundreds of millions 
of women already use these tools, they are largely developed, promoted and maintained outside the 
clinical sphere, and there is little documented evidence that their usage improves perinatal health 
outcomes?  
The primary aim of this thesis was to assess the effect of mobile application interventions on health 
care-seeking behaviour and perinatal health outcomes among pregnant women with concerns about 
fetal movement. In order to achieve this aim, this thesis was designed with four components: 
▪ Update and publication of the clinical practice guideline on Care of women with decreased 
fetal movements 
▪ Systematic review of effect of mobile applications on maternal health care-seeking 
behaviour and perinatal outcomes 
▪ Content analysis and review of information about decreased fetal movement presented by 
mobile applications intended for use by pregnant women 
▪ Analysis of mobile application uptake, reporting of decreased fetal movement and perinatal 
health outcomes for users of the My Baby’s Movements app. 
This final thesis chapter presents a summary of the findings and limitations of the studies described 
in Chapters 3, 4 and 5. Translational significance of this research for public health interventions is 
also considered.  
 Overview of findings 
Chapter 2 offered a literature review describing associations between decreased fetal movement, 
stillbirth, selected adverse perinatal health outcomes and maternal risk factors. Interventions to 
increase awareness of fetal movement, encourage prompt reporting of decreased fetal movement, 
and reduce adverse perinatal outcomes, including stillbirth, were also highlighted, with a focus on 
emergence of mobile applications intended for use during pregnancy.  
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The latter half of this chapter included a published, updated clinical practice guideline on the Care 
of pregnant women with decreased fetal movements. These guidelines provide a means of guiding 
patient education and offer recommendations for fetal movement monitoring and investigations of 
fetal movement concerns, and were written with six objectives: 
▪ Provide an evidence-based approach to the management of women with DFM; 
▪ Improve consistency in the management of women with DFM; 
▪ Assist health care providers to counsel women with DFM; 
▪ Aid in the identification of women with higher-risk pregnancy  
▪ Reduce maternal anxiety about fetal activity and self-monitoring; and 
▪ Improve outcomes for women and their babies. 
 
These guidelines were updated from a 2010 version and were endorsed by 7 leading perinatal health 
organisations. The guidelines were published in full by PSANZ and the Stillbirth CRE, and as a 
Short Communication in the Australian and New Zealand Journal of Obstetrics and Gynaecology 
(ANZJOG). Additional consumer resources have been developed as an adjunct to the guidelines to 
improve uptake, including patient information brochures endorsed by the International Stillbirth 
Alliance. There has not been an evaluation of implementation of the guidelines in practice, but 
adoption of the guideline by clinicians and maternity hospitals may result in earlier identification of 
higher-risk pregnancies, improved perinatal health outcomes for women and their babies, and 
reduced stillbirth rates.   
Chapter 3 offered a systematic review to assess the effects of mobile application interventions 
during pregnancy on influencing healthy maternal behaviour and improving perinatal health 
outcomes, compared to interventions using other communication modalities or standard care. The 
primary outcome measure was a change in maternal behaviours, and secondary outcomes addressed 
maternal and infant health outcomes, maternal experience with the intervention, and health service 
utilisation measures. Out of 3,162 screened articles, four studies were eligible for the review; 
however, meta-analysis was not performed due to the considerable heterogeneity of participant 
characteristics, intervention features, and reported outcomes. Results were summarized in a 
narrative synthesis.  
All studies included in the review reported on the primary outcome, “change in maternal behaviours 
by intervention goals,” but the specific outcomes reported varied by intervention. None of the 
studies included in this review reported statistically significant differences between intervention and 
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control groups for neonatal outcomes, birth or pregnancy complications. As an increasing number 
of pregnant women use mobile apps, further research on intervention components, usage, and 
associated perinatal health outcomes should influence content, features, and quality of interventions. 
The effect of mobile app interventions on maternal knowledge, behaviour, and perinatal outcomes 
is still largely underreported. Results of this systematic review may contribute to decision making 
by health systems, hospitals, and clinicians about the integration of mobile applications into clinical 
care. 
Chapter 4 described a study exploring how mobile apps inform women about DFM during 
pregnancy and encourage them to monitor fetal movement. This study was not part of the original 
thesis plan, but it became evident during the course of research that millions of women were using 
commercially-available mobile apps during pregnancy, and that they presented variable information 
about decreased fetal movement and associations with adverse perinatal outcomes. A solid 
methodology for developing a sample of apps does not exist, so this was devised for the study, 
around the domains of accessibility, reach, relevance and quality. Using GooglePlay as the 
platform, because of the unique metrics reported per app, a study sample was derived of 24 apps.  A 
data collection form with 34 items was organised into five sections: (1) Information about decreased 
fetal movement; (2) Fetal movement monitoring; (3) “Kick counting”; (4) Information about the 
app developer; (5) Privacy, security and data sharing features. To collect data from text describing 
decreased fetal movement, data were extracted from the main content pages of each app, including 
the gestational week-by-week pages that structure most pregnancy apps. These pages provide 
information about fetal development and what the mother may experience at that stage of 
pregnancy. 
The study found that information about fetal movement is a cornerstone of antenatal education 
provided by these apps, but there is substantial variability of guidance for fetal movement 
stimulation and monitoring may influence the behaviour of women with DFM concerns. Many of 
the apps focus on “counting kicks” despite inconclusive evidence to support such recommendations. 
The lack of cited references or content endorsement with the apps also makes it challenging for 
users, midwives or other clinicians to assess app quality independently. Opportunities are ripe for 
partnership between industry, researchers and healthcare organisations to develop quality content 
that provides accurate information about healthy fetal movement and encourages users to act 
promptly when concerned. This review may also help inform establishment of guidelines and 
quality frameworks for implementing evidence into antenatal health information. Further rigorous 
studies to evaluate impact of mobile app content would assist to guide investments by developers 
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and healthcare organisations in what interventions could improve perinatal health outcomes, 
including reduction of stillbirth. 
Finally, Chapter 5 provides an exploratory analysis of data from one hospital participating in the My 
Baby’s Movements (MBM) clinical trial, currently underway at 27 hospitals across Australia and 
New Zealand. The MBM trial aims to reduce stillbirth rates in Australia through an interactive 
mobile app for use by pregnant women, to educate them about fetal movement and prompt them to 
act if concerns arise. This chapter described findings from a prospective cohort study embedded in 
the trial, which aimed to understand 1) uptake of a mobile app intended to raise awareness of 
healthy fetal movement; 2) associations between app usage and maternal demographics, knowledge, 
attitudes and behaviour; and 3) effects of app usage on perinatal health outcomes. The primary 
hypothesis of this study was that uptake of the app would be associated with primigravidity, 
primiparity, and previous experiences of pregnancy loss and stillbirth. The secondary hypothesis of 
this study was that selected perinatal health outcomes would be better for MBM users, compared to 
non-users. 
The study reviewed the data from Gold Coast University Hospital, during the first year of the 
intervention. It was not anticipated that fewer than one-fifth of women invited to access the app 
would download it; but among women who accessed the app, there was a statistically significant 
association between uptake and the maternal characteristics of primigravidity and primiparity. The 
majority of MBM app users downloaded the app within one day of receiving the invitation text 
message at 27 weeks’ gestation, and 63% of all users used the tool within that week. Usage 
plateaued until 36 weeks of pregnancy and then dropped for each gestational week until birth. 
Usage was not associated with a difference across MBM user groups for the perinatal health 
outcomes of DFM reporting, labour induction, caesarean delivery, gestational age at birth or 
stillbirth. Users reported high rates of satisfaction with the app and felt that it was a useful 
complement to antenatal care. 
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 Study limitations 
The overall aim of this research is to improve maternal awareness about decreased fetal movement 
and improve perinatal health outcomes, particularly prevention of stillbirth. The key research 
questions were, compared to other interventions to impact stillbirth rates, can a mobile application 
intervention: 
▪ effectively influence health care-seeking behaviour of women at higher risk of adverse 
outcomes 
▪ impact maternal health care-seeking behaviour about decreased fetal movement or other 
concerns 
▪ associate with improved perinatal health outcomes including reduction of stillbirth 
In addition to the findings summarised in section 6.1, the studies described in chapters 3, 4, 5 and 6 
had limitations. These limitations are described in more detail at the end of each of these chapters 
and is also summarised below. 
Chapter 2 began with a literature review describing the association between decreased fetal 
movement, stillbirth, selected adverse perinatal health outcomes and maternal risk factors. Given 
the breadth of these topics, only those studies most relevant to the thesis were presented, and some 
studies or data may have been left out inadvertently. Most of the information available focuses on 
stillbirth and related adverse perinatal health outcomes, with far less information available on 
decreased fetal movement and its relationship to maternal characteristics and outcomes. This 
literature review also highlights the dearth of information available about mobile app interventions 
to raise awareness about fetal movement and improve adverse perinatal health outcomes.  
The second half of the chapter provided recommendations and a clinical care pathway from the 
published clinical practice guideline on Care of women with decreased fetal movements16. The 12 
key guideline recommendations cover two key areas: 1) information for pregnant women about 
what constitutes normal fetal movements and advice about reporting DFM concerns to a health care 
provider; and 2) information for clinicians regarding management and investigation of women 
reporting DFM. But in the absence of high-quality, randomised controlled trials, and after careful 
consideration of available evidence, recommendations are largely based on consensus among 
guideline authors, stakeholders and representatives from endorsing organisations. Reporting from 
further trials are needed to determine appropriate intervention strategies for women with DFM, and 
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these trials should be adequately powered to examine effects on perinatal mortality and major 
neonatal morbidity, as well as maternal anxiety, health care utilisation and cost.  
The majority of women examined for perceived DFM in their third trimester continue with 
uncomplicated pregnancies; so while maternal perception of DFM is recognised as an indicator of 
potential fetal compromise, its predictive value for adverse outcomes is low. It is also unknown how 
many Australian hospitals have implemented the guideline, and whether this has impact stillbirth 
rates in the hospital. Stillbirths preceded by a reported decrease in fetal activity form an important 
group on which to focus future research. 
Chapter 3 presented a systematic review of the effects of mobile application interventions during 
pregnancy on influencing healthy maternal behaviour and improving perinatal health outcomes, 
compared to interventions using other communication modalities or standard care. This review 
followed an established methodology for the conduct of systematic reviews but may have some 
methodological limitations. Findings are limited by the few studies that met inclusion criteria, and 
the small sample sizes involved in each study. Although search criteria and the databases searched 
were comprehensive, relevant articles may have been missed. Only articles published in peer-
reviewed journals were included, which may have left out some studies described in “grey” 
literature. Over 3,000 published study abstracts were assessed, and it was unexpected that only four 
studies would meet inclusion criteria. The heterogeneity of outcome measures further hampered the 
ability to meta-analyse data as originally intended. Future updates of this review could search 
additional databases and expand the inclusion criteria to enable the analyses originally intended by 
the authors. 
A standardised approach using reliable and valid methods to analyse participant usage, navigation, 
adherence, and satisfaction would also improve comparability further and inform the design of 
future interventions. In addition, all studies focused on bespoke mobile apps developed by 
researchers, but did not report extensively on their development, testing or architecture, which 
would assist replication efforts. Further, none of the included studies reported an economic analysis, 
comparing the cost of the intervention with standard care or comparators. No longitudinal outcome 
data were presented, which limits analysis of longer-term benefits for women and their children.  
Policymakers and those guiding educational or clinical interventions during pregnancy would likely 
require such information to gauge investment alongside projected perinatal health benefits. 
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Chapter 4 explored how mobile apps inform women about DFM during pregnancy and encourage 
them to monitor fetal movement.  This study may be limited by a number of factors. Firstly, the 
study sample was derived using GooglePlay, one of the two major “app stores”. Some popular apps 
only available to iOS users may have been missed, and the GooglePlay algorithm indexing results 
may also have been affected by algorithms unbeknownst to researchers. Another possible limitation 
is a rapid rate of change of app content or features. Data were collected during a “snapshot” period 
of one month, but app rankings, reviews, and content may have changed over time. Mobile apps 
more recently launched may also be less likely to meet eligibility criteria for review, so the search 
strategy may have yielded apps with longer standing and more users, rather than those with a rapid 
onset of popularity. Thus while the 24 apps that met inclusion criteria for this review provide useful 
data, there may be others that did not come up in the search that could have also been eligible. 
Valid methods to systematically evaluate content and quality of commercial health apps is also 
limited in the academic literature, despite the explosion of apps available to the public. Challenges 
to analysing content of commercial apps have been identified, including the subjectivity and 
discretion of researchers. It is possible that app content may have been misidentified during data 
collection; this risk was limited by having two researchers use standardised forms and extract data 
independently from each app before reviewing data together to ensure consistency. However, there 
may have been errors of interpretation by researchers in data collection or interpretation for 
meaning. 
In Chapter 5, data from one hospital implementing the My Baby’s Movements trial was analysed, to 
assess user engagement with information about DFM, and to understand how usage is associated 
with maternal characteristics and related perinatal health outcomes. This study was part of a larger 
clinical trial underway at 27 hospitals in Australia and New Zealand and was limited by numerous 
factors. Because this is the first trial of its kind, hypotheses were exploratory. Though statistically 
significant results were measured and described, definitive conclusions about the impact of the app 
are limited, as the hospital download rate was low (15.3%). While perinatal health data were 
collected for non-users, there was no insight into why they chose not to engage in the intervention – 
information which could help future recruitment for app or perinatal health studies. Evaluations of 
the app by users provided feedback on satisfaction and how users interacted with the tool but were 
also only completed by a minority of users (20.9%). The larger MBM trial may benefit from 
availability of further surveys and audits of DFM experiences by users. While these data collection 
tools were intended for inclusion in this thesis, completion rates were so low that this data were 
disregarded and not reported here.  
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Importantly, this study reports no statistically significant association between MBM app uptake and 
the perinatal health outcome of DFM reporting, with 16.4% of users reporting DFM, compared to 
14.3% of non-users. However, among MBM users, there was a different pattern of usage among 
women reporting DFM, compared to women who did not report DFM. A limitation of this finding, 
however, is that it is unknown when during pregnancy a user reported DFM, as date of reporting is 
not documented in the health record. This lack of information could have consequences for 
interpreting decision-making around labour induction or caesarean delivery, as clinicians may 
recommend different approaches to managing DFM concerns based on week of gestation, other risk 
factors present, and clinical practice guidelines followed in the hospital. This information about 
timing of DFM complaints could also add a valuable timepoint for interpreting app usage among 
those women using the app.  
 Translational significance of this research 
 Raising awareness of DFM among pregnant women 
The term quickening describes the first time a pregnant woman feels the baby move, usually by 20 
weeks’ gestation. The ancient definition of the root word “quick” is “alive”. For thousands of years, 
a woman’s perception of her baby’s movement during pregnancy has been considered a vital 
indicator of the baby’s health and wellbeing. The majority of stillbirths are preceded by a mother’s 
perception of a change in her baby’s movements. Many of these women wait more than a day 
before seeking help, and a woman pregnant for the first time may wait until she perceives an 
absence of movement before seeking help. 
This thesis has described ways in which pregnant women in Australia can learn about healthy fetal 
movement and how to approach DFM. A number of reviews and studies have analysed benefits of 
interventions for pregnant women that raise awareness about fetal movement and enhance clinical 
identification and management of maternal risk factors for adverse perinatal health outcomes. 
However, most of these studies focus on fetal movement counting as the intervention, either in 
contrast to no counting or to different methods of counting. This was corroborated by the review 
and content analysis of pregnancy apps (Chapter 3), which found that guidance on fetal movement 
monitoring was variable, with most apps providing advice about stimulating fetal movement and 
highlighting “kick counting” parameters that are unsupported by clinical practice guidelines. In fact, 
two-thirds of all pregnancy apps in the sample included a kick counter feature. All apps in the 
sample mentioned decreased fetal movement, but only 5 apps in the sample explicitly linked DFM 
to stillbirth in text.  
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The My Baby’s Movements (MBM) app was launched as part of a clinical trial across 27 hospitals 
in Australia in 2017, and this thesis analysed data from one hospital rolling out the intervention, 
during its first year of implementation. As described in Chapter 5 of this thesis, the download rate 
was considerably lower than anticipated (15.3%). While reasons for this low download rate have 
not been explored through existing data collection tools within the project, one might speculate and 
explore these hypotheses in future research. One possibility could be that women were not invited 
to download the app until 27 weeks’ gestation, and by this final trimester of pregnancy, some 
women may have already found mobile apps, tracking tools, or other informational resources. It is 
possible that some women trust the accuracy of these commercially-available apps, and did not feel 
that another app could offer unique information. However, as seen in the content review of 
pregnancy apps in Chapter 4, this trust might be misplaced in some circumstances, whereby 
information provided is incorrect.  
Lower-than-anticipated download rates may also have been influenced by the way in which the trial 
was introduced to the user. Hospitals across the MBM trial have introduced the app to women in 
different ways; some hospitals have registered women “in bulk” without informing her about it first, 
such that the invitation text message may have been received without prior discussion from a 
midwife. Other hospitals have included discussion about MBM into topics discussed during 
antenatal care appointments, and women at these hospitals may have agreed to registration or had 
some insight from midwives about what MBM could offer them. It has also been noted anecdotally 
that women are overloaded with information during pregnancy, including brochures, pamphlets, 
magazines and bags handed out at hospitals, and some important educational tools may get lost in 
the mass of information.  
The app was popular with primiparous women, and while no data were collected to explore the 
motivation of these women to download the app, it is plausible that women who are anticipating 
their first birth event, or who are feeling fetal movement for the first time, may seek information to 
understand this nascent experience. Concerns had been raised during the app development phase 
about vulnerable populations of women who might not receive the benefit of the app due to 
socioeconomic disadvantage or non-English-speaking background. Of translational significance, 
though the sample was small, women at the lowest quintile of SES, according to ABS postcode 
statistics, had the highest download rates (24.1%), compared to other SES quintiles.  
Download rates among women identifying as Aboriginal and Torres Strait Islander ethnicity were 
similar to non-Indigenous women (14.3% versus 15.7%, respectively), signifying that project 
investment in coordinating an Indigenous reference group, engaging Indigenous women in the 
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development phase, printing a culturally-sensitive pamphlet and app interface may have been 
helpful. Further research among Indigenous participants would aid to unpack this finding, and data 
analysed from the entire MBM trial may also provide more insight. By country of birth, app uptake 
was highest among women born in the Americas (23.1%) and Southern and Central Asia (21.7%), 
compared to women born in Australia (15.7%). While app uptake by maternal region of birth was 
not explored in detail, further research may help understand decision-making by these women. For 
example, how might an app provide information, or supplement information from care providers, 
among women of different ethnic, linguistic or cultural backgrounds. Future iterations of the trial or 
app interventions might continue to target populations at higher risk of stillbirth, tailoring content 
and support to best suit their needs. 
Analysis of the MBM cohort study illuminated another important point of translational significance 
for interventions to raise awareness of DFM; they may have greater success if they utilise 
interactive features to encourage engagement. Mobile app interventions rely on user engagement, 
but developers must still consider how to meaningfully measure what makes engagement effective. 
As one blogger posited, “how can we use technology in the most minimal way, requiring the 
smallest possible time commitment, to plunge people into the behaviour change process and help 
them succeed?”231  
Of MBM app users, 64.1% of users opened the “About” app page, 73.6% opened the “Information” 
page, and 96.5% opened the “Movement counter” page. However, there was no statistically 
significant association observed between DFM reporting and movement counter. So, the prospect of 
an interactive feature to engage with may have attracted MBM users to that part of the app, more 
than any other section, but engagement with that feature was not associated with DFM reporting, or 
with any other perinatal health outcome measured. Furthermore, it is still unclear whether user 
engagement with a mobile app offering information about DFM has any benefit, compared to other 
communication modalities such as public service announcements, pamphlets, integration into face-
to-face antenatal care visits, websites, books, or anything else. 
Still, perinatal health outcomes did not differ significantly between MBM users and non-users. 
Within this cohort, there was not a statistically significant association between MBM usage and 
reporting of DFM concerns (as documented on the perinatal health record), nor were there any 
associations between MBM usage and adverse perinatal health outcomes of stillbirth, preterm birth, 
caesarean delivery or labour induction. It will be helpful to compare these results with the results 
from other hospitals engaged with the MBM trial, to better understand how the intervention was 
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conducted across different sites and whether these differences had any measurable impact on 
outcomes. 
 Mobile app interventions for perinatal health 
Mobile apps are a popular platform for women to gather information during pregnancy, and they 
provide rich opportunities for public health interventions. Broadly, they can be used to recruit, 
retain and engage with high user numbers. As users engage with the tool, developers can tap into 
“big data” collection; and for health systems with access to other information such as perinatal 
health records, data can be triangulated to paint a more comprehensive story about the user using 
multiple streams: surveys, user behaviour, qualitative data analysis of social media posts, and other 
physiological data collected through devices like thermometers, fitness trackers, etc. If the user has 
granted further permissions, there may even be access to photos, videos, calendars and web 
browsing history. In two Queensland maternity hospitals, the national Digital Pregnancy Health 
Record (dPHR) initiative is currently trialling a secure digital record to capture and share relevant 
health information between a pregnant woman and her healthcare providers. This initiative may 
provide more information and understanding about how these processes work. 
Similarly, mobile apps have the functionality for “responsive” health promotion that can quickly 
impart quality health information, conduct updates, adapt to user trends (such as sending 
notifications at times when the user is most active on the device), or add features that become 
possible with new software or technology developments. These features may be worth exploring for 
future development of the My Baby’s Movements app or other perinatal health apps. Further 
responsiveness can be achieved where data collected from patient use of apps can be viewed by 
clinicians, who may track patient data, help them manage risk factors with reminders, tips and 
referrals to community resources.  For these reasons, some researchers or clinicians may seek to 
develop their own apps and maintain full ownership of content, user relationships and opportunities 
for commercialisation. 
However, there are many potential benefits to researchers collaborating with industry developers of 
mobile applications. Researchers typically rely on funds from grants and health systems, and the 
process of applying for funding, developing a product and launching into a patient marketplace can 
take an extended period. As an example, the MBM app was proposed in 2013, an NHMRC grant 
was received in 2014, and the app was launched in 2016; thus the entire project cycle from 
inception to anticipated conclusion in 2019 is 5 years. During this span of time, mobile app 
technology and user patterns have changed markedly, and clinical practice guidelines underpinning 
LM Daly                           Page 133                                                                            
 
app content have also been updated. This extended timeframe contrasts markedly to industry 
deadlines, where investment may be optimised by raising capital quickly to upgrade services, add 
capability and hopefully, retain user loyalty. Industry may also offer nimble or agile platforms that 
can quickly adapt to changes in the “user marketplace”, continuing to meet client demand with 
supply. Further benefits to partnership with industry app developer(s) could include the ability to 
utilise existing data and the ability to participate in content development, advisory boards, or 
targeted information provision to groups at higher risk of adverse outcomes. 
But in considering translational significance and industry partnership for mobile app interventions, 
there are also some important considerations, including: 
▪ Agreed approaches to behaviour change strategies to address risk factors 
▪ Synergy between institutions: identity, reputation, stability, values, accountability 
▪ Multiple and diverse stakeholders, health systems, partners and users.  
▪ Marketing and audience segmentation strategy, which may differ 
▪ Study populations, representation and biases introduced by communication mode 
▪ Privacy policies, responsibilities to research participants and regulations around sharing 
personal health information.  
Careful navigation of these potential issues, alongside benefits, can influence success of mobile app 
interventions, partnerships between research and industry, and the possibility of reducing adverse 
perinatal health events through this modality.  
Though outside the scope of this thesis, future research questions can be explored about provision 
of mobile app interventions in perinatal health: Does the use of mobile apps, and the introduction of 
a “quantified self” in relation to data collection of mother and baby, reduce women’s agency in 
describing their own experiences of fetal movement? How might a reliance on data impact clinician 
responses to these subjective experiences of fetal movement by women in their care? And how are 
“place-based” approaches to public health interventions accounting for communities in digital 
spaces that are not physically bound by geography? Researchers with access to mobile app user data 
can designate their own “community” groupings with shared characteristics aside from physical 
place – such as by age group, parity, disease prevalence or usage patterns – and tailor interventions, 
notifications and communications accordingly, in real time. How are we maximising these 
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opportunities to engage with individuals and communities in this technological framework, to 
support the health and wellness of mothers and babies? 
Research linking perinatal health and mobile apps can be complex, as it is difficult to attribute 
effectiveness to a single component or issue. A plethora of components, combinations, “dose-
response” relationships, and clinical decision-making all have an impact on outcomes, and are not 
easy to measure. There is also little discussion in the literature about communication theories of 
engagement and persuasion that are possible using mobile app features, but which could be useful 
in conjunction with health behaviour theories. Furthermore, there may be long-term benefits or 
outcomes that are not immediately captured in usage data or perinatal health records. Finally, 
further research is warranted on potential harms of mobile applications as a mode for pregnancy 
education, and whether usage leads to any increase in maternal anxiety, interventions such as labour 
induction or caesarean birth, or other perinatal health outcomes. Further to this, a standardised set of 
perinatal health outcomes for such studies would be helpful to ensure that a range of outcomes are 
documented, not only those solely related to the specific condition or research question under 
investigation.    
 Conclusions 
In Australia, at least three-quarters of pregnant women regularly use a pregnancy app. Worldwide, 
pregnancy apps have been downloaded hundreds of millions of times. Many women enjoy the 
functionality, features and connection they gain from apps used during pregnancy. But aside from 
user satisfaction, an essential question remains: is maternal use of pregnancy apps significantly 
associated with health care-seeking behaviour, and healthier outcomes for mother and baby? This 
thesis aimed to fill this gap and has reflected on how innovative, patient-centred mobile tools may 
contribute to more Australian women coming home from the hospital with a healthy baby. 
Antenatal education, whether delivered through publicly-available mobile apps or routine clinical 
care, should reflect information from evidence-based sources or updated, endorsed clinical practice 
guidelines wherever possible, to ensure accuracy and to mitigate potential harm for mother or baby. 
An opportunity exists for industry, clinicians and healthcare systems to collaboratively develop 
quality app content and measure how these tools impact maternal experiences and perinatal health 
outcomes, including reduction of stillbirth rates. 
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  Selected conference abstracts 
Mobile pregnancy apps, decreased fetal movement and self-assessment of risk 
Authors: Daly LM1, 2, Boyle F1, Gibbons K1, Flenady V1 
1Mater Research Institute, The University of Queensland, Brisbane, Australia 
2School of Public Health, The University of Queensland, Brisbane, Australia 
 
Background: Millions of women download mobile applications (“apps”) during pregnancy to build 
knowledge, track data and seek reassurance. Content of mobile applications may influence self-
assessment of risk and health care-seeking behaviour of pregnant women concerned about 
decreased fetal movement (DFM). 
Method: A systematic review was conducted to assess how mobile “pregnancy” apps (1) address 
DFM, (2) encourage self-assessment of risk, and (3) link DFM to potential adverse perinatal health 
outcomes. Based on inclusion criteria with domains of relevance, reach, accessibility and quality, 
24 mobile applications were selected for review. Data were extracted by two reviewers and 
analysed within a qualitative and quantitative framework.   
Results: All apps mentioned DFM and encouraged fetal movement awareness. Few apps link DFM 
explicitly to stillbirth (20%), preterm birth (8%), low birthweight (8%) or emergency delivery (8%). 
Two-thirds of the sample offer guidance on “kick counting” for self-assessment, and one-third of 
the apps incorporate a “kick counter” feature. Few of the apps reference clinical practice guidelines 
or cite expert authorship. 
Conclusions: This review is the first to evaluate content about fetal movement presented by mobile 
apps providing information during pregnancy. Perinatal mortality and morbidity may be influenced 
by accuracy of this information, features that encourage awareness, and language encouraging 
women to promptly address fetal movement concerns.  
 
 
Citation: Daly LM, Boyle F, Gibbons K, Flenady V. Mobile pregnancy apps, decreased fetal 
movement and self-assessment of risk. Perinatal Society of Australia and New Zealand (PSANZ) 
22nd Annual Scientific Congress, Auckland (New Zealand), March 2018 (oral presentation). 
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The effect of mobile application interventions on influencing healthy maternal behaviour and 
improving perinatal health outcomes:  A systematic review  
Authors: Daly LM1, 2, Boyle FM1, Horey D3, Middleton PF4, Flenady V1 
1Mater Research Institute, The University of Queensland, Brisbane, Australia 
2School of Public Health, The University of Queensland, Brisbane, Australia 
3School of Psychology and Public Health, La Trobe University, Bundoora VIC, Australia 
4Healthy Mothers, Babies and Children’s Theme, SAHMRI, Adelaide SA, Australia 
 
Background: Mobile health strategies have the potential to improve access to information, modify 
demand for services and enable provision of targeted care. This systematic review assessed the 
effect of mobile application interventions, used by women during pregnancy, on influencing 
behaviour and improving perinatal health outcomes. 
 
Method:  We included randomised and non-randomised studies, published in peer-reviewed 
publications, reporting effects of mobile application-based interventions designed to influence 
maternal knowledge or behaviour during pregnancy, with no date or language restrictions.  
 
Results: Four studies were eligible for analysis, all reporting outcomes from randomised controlled 
trials. All studies reported some benefit of the intervention on the primary outcome of “change in 
maternal behaviours, by specific intervention goals.” No meta-analysis was performed due to 
heterogeneity. No statistically significant differences between groups were reported for pregnancy 
complications, delivery or infant outcomes. 
 
Conclusions: For future trials, authors recommend a standard set of perinatal outcome measures 
alongside those specific to the intervention. This review is limited by the few studies that met 
inclusion criteria, small sample sizes and heterogeneity of interventions, comparators and outcome 
measures.  
 
 
 
Citation: Daly LM, Boyle FM, Horey D, Middleton PF, Flenady V. The effect of mobile 
application interventions on influencing healthy maternal behaviour and improving perinatal 
health outcomes:  A systematic review. Perinatal Society of Australia and New Zealand (PSANZ) 
22nd Annual Scientific Congress, Auckland (New Zealand), March 2018 (poster presentation). 
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My Baby's Movements: Women’s feedback about a mobile application intervention aimed at 
raising awareness of fetal movements 
Authors: Weller M1, Daly L1, Gardener G1, Henry S1, Reinebrant HE1, Warrilow K1, Flenady V1 
1Centre of Research Excellence in Stillbirth, Mater Research Institute- University of Queensland, 
Brisbane, Australia 
 
Background: Stillbirth is a major global public health problem. Studies have linked maternal 
perception of decreased fetal movements (DFM) with stillbirth and other adverse outcomes. The 
My Baby’s Movements (MBM) trial aims to reduce stillbirth rates using a mobile platform to 
enhance maternal knowledge about decreased fetal movements and encourage timely health-care 
seeking behaviour combined with clinician education programs on management of DFM. 
Method:  This trial uses a stepped-wedge, cluster-randomised design, involving 27 hospitals (8 
clusters) and 260,000 women in Australia and New Zealand (ANZ) over a 3-year period (2016-
2018). The primary outcome measure is stillbirth rates after 28 weeks’ gestation, and the trial aims 
to reduce these rates by 30% during the intervention period. User satisfaction with the app is gauged 
through analysis of responses to a brief survey incorporated into the app 
Results: Women’s feedback about the MBM app has been analysed from the end user survey, 
completed after birth. Of the 496 surveys collected, 84% of women agreed the app was easy to use; 
75.3% of women found the reminders about fetal movements helpful, and 92.4% of women found 
the MBM app increased awareness of their baby’s movements. 
Conclusions: Preliminary data analysed from the end user survey suggests the MBM mobile phone 
app is not only well received by users but is also helpful to increase maternal awareness of fetal 
movements. These factors may be integral to interventions aiming to improve timely reporting of 
decreased fetal movements and reduce stillbirth rates. 
 
 
Citation: Weller M, Daly L, Gardener G, Henry S, Reinebrant HE, Warrilow K, Flenady V. My 
baby's movements: Women’s feedback about a mobile application intervention aimed at raising 
awareness of fetal movements. Perinatal Society of Australia and New Zealand (PSANZ) 22nd 
Annual Scientific Congress, Auckland (New Zealand), March 2018 (poster presentation). 
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How do mobile pregnancy applications address decreased fetal movement as a risk factor for 
adverse perinatal health outcomes and stillbirth? 
Authors: Daly LM1, 2, Flenady V1, Le H3, Roberts J4, Gibbons K1. 
1Mater Research Institute, The University of Queensland, Brisbane, Australia 
2School of Public Health, The University of Queensland, Brisbane, Australia 
3Institute for Teaching and Learning Innovation, The University of Queensland, Brisbane, Australia 
4School of Education, The University of Queensland, Brisbane, Australia 
 
Introduction: Maternal perception of fetal movement is an indicator of fetal wellbeing, while a 
perceived decrease in fetal movement (DFM) has clinical significance as a predictor of pregnancies 
at risk of adverse outcomes, including stillbirth. Increasingly, pregnant women are turning to digital 
sources of health information to build knowledge, track data, share experiences and seek 
reassurance. Mobile applications intended for use during pregnancy offer information about fetal 
movement and may influence behaviour of women experiencing DFM.  
 
Methods: A systematic review was conducted to assess how mobile “pregnancy” applications 
address decreased fetal movement, utilise evidence-based information, and encourage health care-
seeking behaviour. The search strategy identified eligible mobile applications, with inclusion 
criteria based on accessibility, reach, relevance and quality. Two reviewers extracted data from 
eligible mobile apps using predefined, standardized formats, investigating the content explicitly 
linking DFM and adverse perinatal health outcomes.  
 
Results: Based on inclusion criteria, 24 mobile applications relevant to pregnancy were included in 
the review; all were available in English, had more than 100,000 installations, and had high user 
quality ratings. All applications provided information about DFM. However, explicit linkage of 
DFM to potential adverse health outcomes was slim: only two mobile applications in the sample 
explicitly linked DFM to each of the following adverse outcomes: low birthweight, fetal growth 
restriction, emergency delivery and preterm birth. Four apps linked DFM to higher risk of stillbirth.  
 
Discussion: This review is the first to assess information about fetal movement available in the 
mobile applications used globally by millions of pregnant women. Women experiencing DFM may 
act more quickly to investigate concerns if aware of potential, related adverse perinatal outcomes. In 
development of antenatal education, clinicians, hospitals and health systems should consider the 
content of mobile applications and their contribution to patient knowledge and decision-making. 
 
Citation: Daly L, Flenady V, Le H, Roberts J, Gibbons K. How do mobile “pregnancy” 
applications explicitly link decreased fetal movement and adverse perinatal health outcomes, 
including stillbirth?: A systematic review. International Stillbirth Alliance Conference, Cork 
(Ireland), Sept 2017 (poster presentation). 
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My Baby's Movements: A stepped-wedge, cluster-randomised controlled trial testing a mobile 
application intervention aimed at lowering stillbirth rates  
 
Authors: Prof Vicki Flenady1, Dr Glenn Gardener1, Prof David Ellwood2, A/Prof Philippa 
Middleton3, A/Prof Fran Boyle1, Prof Caroline Crowther4, Dr Michael Coory1, Prof Chris East13, Dr 
Emily Callander6, Dr Adrienne Gordon7, Prof Jonathan Morris7, Ms Victoria Bowring8, Prof Alison 
Kent10, Sue Vlack9, A/Prof Glyn Teale5, Ms Lisa Daly1, 9, Dr Sarah Henry1, Dr Hanna Reinebrant1, 
Ms Aleena Wojcieszek1, Dr Frederik Froen11, Prof Jane Norman12 
  
1 Mater Research Institute - The University of Queensland, Brisbane, Australia 
2 Griffith University, Australia  
3 South Australian Health and Medical Research Council, Australia 
4 University of Auckland, New Zealand   
5 University of Melbourne, Australia  
6 James Cook University, Australia  
7 University of Sydney, Australia 
8 Stillbirth Foundation Australia, Australia 
9 School of Public Health, The University of Queensland, Australia 
10 Australian Capital University, Australia   
11 Norwegian Institute of Public Health, Norway 
12 Tommy’s Centre for Maternal Fetal Health, University of Edinburgh, Scotland 
13 Monash University, Australia  
 
Introduction: Stillbirth is a major global public health problem. Maternal perception of decreased 
fetal movements (DFM) is often the only warning sign. The My Baby’s Movements (MBM) trial 
aims to reduce stillbirth rates using a mobile platform to enhance maternal knowledge about 
decreased fetal movement and encourage timely health-care seeking behaviour combined with a 
clinician education program on management of DFM. 
 
Methods: A stepped-wedge, cluster-randomised design, involving 26 hospitals (8 clusters) and 
260,000 women in Australia and New Zealand (ANZ) over a 3-year period (2016-2018). The 
primary outcome measure is stillbirth rates after 28 weeks’ gestation will be reduced by 30%. 
Satisfaction with the app is sought from users through a brief survey incorporated into the app. 
 
Results: The MBM mobile application has been developed, after pilot testing including iterative 
cycles of testing and improvement. App content is based on the ANZ DFM Clinical practice 
guidelines and brochure for women. MBM implementation is underway with results due in 2019. 
Initial feedback from users is very positive. The SWCRCT is an ideal design for large scale trials 
required to address stillbirth providing a pragmatic while robust evaluation model.   
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Discussion: The My Baby’s Movements trial will generate information about fetal movement 
awareness, health promotion and perinatal health outcomes associated with a mobile application 
intervention. Preliminary data suggests that the mobile phone app is well received by users. 
Ethical approval for the study was granted by the Mater Health Services Human Research Ethics 
Committee (Reference; HREC/14/MHS/141 AM02) and seven additional HRECs across Australia 
and New Zealand. 
 
Citation: Flenady V, Gardener G, Ellwood D, Middleton P, Boyle FM, Crowther C, Coory M, East 
C, Callander E, Gordon A, Morris J, Bowring V, Kent A, Vlack S, Teale G, Daly L, Henry S, 
Reinebrant H, Wojcieszek A, Frøen F, Norman J. My Baby's Movements: A stepped-wedge, cluster-
randomised controlled trial testing a mobile application intervention aimed at lowering stillbirth 
rates. International Stillbirth Alliance Conference, Cork (Ireland), Sept 2017 (oral presentation). 
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Apps and opps: mobile applications and opportunities for longitudinal data collection across 
the reproductive lifespan 
Author: Lisa Daly, The University of Queensland, Brisbane, Australia 
Objectives: Mobile health modalities offer the potential to reach, teach, connect, motivate and 
empower individuals to address specific health concerns. This presentation offers a descriptive 
review of how mobile applications (“apps”) available to women during their reproductive years 
may also serve as a rich source of longitudinal data, with their focus on a continuum of age and 
health experiences.  
Methods: An exploratory review was performed to investigate how mobile applications for women 
of childbearing age offer a platform for longitudinal data collection. A literature review was also 
conducted to link mobile app usage to perinatal health outcomes. A selection of the most popular 
preconception, pregnancy and parenting apps used by Australian women are analysed in more 
detail. 
Results: Over 40,000 medical apps are available in the global health marketplace, with more apps 
for pregnancy than any other medical topic. Over 90% of Australian women aged 18-34 years 
downloaded an app on a mobile phone in the past year, and millions of women in Australia use 
mobile apps to access, store and share personal health information. App developers are increasingly 
designing products to retain users across the reproductive lifespan, offering resources to track 
menstruation, fertility, pregnancy and child development. Many apps link to social media sites, 
online communities, and commerce. A plethora of data is captured, which users can access, 
manipulate, organise and share for health and lifestyle planning. However, little peer-reviewed 
literature exists to demonstrate associations between mobile app usage and health outcomes. 
Conclusions: This study explores longitudinal data collection opportunities using mobile apps and 
social media. Relationships between researchers, industry, government and healthcare agencies 
could afford new avenues for data collection, survey distribution, sharing of quality health 
information, and linkages to community health programs and clinicians. Potential issues exist 
alongside benefits and must be carefully navigated to ensure quality, access and confidentiality. 
Citation: Daly L. Apps and opps: mobile applications and opportunities for longitudinal data 
collection across the reproductive lifespan. Australian Longitudinal Study of Women’s Health 
(ALSWH) – Scientific Meeting, Newcastle, May 2016 (oral presentation). 
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Health promotion through mobile applications: Impact on maternal health care-seeking 
behaviour and stillbirth rates 
Author: Lisa Daly, The University of Queensland, Brisbane, Australia 
Theme: Mobile health modalities offer the potential to reach, teach, connect, motivate and 
empower individuals to address specific health concerns. Mobile applications are an emerging 
platform for health promotion efforts to ensure healthy pregnancy and birth outcomes. Fetal death 
rates in Australia have changed little over the past decade, with over 2,000 families suffering a 
stillbirth each year. Maternal perception of decreased fetal movement is associated with stillbirth 
and other adverse pregnancy outcomes. Health promotion using a mobile platform may provide the 
educational resources to enhance maternal knowledge and encourage timely health-care seeking 
behaviour when concerns about fetal movement arise. 
What was the aim of your project or research?: This project aims to 1) describe a health 
promotion intervention using a mobile application; 2) demonstrate the importance of promoting 
maternal awareness of fetal movement to reduce stillbirth rates; and 3) focus on efforts to promote 
uptake by those at highest risk of stillbirth, including Indigenous women. 
Challenges of issue or topic of concern: Half of all stillbirths are preceded by maternal perception 
of decreased fetal movement. Empowering pregnant women to report and investigate fetal 
movement concerns may result in a 30 percent reduction of stillbirth rates. A mobile application has 
been proposed as a health promotion tool to enhance maternal knowledge, prompt health care-
seeking behaviour and improve perinatal health outcomes. 
What did you do?: A literature review was performed to investigate maternal health promotion 
interventions using mobile applications. Methodology for the My Baby’s Movements clinical trial 
underway among 27 hospitals and 260,000 women in Australia and New Zealand is also described 
with hypothesised outcomes and implications for health promotion among women at risk of 
stillbirth.  
What were the outcomes?: Health promotion interventions using mobile apps provide a direct 
medium to increase maternal awareness of fetal movement. The My Baby’s Movements trial is set to 
launch in mid-2016. The research methodology is presented with results of the literature review.  
Why does it matter?: Little research has been conducted on the translation of maternal knowledge, 
derived from information on a mobile application, into health care-seeking behaviour and improved 
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perinatal outcomes. Potential issues exist alongside benefits and must be carefully navigated to 
ensure quality, access and confidentiality. 
Citation: Daly L. Health promotion through mobile applications: Impact on maternal health care-
seeking behaviour and stillbirth rates. Australian Health Promotion Association (AHPA) 23rd 
National Conference, Perth, June 2016 (oral presentation). 
 
My Baby’s Movements: can a mobile application impact stillbirth rates in Australia? 
Author: Lisa Daly, The University of Queensland, Brisbane, Australia 
Context: Pregnant women who adopt, practice and maintain healthy behaviours can potentially 
impact the health of themselves and their babies. Stillbirth affects over 2,000 Australian families 
each year; half of all stillbirths are preceded by maternal perception of decreased fetal movement. 
Mobile health modalities offer the potential to reach, teach, motivate and empower women to 
address fetal movement concerns, which may result in significant reduction of stillbirth rates. 
Process: Methodology for the My Baby’s Movements clinical trial is described with hypothesised 
outcomes and implications for clinical practice. This trial uses a stepped-wedge, cluster-randomised 
design, involving 27 hospitals and 280,000 women in Australia and New Zealand over a 3-year 
period.  
Analysis: The My Baby’s Movements trial data collection phase is underway; thus this presentation 
analyses the mobile application features, data collection tools and projected impact. Many health 
systems are initiating mobile applications to support antenatal care, connect patients with clinicians, 
and support referral networks. However, formal evaluation of such programs is in its infancy.  
Outcomes: The My Baby’s Movements trial will generate information about fetal movement 
awareness, health promotion and perinatal health outcomes associated with a mobile application 
intervention. Potential issues exist alongside benefits and must be carefully navigated to ensure 
quality, access and confidentiality. As part of a linked health system, innovative, patient-centred 
mobile tools may contribute to reducing perinatal mortality. 
Citation: Daly L. My Baby’s Movements: can a mobile application impact stillbirth rates in 
Australia? Public Health Association of Australia (PHAA) 44th Annual Conference, Alice Springs, 
Sept 2016 (oral presentation). 
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 Clinical practice guideline literature review 
Guiding research questions 
The following questions were raised by the working party and formed the basis of the search 
strategy: 
▪ What is the definition of DFM?  
▪ Within what time frame should a woman report concerns of DFM? 
▪ What is the role of formal fetal movement monitoring in reducing adverse pregnancy 
outcome?  
▪ Which investigations should be conducted when a woman presents with DFM? 
▪ What follow-up care should be provided to women who report DFM? 
Search strategy  
A literature search was undertaken of major guideline websites (see below) and electronic 
databases: Medline OVID, CINAHL, Cochrane Library databases and Maternity and Infant Care. 
The search of electronic databases was limited to the English language, and searches were 
undertaken using the following terms: 
Medline OVID 
((“fetal Movement” OR “foetal movement”).sh,ab,ti. OR ("fetal motility" or "foetal 
motility").sh,ab,ti. OR ("fetal activity" or "foetal activity").sh,ab,ti. OR ("fetal hypomotility" or 
"foetal hypomotility").sh,ab,ti. OR ("fetal hypoactivity" or "foetal hypoactivity").ab,ti. OR (fetal 
adj2 movement).ab,ti. OR (foetal adj2 movement).ab,ti.))  
Cochrane Library 
(fetal OR foetal) near/3 (movement* OR activity OR motility OR hypomotility OR 
hypoactivity).ti,ab. MeSH descriptor Fetal Movement explode all trees 
CINAHL 
"Fetal Movement” (CINAHL heading) OR ("fetal movement*" OR "foetal movement*" OR "fetal 
activity" OR "foetal activity" OR "fetal hypoactivity" OR "foetal hypoactivity" OR "fetal 
hypomotility" OR "foetal hypomotility" OR "fetal motility" OR "foetal motility").ab,ti   
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Maternity and infant care 
“fetal movement”.de OR ("fetal movement$" OR "foetal movement$" OR "fetal activity" OR 
"foetal activity" OR "fetal hypoactivity" OR "foetal hypoactivity" OR "fetal hypomotility" OR 
"foetal hypomotility" OR "fetal motility" OR "foetal motility").ab,ti 
Relevant references provided in bibliographies from various articles were searched manually, as 
were any references recommended in personal communications with experts in the field.   
The relevant existing guidelines were searched at the National Guideline Clearinghouse 
(http://www.guideline.gov/). 
The literature review was updated in 2016 to include evidence published between May 2010 and 
July 2016. As such, 42 articles were added as key citations in this update. 
Level of evidence & grading of recommendations  
The relevant papers were identified and classified according to level of evidence.  Evidence based 
recommendations were prepared and graded on the strength of the evidence.  This classification of 
the evidence and grading of the recommendations was based, as stated below, on criteria advocated 
by the National Health and Medical Research Committee149. 
Levels of Evidence 
Level Description 
I Evidence obtained from a systematic review of all relevant randomised controlled 
trials. 
II Evidence obtained from at least one properly designed randomised controlled trial.  
III-1 Evidence obtained from well-designed pseudo-randomised controlled trials (alternate 
allocation or some other method).  
III-2 Evidence obtained from comparative studies with concurrent controls and allocation 
not randomised (cohort studies), case control studies, or interrupted time series with a 
control group.  
III-3 Evidence obtained from comparative studies with historical control, two or more 
single-arm studies, or interrupted time series without a parallel control group. 
IV Evidence obtained from case series, either post-test or pre-test and post-test.  
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Grading of recommendations148 
Rec grade  Description  
A  Body of evidence can be trusted to guide practice  
B  Body of evidence can be trusted to guide practice in most situations  
C  Body of evidence provides some support for recommendation(s) but care should be taken in 
its application  
D The body of evidence is weak and the recommendation(s) must be applied with caution. 
 √ Body of evidence is inadequate and recommendation is based on consensus for good 
clinical practice. 
 
Body of Evidence Matrix148 
1Level of evidence determined from the NHMRC evidence hierarchy. 2If there is only one study, rank this component 
as ‘not applicable’. 3For example, results in adults that are clinically sensible to apply to children OR psychosocial 
outcomes for one cancer that may be applicable to patients with another cancer.  
Component  A  B  C  D  
Excellent  Good  Satisfactory  Poor  
Evidence base
1
 several level 
I or II 
studies with 
low risk of 
bias  
one or two level II 
studies with low 
risk of bias or a SR/ 
multiple level III 
studies with low 
risk of bias  
level III studies with 
low risk of bias, or 
level I or II studies 
with moderate risk of 
bias  
level IV studies, or 
level I to III studies 
with high risk of 
bias  
Consistency
2
 all studies 
consistent  
most studies 
consistent and 
inconsistency may 
be explained  
some inconsistency 
reflecting genuine 
uncertainty around 
clinical question  
Evidence is 
inconsistent  
Clinical impact  very large  substantial  moderate  slight or restricted  
Generalisability  population/s 
studied in 
body of 
evidence are 
the same as 
the target 
population 
for the 
guideline  
population/s studied 
in the body of 
evidence are similar 
to the target 
population for the 
guideline  
population/s studied 
in body of evidence 
differ to target 
population for 
guideline but it is 
clinically sensible to 
apply this evidence to 
target population3 
population/s 
studied in body of 
evidence differ to 
target population 
and hard to judge 
whether it is 
sensible to 
generalise to target 
population  
Applicability  directly 
applicable to 
Australian 
healthcare 
context  
applicable to 
Australian 
healthcare context 
with few caveats  
probably applicable 
to Australian 
healthcare context 
with some caveats  
not applicable to 
Australian 
healthcare context  
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 Systematic review: PRISMA-P (Protocol) checklist 
Section/topic # Checklist item 
Information 
reported   Comments 
Yes No 
ADMINISTRATIVE INFORMATION   
Title  
  Identification  1a Identify the report as a protocol of a systematic review    
  Update  1b If the protocol is for an update of a previous systematic review, identify as such   N/A 
Registration  2 
If registered, provide the name of the registry (e.g., PROSPERO) and registration 
number in the Abstract 
   
Authors  
  Contact  3a 
Provide name, institutional affiliation, and e-mail address of all protocol authors; 
provide physical mailing address of corresponding author 
   
  Contributions  3b Describe contributions of protocol authors and identify the guarantor of the review    
Amendments  4 
If the protocol represents an amendment of a previously completed or published 
protocol, identify as such and list changes; otherwise, state plan for documenting 
important protocol amendments 
  N/A 
Support  
  Sources  5a Indicate sources of financial or other support for the review    
  Sponsor  5b Provide name for the review funder and/or sponsor    
  Role of sponsor 
or funder  
5c 
Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the 
protocol 
  N/A 
INTRODUCTION  
Rationale  6 Describe the rationale for the review in the context of what is already known    
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Section/topic # Checklist item 
Information 
reported   Comments 
Yes No 
Objectives  7 
Provide an explicit statement of the question(s) the review will address with 
reference to participants, interventions, comparators, and outcomes (PICO) 
   
METHODS  
Eligibility criteria  8 
Specify the study characteristics (e.g., PICO, study design, setting, time frame) and 
report characteristics (e.g., years considered, language, publication status) to be used 
as criteria for eligibility for the review 
   
Information sources  9 
Describe all intended information sources (e.g., electronic databases, contact with 
study authors, trial registers, or other grey literature sources) with planned dates of 
coverage 
   
Search strategy  10 
Present draft of search strategy to be used for at least one electronic database, 
including planned limits, such that it could be repeated 
   
Study Records: 
       Data management  
11a 
Describe the mechanism(s) that will be used to manage records and data throughout 
the review 
   
  Selection process  11b 
State the process that will be used for selecting studies (e.g., two independent 
reviewers) through each phase of the review (i.e., screening, eligibility, and inclusion 
in meta-analysis) 
   
  Data collection  11c 
Describe planned method of extracting data from reports (e.g., piloting forms, done 
independently, in duplicate), any processes for obtaining and confirming data from 
investigators 
   
Data items  12 
List and define all variables for which data will be sought (e.g., PICO items, funding 
sources), any pre-planned data assumptions and simplifications 
   
Outcomes and 
prioritization  
13 
List and define all outcomes for which data will be sought, including prioritization of 
main and additional outcomes, with rationale 
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Section/topic # Checklist item 
Information 
reported   Comments 
Yes No 
Risk of bias in 
individual studies  
14 
Describe anticipated methods for assessing risk of bias of individual studies, 
including whether this will be done at the outcome or study level, or both; state how 
this information will be used in data synthesis 
   
Data synthesis  
15a Describe criteria under which study data will be quantitatively synthesized    
15b 
If data are appropriate for quantitative synthesis, describe planned summary 
measures, methods of handling data, and methods of combining data from studies, 
including any planned exploration of consistency (e.g., I 2, Kendall’s tau) 
   
15c 
Describe any proposed additional analyses (e.g., sensitivity or subgroup analyses, 
meta-regression) 
   
15d If quantitative synthesis is not appropriate, describe the type of summary planned    
Meta-bias(es)  16 
Specify any planned assessment of meta-bias(es) (e.g., publication bias across 
studies, selective reporting within studies) 
   
Confidence in 
cumulative evidence  
17 Describe how the strength of the body of evidence will be assessed (e.g., GRADE) 
   
Note: This checklist has been adapted for use with protocol submissions to Systematic Reviews from Table 3 in Moher D et al: Preferred reporting items for systematic review 
and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews 2015 4:1. 
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 Systematic review: PRISMA checklist 
Section/topic  # Checklist item  
Reported on 
page numbera  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; 
study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; 
results; limitations; conclusions and implications of key findings; systematic review registration 
number.  
2-3 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3-4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS).  
5-6 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number.  
3 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., 
years considered, language, publication status) used as criteria for eligibility, giving rationale.  
5-6 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study 
authors to identify additional studies) in the search and date last searched.  
7-9 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such 
that it could be repeated.  
Appendix 1 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, 
and, if applicable, included in the meta-analysis).  
7 
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Section/topic  # Checklist item  
Reported on 
page numbera  
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) 
and any processes for obtaining and confirming data from investigators.  
8 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made.  
6 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in 
any data synthesis.  
8 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  8 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including 
measures of consistency (e.g., I2) for each meta-analysis.  
N/A 
Risk of bias across 
studies  
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication 
bias, selective reporting within studies).  
8 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), 
if done, indicating which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with 
reasons for exclusions at each stage, ideally with a flow diagram.  
9-10 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, 
follow-up period) and provide the citations.  
10-11 
Risk of bias within 
studies  
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see 
item 12).  
11, Appendix 3 
Results of individual 
studies  
20 For all outcomes considered (benefits or harms), present for each study: (a) simple summary data 
for each intervention group (b) effect estimates and confidence intervals, ideally with a forest 
plot.  
12-16, Appendix 
6 
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Section/topic  # Checklist item  
Reported on 
page numbera  
Synthesis of results  21 Present the main results of the review. If meta-analyses are done, include for each, confidence 
intervals and measures of consistency. 
12-16 
Risk of bias across 
studies  
22 Present results of any assessment of risk of bias across studies (see Item 15).  11, Appendix 3 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-
regression [see Item 16]).  
N/A 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider 
their relevance to key groups (e.g., healthcare providers, users, and policy makers).  
17 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., 
incomplete retrieval of identified research, reporting bias).  
18-19 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications 
for future research.  
19 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); 
role of funders for the systematic review.  
21 
Note: aPage numbers listed in this column reference the submitted manuscript and will not correspond to page numbers in this thesis document. Based upon Moher, D., et al. (2009). 
"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement." PLoS Med 6(7): e1000097. 
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 Systematic review: Search terms and articles retrieved 
 
Database Search terms Articles 
retrieved 
Search 
date 
Notes 
PubMed Search ((((((((((((("mobile app*") OR "mobile phone") OR 
"cell phone") OR smartphone) OR iPhone) OR iPad) OR 
Android) OR "handheld computer") OR "mobile 
applications"[MeSH Terms]) OR "smartphone"[MeSH 
Terms]) OR "cell phones"[MeSH Terms]) OR "computers, 
handheld"[MeSH Terms])) AND ((((((((((((pregnan*) OR 
pregnancy[MeSH Terms]) OR pregnant women[MeSH 
Terms]) OR matern*) OR mother*) OR prenat*) OR pre-
nat) OR perinat*) OR peri-nat*) OR antenat*) OR ante-
nat*) OR reproducti*) 
1007 15 Feb 
2017 
 
Embase 'pregnan*' OR 'matern*' OR 'mother*' OR 'prenat*' OR 'pre-
nat*' OR 'perinat*' OR 'peri-nat*' OR 'antenat*' OR 'ante-
nat*' OR 'reproducti*' AND ('mobile app*' OR 'mobile 
application' OR 'mobile phone' OR 'cell phone' OR 
'smartphone' OR 'iphone' OR 'ipad' OR 'android' OR 
'personal digital assistant') 
1426 15 Feb 
2017 
All fields searched (not just .ti, .ab) 
Cochrane 
Library 
(pregnan* or matern* or mother* or prenat* or pre-nat* or 
perinat* or peri-nat* or antenat* or ante-nat* or 
reproducti*) and ("mobile app*" or "cell phone" or 
smartphone or iphone or ipad or android or handheld 
computer) 
108 15 Feb 
2017 
 
CINAHL TX (pregnan* OR matern* OR mother* OR prenat* OR 
pre-nat* OR perinat* OR peri-nat* OR antenat* OR ante-
nat* or reproducti* ) AND TX ( "mobile app" OR "mobile 
174 15 Feb 
2017 
Of these, 100 were NOT already present 
in Medline.  
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Database Search terms Articles 
retrieved 
Search 
date 
Notes 
phone" OR "cell phone" OR smartphone OR iPhone OR 
iPad OR android OR handheld computer )   
WHO Global 
Health 
Library  
tw:((pregnan* OR matern* OR mother* OR prenat* OR 
pre-nat* OR perinat* OR peri-nat* OR antenat* OR ante-
nat* OR reproducti*) AND ("mobile app*" OR "mobile 
phone" OR "cell phone" OR smartphone OR iphone OR 
ipad OR android OR handheld)) AND (instance:"ghl") 
1697 15 Feb 
2017 
WHO Global Health Library only allows 
for title, subject, abstract lookup, not “all 
fields” or “all text”. 1697 returned 
include 1652 from Medline (duplicates).  
POPLINE ((((pregnan* OR matern* OR mother* OR prenat* OR pre\-
nat* OR perinat* OR peri\-nat* OR antenat* OR ante\-nat* 
OR reproducti*))) AND (((“mobile app*” OR “cell phone” 
OR smartphone OR iphone OR ipad OR android OR 
handheld computer))))) AND (Language:English) 
674 15 Feb 
2017 
 
CABI Global 
Health 
(pregnan* or matern* or mother* or prenat* or pre-nat* or 
perinat* or peri-nat* or antenat* or ante-nat* or 
reproducti*) and (“mobile app*” or “cell phone” or 
smartphone or iphone or ipad or android or handheld 
computer) 
3 16 Feb 
2017 
To be thorough, also did simple search 
for “pregnan*” and “mobile*”, resulting 
in 201 articles, no further of relevance. 
Handsearching 
(post-hoc) in 
JMIR 
Publications 
(pregnan* OR perinat* OR antenat* OR prenat* OR 
matern* OR mother) 
143 5 Apr 2018 Post-hoc handsearch in JMIR 
publications for dates up to 15 June 2017, 
with 143 articles returned. Two reviewers 
(LD & VF) screened for title/abstract and 
none were eligible: wrong design (56), 
wrong intervention (42), wrong 
population (45). Several articles had 
multiple reasons for exclusion, although 
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Database Search terms Articles 
retrieved 
Search 
date 
Notes 
each was allocated to a single category. 
In PRISMA diagram as “handsearching”. 
Handsearching 
(post-hoc) 
reference lists 
of retrieved 
articles 
 948 6 May 2018 Post-hoc handsearch of reference lists 
among 69 retrieved articles (full-text 
assessed for eligibility), with 778 articles 
assessed (after duplicates removed). Ti/ab 
screening performed by 2 reviewers (LD 
& VF); none were eligible: wrong design 
(197), wrong intervention (463), wrong 
population (118). Several articles had 
multiple reasons for exclusion, although 
each was allocated to a single category. 
In PRISMA diagram as “handsearching”. 
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 Systematic review: Excluded studies 
To assess eligibility, full-text of 69 articles was reviewed by 2 reviewers. The reason for exclusion 
was allocated to a single category as listed below, though several articles had multiple reasons for 
exclusion. 
Authors (publication year) Reason for exclusion 
Wrong study design (20) 
Ashman, Collins et al. (2017) No comparison arm. Intervention allows dietitian to 
view food photos to support paper dietary records. 
Bartholomew, Church et al. (2011) Crossover study design. 
Bartholomew, Soules et al. (2015) Crossover study design. 
Daly, Baum et al. (2016) Survey results about app usage. No comparative arm. 
Fowles and Gentry (2008) Descriptive study design. 
Ganju, Krapf et al. (2016) Compares intervention group ("low-risk") to general 
population statistics 
García-Sáez, Martínez-Sarriegui et al. 
(2014) 
Design evaluation of a prototype. 
Hirst, Farmer et al. (2015) Service development project; not intended to influence 
maternal knowledge or behaviour. 
Hirst, Loerup et al. (2016) Service development project; not intended to influence 
maternal knowledge or behaviour. 
Hirst, Mackillop et al. (2015) Service development project; not intended to influence 
maternal knowledge or behaviour. 
Hirst, Mackillop et al. (2015) Cross-sectional study design. 
Knight-Agarwal, Davis et al. (2015) Describes app development using cross-sectional and 
qualitative methods. 
Loerup, Gibson et al. (2014) Pilot cohort observational study; not intended to 
influence maternal knowledge or behaviour. 
Loerup, Gibson et al. (2015) Service development project; not intended to influence 
maternal knowledge or behaviour. 
Loerup, Hirst et al. (2014) Cross-sectional study design. 
Mackillop, Loerup et al. (2014) Describes development of an intervention.  
Marko, Krapf et al. (2016) Prospective observational study. 
Miles and Mynard (2013) Describes development of an app. No user or 
comparison data.  
O'Brien, Cramp et al. (2016) Mobile app interventions not specifically mentioned. 
Tombor, Shahab et al. (2016) About development of program. 
Wrong intervention (20) 
Arnold, Nguyen et al. (2013) Not a mobile app intervention. 
Calle-Pascual, Pérez-Ferre et al. (2010) SMS intervention using software to transmit data. 
Colaci, Chaudhri et al. (2016) No mobile app interventions for pregnant women 
mentioned. 
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Authors (publication year) Reason for exclusion 
Davis, Wambach et al. (2014) Not a mobile app intervention. SMS and PowerPoint 
presentation preloaded onto an iPad.  
Fawsitt, Meaney et al. (2016) Not a mobile app intervention. Survey of women's 
willingness to pay for a type of intervention. 
Graham, Uesugi et al. (2014) Not a mobile app intervention. 
Kingston, McDonald et al. (2014) Not a mobile app intervention. Uses tablet for a 
screening questionnaire during a prenatal appointment. 
Kirtley and Chien (2012) Not a mobile app intervention. Overview of new 
research. 
Logsdon, Davis et al. (2015) Not a mobile app intervention; streams YouTube on 
iPad while mothers are in hospital. 
Marcano-Belisario, Gupta et al. (2016) Not a mobile app intervention; survey on a tablet 
computer.  
Marko, Ganju et al. (2016) As described, purpose of intervention to connect 
device and transmit data, not to provide information to 
pregnant women, influence maternal knowledge or 
behaviour. 
Matsubara (1985) Not a mobile app intervention. 
Mauriello, Van Marter et al. (2016) Not a mobile app intervention; web-based clinical 
intervention using iPad at prenatal appointments. 
McLean, Osgood et al. (2017) Feasibility study of a data collection system. 
Nau (2016) Not a mobile app intervention. 
Olson, Graham et al. (2013) Not a mobile app intervention. 
Peter, Barron et al. (2015) Not a mobile app intervention. About SMS. 
Rotheram-Borus, Tomlinson et al. (2012) Not a mobile app intervention.  
Takeuchi and Horiuchi (2016) Not a mobile app intervention; website. 
Wang and Kim (2015) Not a mobile app intervention; website. 
Wrong population (5) 
Cheng, Huang et al. (2016) Target population are postpartum women.  
Demirci and Bogen (2016) Target population are postpartum women. 
Maycock, Scott et al. (2015) Target population are male partners. 
Ramallo-Farina, Garcia-Perez et al. 
(2015) 
Pregnant women excluded from study. 
Suleman (2015) Target population are community midwives. 
Wrong outcomes (2) 
Atkinson, Westeinde et al. (2016) Immunisation focus. 
Burgess, Atkinson et al. (2016) Immunisation focus. 
No study data reported (18) 
No named author (a) (2013) Promotional piece about an app. No study presented. 
No named author (b) (2013) Promotional piece about an app. No study presented. 
Agarwal and Labrique (2014) Does not describe specific intervention. Studies 
described on SMS interventions or data management. 
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Authors (publication year) Reason for exclusion 
Choi, Fukuoka et al. (2013) No data reported. About development of program. 
Daniels and Wedler (2015) No studies reported. About pregnant womens' app use 
Garnweidner-Holme, Borgen et al. 
(2015) 
No data reported. About app development for GDM. 
Griffiths, Brown et al. (2016) Systematic review protocol. 
Kennelly, Ainscough et al. (2016) Study protocol. 
Larsson (2014) Commentary. 
Mackillop, Bartlett et al. (2016) Study protocol. 
Malloy (2015) Commentary on radiation in utero, neurological 
effects 
Mathew, Nimbalkar et al. (2016) Journal club review 
Mudey, Goyal et al. (2015) No data reported. Type of intervention unclear. 
Nguyen, Vu et al. (2015) No data reported. HMIS project underway.  
Schuster (2014) Broadly describes mobile apps; not a mobile app 
intervention. 
Stabile (2015) Could not access article. 
Stevenson, Wojcieszek et al. (2016) Describes development of an app. No data reported. 
Zairina, Abramson et al. (2015) Study protocol. 
 
Reference list for excluded studies (65) 
(2013). "Best beginnings mobile apps: the transition to parenthood." Community Pract 86(4): 11. 
(2013). "bump buddy and baby buddy smartphone apps trialled." Nursing Children & Young People 25(6): 
5-5. 
Agarwal, S. and A. Labrique (2014). "Newborn health on the line: the potential mHealth applications." Jama 
312(3): 229-230. 
Arnold, C. W., T. Nguyen and C. Janzen (2013). "BabySTEPS: a sugar tracking electronic portal system for 
gestational diabetes." Stud Health Technol Inform 192: 1123. 
Ashman, A. M., C. E. Collins, L. J. Brown, K. M. Rae and M. E. Rollo (2017). "Validation of a Smartphone 
Image-Based Dietary Assessment Method for Pregnant Women." Nutrients 9(1). 
Atkinson, K. M., J. Westeinde, R. Ducharme, S. E. Wilson, S. L. Deeks, N. Crowcroft, S. Hawken and K. 
Wilson (2016). "Can mobile technologies improve on-time vaccination? A study piloting maternal use of 
ImmunizeCA, a Pan-Canadian immunization app." Human Vaccines and Immunotherapeutics 12(10): 2654-
2661. 
Bartholomew, M. L., K. Church, G. Graham, J. Burlingame, I. Zalud, L. Sauvage, K. Soules and S. Shaha 
(2011). "Managing diabetes in pregnancy using cell phone/internet technology." American Journal of 
Obstetrics and Gynecology 204(1): S113-S114. 
Bartholomew, M. L., K. Soules, K. Church, S. Shaha, J. Burlingame, G. Graham, L. Sauvage and I. Zalud 
(2015). "Managing Diabetes in Pregnancy Using Cell Phone/Internet Technology." Clin Diabetes 33(4): 169-
174. 
Burgess, K., K. M. Atkinson, J. Westeinde, N. Crowcroft, S. L. Deeks and K. Wilson (2016). "Barriers and 
facilitators to the use of an immunization application: a qualitative study supplemented with Google 
Analytics data." J Public Health (Oxf). 
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Calle-Pascual, A. L., N. Pérez-Ferre, M. Galindo, M. D. Fernández, V. Velasco, I. Runkle, M. J. De La Cruz, 
P. Martín Rojas-Marcos and L. Del Valle (2010). "The outcomes of gestational diabetes mellitus after a 
telecare approach are not inferior to traditional outpatient clinic visits." International Journal of 
Endocrinology 2010. 
Cheng, H. Y., T. Y. Huang, L. Y. Chien, Y. F. Cheng and F. J. Chen (2016). "[The Effects of a Mobile 
Application Social Support Program on Postpartum Perceived Stress and Depression]." Hu Li Za Zhi 63(6): 
52-60. 
Choi, J., Y. Fukuoka and K. A. Lee (2013). "Development of a Mobile Phone-Based Physical Activity 
Program in Pregnant Women." Communicating Nursing Research 46: 386-386. 
Colaci, D., S. Chaudhri and A. Vasan (2016). "MHealth Interventions in Low-Income Countries to Address 
Maternal Health: A Systematic Review." Annals of Global Health. 
Daly, H., A. Baum, J. Ritchie and M. Blair (2016). "Baby buddy app-a public health opportunity for new 
parents; evaluation of the first 46,000 downloads." Archives of Disease in Childhood 101: A184-A185. 
Daniels, M. and J. A. Wedler (2015). "Enhancing Childbirth Education through Technology." International 
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 Systematic review: Intervention characteristics 
Study                                                                    
(publication year) 
Ainscough 
et al198  
(2016) 
Zairina 
 et al200  
(2016) 
Ledford  
et al157  
(2016) 
Choi  
et al199  
(2016) 
Participant risk category Moderate Low 
User experience 
User or “pilot” testing of app in design or 
development stage  
- - - Yes 
Links to shared participant “chat” spaces - No No No 
Content 
App developed specifically for the 
intervention 
- Yes Yes Yes 
App is publicly available - No No No 
Study cites stakeholder review for quality 
assurance 
- - - - 
Study cites evidence base for app content 
(e.g. references clinical practice guidelines, 
endorsed educational content, published 
manuals, etc) 
- Yes -  Yes 
Patient-provider communication 
Facilitation within the app by expert, 
clinician, other 
- No No No 
Healthcare provider access to user data for 
tracking purposes 
- Yes - No 
Functionality 
App connects to a device built in to phone No No No No 
App connects to a device through a “plug-in” No Yes No Yes 
“Push communication” feature where 
messages sent directly to user (e.g. reminders 
to use the app, fill in a survey) 
- Yes - Yes 
Study provides information comparing cost 
of app intervention with other 
communication modes 
No No No No 
Data tracking 
Feature(s) for user to record own data - Yes Yes Yes 
Feature(s) to automatically record user data - Yes Yes Yes 
User access to data for tracking - Yes Yes Yes 
App privacy policies or terms of use 
articulated 
- - - Yes 
Notes: - Dash represents that data were not reported.  
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 Systematic review: Inventories used in included studies 
Inventory Range of scores Comment Primary 
study author 
Questionnaire developed 
from the Transtheoretical 
Model 
Stage-of-change score 
(1-5) 
Assesses readiness to engage 
in new or change existing 
lifestyle behaviours. 
Ainscough198  
Stanford Brief Physical 
Activity Survey (SBAS) 
5 response choices per 
item, including a 
global statement about 
the activity and the 
dimensions of 
frequency, intensity, 
time, and type of 
activity. 
2-item, self-report PA 
assessment tool designed to 
obtain a quick assessment of 
the usual amount and 
intensity of physical activity 
that a person currently 
performs throughout the day.  
Choi199 
Physical Activity Stages 
of Change 
Scores motivational 
readiness for 
behaviour change 
(from pre-
contemplation to 
maintenance stages) 
4-item questionnaire with 
Yes/No responses 
Choi199 
Self-Efficacy for 
Physical Activity 
6 (low) to 30 (high) 5-item questionnaire 
measuring stages of change 
for exercise behaviour 
Choi199 
Social Support and 
Exercise Survey 
13 (less) to 65 (more 
support) 
13-item questionnaire, each 
with 5-point scale, listing 
things people might do or say 
to someone who is trying to 
exercise regularly. 
Choi199 
Barriers to Being Active 
Quiz (CDC) 
0 (low) to 9 (high) 21-item questionnaire on 4-
point scale. Barriers to 
physical activity fall into 1 or 
more of 7 categories: lack of 
time, social influences, lack 
of energy, lack of willpower, 
fear of injury, lack of skill, 
and lack of resources. 
Choi199 
Center for 
Epidemiological Studies 
Depression Scale (CES-
D) 
0 (no) to 60 (severe 
depression) 
20-item questionnaire with 4 
response categories, asking 
respondents how they may 
have felt or behaved. 
Choi199 
Pregnancy Discomfort 
Checklist (modified) 
Frequency, Severity: 
32 (less) to 128 
Assessed the severity and 
“distressfulness” of 
symptoms in addition to 
Choi199 
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Inventory Range of scores Comment Primary 
study author 
(more). Distress: 0 
(less) to 128 (more) 
frequency, sleep disturbance 
and restless legs syndrome. 
Patient activation 
measure (PAM) 
0=not activated, 
100=most activated 
13 Likert-type items to create 
a continuous patient 
activation measure.  
Ledford157 
Prenatal Interpersonal 
Processes of Care (PIPC) 
scale 
Scale of 0-100. Items 
averaged to create 
subscales. Subscales 
averaged to calculate 
overall PIPC score. 
30 items, each with 7-point 
scale. PIPC is conceptualized 
as the social and 
psychological aspects of 
provider interactions with 
patients. Focuses on 3 
dimensions: Communication, 
Patient-Centered Decision 
Making, and Interpersonal 
Style. 
Ledford157 
Asthma Control 
Questionnaire (ACQ-7) 
ACQ score is the 
mean of the 7 items, 0 
(well controlled) and 6 
(extremely poorly 
controlled).  
7-item questionnaire, each 
with 7-point scale. Given at 
3- and 6-months for primary 
outcome measures. Can be 
completed in the clinic 
without daily recordings of 
symptoms, medication use 
and airway calibre. Patients 
recall their experiences 
during the previous 7 days.   
Zairina200 
Juniper’s mini-Asthma 
Quality-of-life 
Questionnaire (mAQLQ)  
Score is the mean of 
all responses.  
15-item questionnaire, each 
with 7-point scale. Self-
administered, with patients 
asked to recall their 
experiences during the 
previous 2 weeks. Measures 4 
domains of symptoms, 
activity limitation, emotional 
function and environmental 
stimuli. 
Zairina200 
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 Systematic review: Secondary outcomes 
Two of the four trials reported secondary outcomes relevant to this review, with data provided below. 
Outcomes N Intervention N Controls  P-value (where 
reported) 
Zairina et al200 
Major adverse maternal outcome (composite of death, admission to intensive care unit or near-miss mortality as defined by WHO)  
Postpartum haemorrhage 33 1 (3%) 36 2 (6%) NR 
“Hypertensive disorders of pregnancy” 33 2 (6%) 36 2 (6%) NR 
Gestational diabetes mellitus  33 3 (9%) 36 6 (17%) NR 
Elective caesarean birth 33 6 (18%) 36 6 (17%) NR 
Emergency caesarean birth 33 4 (12%) 36 6 (17%) NR 
Maternal general health (as defined by standardised measures such as general health questionnaires) 
FEV1 – 6 months from baseline 33 0.11 ± 0.06 36 0.07 ± 0.05 0.57a 
FEV1/FEV6 – 6 months from baseline 33 1.53 ± 1.07 36 -0.56 ± 0.98 0.16a 
Prescribed an oral corticosteroid 33 1 user 36 2 users   
Maternal psychosocial outcomes, such as satisfaction, self-efficacy or anxiety (as measured by any validated, standard instrument) 
mAQLQ – 6 months from baselinee 33 0.51 ± 0.16 36 -0.22 ± 0.15 0.002b,c 
Health service utilisation (antenatal care attendance, maternal antenatal admission, length of hospital stay of mother or infant) 
Unscheduled health visit related to asthma 
 
33 0 users 36 1 user  
Choi et al199 
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Outcomes N Intervention N Controls  P-value (where 
reported) 
Maternal general health (as defined by standardised measures such as general health questionnaires) 
Pregnancy symptoms: severityf 13 48.6±8.1 14  55.3±11.4 0.10d   
Pregnancy symptoms: frequencyf 13  67.1±13.7 15  73.7±13.7 0.17d   
Pregnancy symptoms: distressg 13  70.0±17.6 14   73.4±17.7 0.91d 
Maternal psychosocial outcomes, such as satisfaction, self-efficacy or anxiety (as measured by any validated, standard instrument)   
Over the 12 weeks of follow-up, the intervention reduced perceived barriers to exercise includingh:  
Lack of time 13 3.08±2.25 15 4.13±2.26 0.08d  
Social influence 13 2.23±2.49 15 2.73±1.34 0.21d  
Lack of energy 13 3.62 ±2.90 15 4.80±2.08 0.02c,d 
Lack of willpower 13 3.23±2.13 15 5.20±2.01 0.06d  
Fear of injury 13 0.77±2.24 15 0.60±0.99 0.65d  
Lack of skill 13 1.15±1.99 15 1.33±1.40 0.70d  
Lack of resources 13 2.38±1.90 15 2.20±1.86 0.43d  
Self-efficacy at 12 weeksi 13 18.7±4.4 15 17.1±5.2 0.58d  
Depression (CES-D) at 12 weeksj 13 8.8±2.7 15 11.1±6.9 0.56d  
Notes: Unless otherwise noted, values reported for intervention and controls groups are presented as mean ± standard error. aP-value of difference between groups, adjusted for 
baseline. bP-value of difference between groups adjusted for baseline. cStatistically significant. dOverall P-values based on ANCOVA models for changes from baseline to 12-week 
visit, adjusting for baseline. eIncreased mAQLQ score suggests better asthma-related quality of life. fPossible scores from 32 (less) to 128 (more). gPossible scores from 0 (less) to 
128 (more). hPossible scores from 0 (low) to 9 (high). iPossible scores from 6 (low) to 30 (high self-efficacy). jPossible scores from 0 (no) to 60 (severe depression). QoL improved 
from baseline. FEV1=forced expiratory volume in 1 second. FEV6=forced expiratory volume in 6 seconds. mAQLQ= Mini-Asthma quality of life questionnaire. NR=Not reported. 
QoL=quality of life. WHO=World Health Organization.  
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 Content analysis: Quality and risk of bias checklist 
Criterion Justifications Page # 
Has the study clearly 
mentioned the data collection 
time frame? 
New apps are frequently released and updated. The period 
in which data collection has taken place is important for 
further research, which may assess the quality of a specific 
group of health-related apps in relation to time. 
1, 6 
Does the study specifically 
mention that the reviewed app 
was downloaded and analyzed 
based on its content?  
Reviewing the app description may not be enough to make 
a full judgment about the app quality. Reporting how apps 
were initially reviewed is necessary to understand the depth 
of analysis. (If it is not mentioned explicitly or only a 
selected sample is fully downloaded, this criterion will not 
be met). 
6, 7 
Does the study clearly describe 
the methods undertaken to 
appraise the app’s quality? 
Describing the assessment methodologies used in app 
appraisal is essential as it will determine the quality of the 
review process and dictate the usability of the study’s 
results. (Some studies may describe the results of some 
quality indicators, but if no quality appraisal criteria are 
explicitly described, this criterion will not be met.) 
5 
Does the study clearly describe 
the methodology taken to 
search for appropriate apps, 
including key words and 
search restrictions? 
This will help further research as it will highlight differing 
means of effectively searching for health-related apps. In 
addition, it will provide evidence as to how thorough the 
study’s search process was. The absence of this criterion 
will prevent future replication of the results. 
5, Table 1 
Does the study clearly mention 
the inclusion and exclusion 
criteria for app selection? 
Providing an explanation for why some apps were included 
and others excluded increases the likelihood of reproducible 
results and further specifies the type of apps included. 
5, Table 1, 
Additional 
file 1 
Does the study identify the 
country in which the search 
was conducted? 
Some app stores such as the Apple app store and Google 
Play allow developers to restrict the purchasing of apps to 
specific countries. Therefore, the search results may vary as 
they are country-dependent. 
6, 11 
Does the study clearly identify 
the targeted group of users the 
app is intended for (consumers 
or healthcare professionals?) 
Identifying the intended audience for apps is important to 
allow for the comparison of app quality within targeted 
groups. 
5 
Does the study provide a list of 
the apps included in this 
review? 
Providing the final apps included in the study will help 
future researchers to monitor the progress and quality of 
apps that may have been updated over time. 
Table 2 
 
Note: Page number correlates to the submitted manuscript, not to this thesis document. Source of the checklist: 
BinDhim NF, Hawkey A, Trevena L. A systematic review of quality assessment methods for smartphone health 
apps. Telemed J E Health 2015, 21:97-104. 
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 Content analysis: Data collection form 
Item 
# 
Areas/Attributes Response 
1 Information about decreased fetal movement   
1a Does app mention fetal movement? Yes/No 
1b If app mentions fetal movement, are there any words used to describe the sensation? Open text  
1c Does app mention decreased fetal movement? Yes/No 
1d If app mentions DFM, does content link DFM with risk of adverse outcome, such as 
low birthweight baby, fetal growth restriction, preterm birth, emergency delivery, 
stillbirth or neonatal death? 
Yes/No 
1e If there is mention of DFM, are any clinical practice guidelines referenced? Yes/No 
1f Information about how or when to proceed if perceiving DFM? Open text 
1g Description of clinical investigations for DFM, if women proceeds further for care? Open text 
2 Fetal movement assessment   
2a-f Does app offer:  
▪ encouragement to be aware of fetal movement 
▪ functions to allow user to set reminders about being aware of fetal 
movement 
▪ additional devices or diagnostic tools available to plug in 
▪ fetal movement trackers using built-in device features 
▪ advice to stimulate fetal movement with consumption of food or drink 
▪ advice about stimulating fetal movement with loud music 
Yes/No 
3 Kick counting   
3a Does app text encourage women to consider “kick counting?” Yes/No 
3b-e Does app offer: 
▪ guidance on kick-counting for self-assessment? 
▪ kick counter or timer function? 
▪ tracking of kick counter data 
▪ other documentation of fetal movement, such as diary/journal? 
Yes/No 
3f If yes to 3a, what guidance is offered on # kicks/# hours for self-assessment? Open text 
4 App developer    
4a Corporate status (nonprofit, health system, corporate, other) described Menu 
4b Advisory panel named within app Yes/No 
4c Citations of content authorship within app?  
4d If named, do authors include health care providers? Yes/No 
4e Reference to an independent organisation for endorsement of app content? Yes/No 
4f Update schedule published in app? Yes/No 
5 Privacy, security and data sharing   
5a-e This app offers: 
▪ disclaimer, terms of use, or privacy policy 
▪ ability to password-protect data 
▪ ability to upload material such as videos, ultrasound images, etc. 
▪ ability to share with social media 
▪ in-app chat spaces 
Yes/No 
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 Content analysis: Apps excluded from review  
250 mobile apps were screened for eligibility and excluded by assessment of reach, relevance, and 
quality (in that order). Tables below list apps that were excluded from the review. Reasons for 
exclusion may be multiple, but only one reason is provided. 
Apps excluded - Reach 
App name App developer Reach  
(# of downloads) 
Contractions Timer Penguin Apps 50,000-100,000 
Pregnant Queen Gives Birth Ozone Development 50,000-100,000 
Pregnancy Calculator Androcia 50,000-100,000 
Arogyam Malayala Manorama Co. Ltd. 50,000-100,000 
BabyChakra Pregnancy Parenting BabyChakra 50,000-100,000 
Garbh Sanskar Nasik Services.com 50,000-100,000 
Happy Baby TZMO SA 50,000-100,000 
Pregnancy Assistant App Alportela Labs 50,000-100,000 
Pregnancy by week MicroLabs App 50,000-100,000 
Pregnancy Checklists kigorosa UG (haftungsbeschränkt) 50,000-100,000 
Pregnancy Tracker Ömer Saritas 50,000-100,000 
Pregnancy: 33000 questions BWCode 50,000-100,000 
Pregnancy Calculator Widget PREIR 50,000-100,000 
Pregnancy week by week Pregnancy soft 50,000-100,000 
Pregnant Mom Birthday Purple Studio 50,000-100,000 
Bloom Period Tracker SMSROBOT LTD 10,000-50,000 
Ela Ovulation & Fertility Adriyo 10,000-50,000 
How To Get Pregnant Faster edufun dev 10,000-50,000 
Pregnancy Calculator river studios 10,000-50,000 
FitMama 5 minute workouts HappyMums Solutions 10,000-50,000 
Maternity Clothes Model Design Rylai Crestfall 10,000-50,000 
Pregnancy Exercises B6Squad Dev. 10,000-50,000 
Pregnancy Pilates We Love Free Apps 10,000-50,000 
Superdoc - Ask a Doctor Online Online doctor appointment app 10,000-50,000 
Ovia Parenting & Baby Ovuline, Inc. 10,000-50,000 
[Amharic] Pregnancy OromNet Software 10,000-50,000 
Aponjon Pregnancy - Shogorbha Dnet 10,000-50,000 
Baby checklist Checklist.com 10,000-50,000 
Enfamama A+ Pregnancy App Mead Johnson Nutrition Philippines 10,000-50,000 
Exynos Pregnancy Calculator Exynos 10,000-50,000 
Happy Pregnancy Ticker - Hindi SOFTCRAFT 10,000-50,000 
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App name App developer Reach  
(# of downloads) 
HiMommy! - Pregnancy AndroidGecko 10,000-50,000 
Pregnancy - 40 Weeks Nekrushev Boris 10,000-50,000 
Pregnancy - 9 Months Pregnant BLK Inc 10,000-50,000 
Pregnancy Calculator Ciencia Technologies 10,000-50,000 
Pregnancy Calculators Pro iMedical Apps 10,000-50,000 
Pregnancy Diet Giant Mobile Apps 10,000-50,000 
Pregnancy Evaluation Ocmeys 10,000-50,000 
Pregnancy Exercise Fitness Consulting Inc 10,000-50,000 
Pregnancy Food Guide kigorosa UG (haftungsbeschränkt) 10,000-50,000 
Pregnancy Garbhasanskar Dr. Vikram Shah & Geetanjali Shah 10,000-50,000 
Pregnancy Guide - Week By Week John Kufa 10,000-50,000 
Pregnancy Mode Free Regmal 10,000-50,000 
Pregnancy Week by Week WeHelp 10,000-50,000 
Pregnancy week by week PhungDinhHau 10,000-50,000 
9 Months Guide 9 Months Guide Team 10,000-50,000 
AstroSecret - Getting Pregnant Astrosecret SIA 10,000-50,000 
Boy or Girl - Gender Predictor KNOOZ Apps 10,000-50,000 
Doula Labour Coach - Pregnancy DTT 10,000-50,000 
Heart Tree - Pregnancy Widget hearttree 10,000-50,000 
Mermaid Pregnant Dressup yuangamesapp 10,000-50,000 
Pony Pregnancy Care ToonZBox Entertainment 10,000-50,000 
Pregnancy & Maternity (PRO) New Technology Advertisements 10,000-50,000 
Pregnancy Due Date Calculator Ground Number 10,000-50,000 
Pregnancy Music - Mozart BLK Inc. 10,000-50,000 
Pregnancy Music Offline MACSoft Apps 10,000-50,000 
Pregnancy test MACSoft Apps 10,000-50,000 
Pregnancy Tips in Hindi Glaxy Champ 10,000-50,000 
Pregnancy tips tamil Jai Tuto 10,000-50,000 
Pregnancy Tracker Sevenlogics, INC 10,000-50,000 
Pregnancy Tracker Week by Week Wachanga 10,000-50,000 
Pregnancy week by week rusakov77 10,000-50,000 
Pregnant Nurse baby yuangamesapp 10,000-50,000 
Pregnant women SarahAnderson 10,000-50,000 
Real Pregnancy Test & Quiz YNR Studios 10,000-50,000 
WishBaby - Get pregnant  Daklhill Labs 10,000-50,000 
Pregnancy Mom Dresses Ideas Rylai Crestfall 5,000-10,000 
Happy Pregnancy App Dr. Sachin Gothi (ObGyn) 5,000-10,000 
LM Daly      Page 190                                                                          
 
App name App developer Reach  
(# of downloads) 
OBS / Pregnancy Calculator 3Majors 5,000-10,000 
Pregnancy Calendar Sergi Mas 5,000-10,000 
Pregnancy Exercises App4Life dev 5,000-10,000 
Pregnancy Stages Health Apps Studio 5,000-10,000 
Pregnancy Tips in Hindi KPAppzSol 5,000-10,000 
Pregnancy Tracker Week by Week ufostudio 5,000-10,000 
See Baby Pregnancy Guide EHD 5,000-10,000 
Am I Pregnant Hybrid Tools 5,000-10,000 
How to Get Pregnant by Natural Appschild Inc 5,000-10,000 
Mayo Clinic on Pregnancy Mayo Clinic 5,000-10,000 
Pregnancy and Baby Sozomosoft 5,000-10,000 
Pregnancy Gender Test Prank Pro.Devroid 5,000-10,000 
Pregnancy Loss Miscarriage thaweepong kongkratin 5,000-10,000 
Pregnancy Prayer App Twelve Tribes Apps 5,000-10,000 
Pregnancy Test By Dr. Tech Hybrid Tools 5,000-10,000 
Pregnancy tips week by week Apps Kings 5,000-10,000 
Pregnancy Week by Week Tracker PregBuddy 5,000-10,000 
Pregnancy/Care tips mAppsGuru 5,000-10,000 
Step by Step Pregnancy Care Medical Software Innovations, LLC 5,000-10,000 
Easy Pregnancy PenniApps 1,000-5,000 
Pregnant Princess Emergency Vingames 1,000-5,000 
Little Baby Steps CenturySoft 1,000-5,000 
Pregnancy and Childbirth Pregniful Services LLC 1,000-5,000 
Pregnancy Buddy App Naya Labs 1,000-5,000 
Pregnancy CaPl My CaPl 1,000-5,000 
Pregnancy Care & ChildBirth Wingz Technologies 1,000-5,000 
Pregnancy Due Date Rahi Patel 1,000-5,000 
Pregnancy Guide WALS Solutions 1,000-5,000 
Pregnancy Plus Prigynelle Apps 1,000-5,000 
101 Pregnancy Wheel Scanner P. Kuniya 1,000-5,000 
Conceive a Baby apsspro 1,000-5,000 
Ectopic Pregnancy Information Emanuel Bolachi 1,000-5,000 
Get Pregnant   apsspro 1,000-5,000 
Ma O Shishu Pregnancy Guide Mangopeople 1,000-5,000 
mermaid princess pregnancy NetApps 1,000-5,000 
Music for Pregnancy   appdivertidas 1,000-5,000 
pony pregnant games NetApps 1,000-5,000 
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App name App developer Reach  
(# of downloads) 
Pregnancy & today Baby kicks Chris Andrea Robert 1,000-5,000 
Pregnancy and Birth BSF 1,000-5,000 
Pregnancy Belly fat removing needful apps 1,000-5,000 
Pregnancy Care Diet Nutrition SendGroupSMS.com  1,000-5,000 
Pregnancy Care Tamil Madhavan Subramanian 1,000-5,000 
Pregnancy Exercise Video Royal Amghar 1,000-5,000 
Pregnancy Guide Putrane Buketik 1,000-5,000 
Pregnancy Guide Droider App 1,000-5,000 
Pregnancy Music - Beethoven BLK Inc. 1,000-5,000 
Pregnancy Music & Relaxation Sound for Life Studio 1,000-5,000 
Pregnancy Signs and Symptoms David Sang 1,000-5,000 
Pregnancy Test Prank Fox in a Box 1,000-5,000 
Pregnancy Tips Ahil Sultan 1,000-5,000 
Pregnancy Tips Diet Nutrition Data Recovery Software  1,000-5,000 
Pregnancy tips tamil webrax 1,000-5,000 
pregnancy with Baby Babble aiDe Software 1,000-5,000 
Pregnancy Workout High Soft App 1,000-5,000 
Pregnant Dua Arabic 1,000-5,000 
Pregnant Mermaid Newborn Baby Unit M Games 1,000-5,000 
Smart Pregnancy & BabyCare App Healofy 1,000-5,000 
Unwanted Pregnancy Alexis G. Aponesto 1,000-5,000 
Fashion Mommy Pregnancy Diary Xiang Junlong Fewer than 1,000 
Pretty Pregnant Hijab Jendral 88 Fewer than 1,000 
iBaby Pregnancy Tracker MediaGeni.com Fewer than 1,000 
Pregnancy and Parenting Insites Fewer than 1,000 
Pregnancy Guide App Droiddoc Fewer than 1,000 
Pregnancy Knowledge Quiz Pregniful Services LLC Fewer than 1,000 
Pregnancy Tips Drop sidee Fewer than 1,000 
LG-Pregnancy Living Goods Fewer than 1,000 
Pregnancy Calculator MPTCamp  Fewer than 1,000 
Pregnancy Diet High Soft App Fewer than 1,000 
Pregnancy Exercises BeDeveloper Fewer than 1,000 
Pregnancy Maybe Jendral 88 Fewer than 1,000 
Pregnancy Stories Andromida apps Fewer than 1,000 
Pregnancy Tips apsspro Fewer than 1,000 
Pregnancy Tracker Chelin Apps Fewer than 1,000 
Pregnancy Week by Week apsspro Fewer than 1,000 
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App name App developer Reach  
(# of downloads) 
Pregnancy Week by Week Gato Apps Fewer than 1,000 
Pregnancy Weight Tracker SR Media Fewer than 1,000 
Pregnant Fashion Hijab Jendral 88 Fewer than 1,000 
SaferMom: Pregnancy App welomobile Fewer than 1,000 
 
Apps excluded - relevance 
App name App developer Relevance 
Contraction Timer James Ots Contraction timer 
Pregnancy Contraction Timer L-J-Holmes Contraction timer 
Avakin Life - 3D Virtual World Lockwood Publishing Ltd. Entertainment (games, cartoons) 
Baby Names Genius Health & Parenting Ltd Entertainment (games, cartoons) 
Episode & Pretty Little Liars Episode Interactive Entertainment (games, cartoons) 
Fallout Shelter Bethesda Softworks LLC Entertainment (games, cartoons) 
Kim Kardashian: Hollywood Glu Entertainment (games, cartoons) 
My New Baby! Play Tales Books Entertainment (games, cartoons) 
Pregnancy Calendar MD Mobile Dimension LLC Entertainment (games, cartoons) 
Pregnancy Test PregnancyCareMe Entertainment (games, cartoons) 
Pregnant Bella's First Baby GameiMax Entertainment (games, cartoons) 
Village Life: Love & Babies Playdemic Entertainment (games, cartoons) 
[Arabic] Pregnancy Guide JValley Software Solutions Language not english 
Arabic title RamzIT Language not english 
Pregnancy app & widget [at]clic Language not english 
Pregnancy App Tracker Sunguy Language not english 
Pregnancy Gestogram Isis Producciones y Cía.  Language not english 
Clue - Period Tracker BioWink GmbH Menstruation/Fertility 
Easy Pregnancy - Get Baby Bestracker Menstruation/Fertility 
Eve by Glow - Period Tracker Glow Inc Menstruation/Fertility 
Feminap - Woman Calendar Pregnancy & Baby App Menstruation/Fertility 
Fertility Friend Tracker Tamtris Web Services Inc. Menstruation/Fertility 
Flo Period and Ovulation Tracker OWHealth Inc. Menstruation/Fertility 
Get Baby roidstudio Menstruation/Fertility 
Get Pregnant - try to conceive Pregnancy Care Me Menstruation/Fertility 
Glow - Ovulation & Fertility Glow Inc Menstruation/Fertility 
Kindara Fertility & Ovulation Kindara, Inc. Menstruation/Fertility 
Maya - My Period Tracker Plackal Tech Menstruation/Fertility 
Menstrual & Ovulation Calendar Grupo Precedo Menstruation/Fertility 
Menstrual Calendar witiz Menstruation/Fertility 
My Calendar - Period Tracker SimpleInnovation Menstruation/Fertility 
My Cycles Period and Ovulation MedHelp, Inc  Menstruation/Fertility 
My Days - Period & Ovulation ™ Christian Albert Mueller Menstruation/Fertility 
My Period Tracker Linchpin Health Menstruation/Fertility 
MyDays X - Period & Ovulation™ Christian Albert Mueller Menstruation/Fertility 
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App name App developer Relevance 
NaturalCycles, your fertility NaturalCycles AG Menstruation/Fertility 
Once - A special period tracker Malang Studio Co Ltd. Menstruation/Fertility 
Ovia Ovulation & Fertility Ovuline, Inc. Menstruation/Fertility 
Ovulation & Period Calendar Vipos Apps Menstruation/Fertility 
Ovulation Calculator: SureBaby CX Interactive Menstruation/Fertility 
OvuView: Ovulation & Fertility Sleekbit Menstruation/Fertility 
Period & Ovulation Tracker SMSROBOT LTD Menstruation/Fertility 
Period Tracker GP International LLC Menstruation/Fertility 
Period Tracker NorthPark.Android Menstruation/Fertility 
Period Tracker Pro (Pink Pad) Alt12 Apps, Inc. Menstruation/Fertility 
Period Tracker, My Calendar Simple Design Ltd. Menstruation/Fertility 
Pink Daily - Period Tracker Cheetah Mobile Inc. Menstruation/Fertility 
Woman diary (calendar) DSN Inc Menstruation/Fertility 
WomanLog Calendar Pro Active App Menstruation/Fertility 
PregApp - 3D Pregnancy Tracker Tap.pm Not free, misclassified 
Kickme - Baby Kicks Counter DilmeWorks Kick counter only 
Glow Baby for Breastfeeding Glow Inc Parenting 
OB Wheel (Pregnancy calculator) Quartertone Due date calculator 
Preg Tickers sromku Due date calculator 
Pregnancy Calculator Yauhen Patsel Due date calculator 
Pregnancy Calculator Anna Sentyakova Due date calculator 
Pregnancy Watcher widget Haekkinen Due date calculator 
WomanLog Pregnancy Calendar Pro Active App Due date calculator 
Pregnancy Workouts Free Power 20 Fitness 
Music for Pregnancy Relaxation Ultimate Mobile Music 
Healthy Pregnancy Food PregnancyCareMe Nutrition 
My Diet Daily Calorie Counter MedHelp, Inc  Nutrition 
Water Drink Reminder Simple Design Ltd. Nutrition 
Baby Story Camera Best Photo Apps Shopping 
Photofy Content Creation Tool Photofy Inc. Shopping 
Android System WebView Google Inc. System software 
S Health Samsung Electronics Co. System software 
Samsung Push Service Samsung Electronics Co. System software 
The SIMS FreePlay Electronic Apps System software 
I’m Expecting - Pregnancy App MedHelp, Inc Technical issues, could not use 
Tinystep: Pregnancy & Parenting TinyStep Technical issues, could not use 
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Apps excluded – Quality 
App name App developer User score (4 
stars+/total review 
ratings) 
Pregnancy Disc HipoApps 0.79 
Woman's DIARY period·diet·cal Nihon Enterprise Co.,Ltd. 0.79 
iMom • Pregnancy & Fertility OB Science S.r.l. 0.78 
Pregnancy Tracker Week By Week Hylal Health Apps 0.78 
Pregnancy Ticker Bitcab 0.78 
My Pregnancy Mobiem 0.78 
Pregnancy Tracker We Care Apps 0.75 
Pregnancy Stages Pregnancy and Baby Apps 0.75 
Pregnancy calculator Androcalc 0.75 
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 MBM: Data collection tools 
The sections below detail the data collection tools selected for this sub-study. 
MBM app feedback survey 
All women who downloaded the app will be prompted to complete this feedback survey after they 
input the date of their baby’s birth, or if they wish to remove the app from their mobile phone. 
Using the pregnant woman’s study identification number, responses will be linked and analysed by 
parity, risk factors, perinatal outcomes and MBM app usage patterns. 
Question Responses 
Rationale for 
inclusion 
Topic 
2. MBM increased my awareness of fetal 
movements. 
 
o Agree 
o Agree somewhat 
o Disagree 
somewhat 
o Disagree 
o Don’t know 
Attitude Information sources 
3. MBM provided me with trustworthy 
information. 
 
4. MBM provided me with information 
about my baby’s movements that I did not 
receive through my antenatal care. 
 
6. I would recommend MBM to a friend or 
family member. 
 
7. Were you ever concerned about your 
baby’s movements during the last 12 weeks 
of pregnancy? (If yes…below) 
 
o Yes 
o No 
 
Behaviour 
Fetal movement 
8. Did you use the MBM app, based on 
concern for your baby’s movements?  
Care-seeking 
behaviour 
9. Did you go to hospital or your care 
provider during your pregnancy, based on 
concern for your baby’s movements?  
10. Did use of the MBM app prompt you to 
go to hospital or your care provider when 
you felt concern about your baby’s 
movements?  
11. Did you discuss the MBM app with 
hospital staff or your care provider at any 
time you felt concern about your baby’s 
movements?  
 
MBM app exposure 
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For all study participants, data were derived regarding frequency of use, maternal risk factors and 
perinatal outcomes through the unique study identification number of each participant. 
App information for analysis 
MBM downloaded 
MBM frequency of use  
MBM pages accessed 
 
Routinely collected data 
Routinely-collected data were provided to this author for the following variables, or were calculated 
based on information provided: 
Title of Variable  Explanation  
Study ID  All women allocated a unique Study Identification Number. 
MBM user As per Application Analytics spreadsheet for dates. 
Survey 1a completion As per Survey 1a returns 
DFM audit completion As per DFM audit returns 
Survey 3 completion As per Application Analytics, App usage survey 
Maternal Age  Mother's age at time of baby birth 
Maternal Date of Birth  Mother's date of birth  
Maternal Ethnicity  Ethnicity the mother identifies with  
Maternal Country of Birth Maternal country of birth  
Maternal Region of Birth Region of country of birth by ABS codes 
Postcode What postcode does the mother live in  
IRSD decile Index of Relative Socioeconomic Disadvantage (IRSD) 
Gravida How many times the woman reports having been pregnant  
Parity How many babies the woman has had over 20 weeks' gestation  
EDC minus 13 weeks EDC minus 91 days (to provide estimate of 27 weeks' gestation) 
EDC Estimated date of baby birth  
Baby's Date of Birth  Actual date of baby birth  
Birth Gestation Age  Gestation at birth (weeks) 
Birth weight  Baby birthweight (grams) 
Birth mode Mode of birth 
DFM Reported during 
Pregnancy  
Were concerns of DFM documented during pregnancy  
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Title of Variable  Explanation  
Neonatal Outcome  Was baby livebirth, stillbirth or neonatal death? 
Stillbirth Time If stillbirth occurred, at what point of labour? 
Baby nursery admission  Was the baby admitted to the NICU or the SCN unit on birth  
Length of Stay in SCN  How long did the baby stay in the SCN (days) 
Length of Stay in NICU How long did the baby stay in the NICU (days) 
Prev Livebirths Number of previous livebirths the mother has had  
Prev Preg Loss Number of previous abortion/miscarriage/hydatidiform moles the woman 
has had. These can not be distinguished apart as reported in RCD. 
Prev Stillbirth  Number of previous stillbirths the woman has had  
Prev Multiple Livebirths Number of previous multiple stillbirths the woman has had 
Prev Multiple Preg Loss Number of previous multiple abortion/miscarriage/hydatidiform moles the 
woman has had. These can not be distinguished apart as reported in RCD. 
Prev Mode Last Birth Mode in which the mother delivered her last child 
prelabourintervention_dfm Indication of labour with DFM as the lead variable being the reason 
prelabourintervention_iufd Indication of labour with intrauterine fetal demise as lead reason 
Indication for Caesarean 
section  
What was the main indication for a caesarean section birth  
Fetal Indication for 
Caesarean section  
What was the main fetal indication for caesarean section birth 
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 MBM: Trial objectives and hypotheses 
OBJECTIVES  
Primary 
▪ To provide women, attending for antenatal care at the participating hospitals, access to the 
MBM mobile phone software, and to provide an educational program for clinicians on its 
use and on management of women reporting DFM, using a stepped wedge cluster 
randomised design.  
▪ To assess the effects of MBM on reporting DFM, stillbirth, and other important 
pregnancy outcomes using routinely collected perinatal data.  
▪ To undertake an economic evaluation of MBM. 
Secondary 
▪ To conduct a clinical audit during the control and intervention phases to determine 
proportion of women presenting with DFM, delays in presentation, and outcome of the 
clinical assessment.  
▪ To undertake cross sectional surveys of women attending for antenatal care and clinical 
staff during the control and intervention phases to determine acceptability of DFM 
information, knowledge about DFM, and a follow-up survey at 6 months postpartum 
regarding psychosocial outcomes, general health, and health service utilisation.   
▪ Survey women after the birth of the baby to determine the acceptability of MBM. 
 
HYPOTHESES  
Primary  
1. In women with a singleton pregnancy, MBM will reduce stillbirth at 28 weeks or more by 
30%, from 3/1000 to 2/1000. 
2. Implementing MBM as part of routine antenatal care for women with a singleton pregnancy 
will be cost effective.  
Secondary  
1. MBM will reduce the proportion of women with a singleton pregnancy delaying reporting of 
DFM for more than 24 hours.  
2. MBM will not increase maternal anxiety or worry, presentations for care due to DFM. 
Source: Australia New Zealand Clinical Trials Registry. Trial review. My Baby’s Movements: a stepped wedge cluster 
randomised controlled trial to raise maternal awareness of fetal movements during pregnancy 
(ACTRN12614000291684). Last updated: 4 October 2018. Access date: 17 February 2019. Accessed at: 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12614000291684.  
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 Information brochures about fetal movement 
Information brochures were provided for hospital staff to distribute to pregnant women in their care 
at antenatal appointments. The English-language brochure was developed by the PSANZ Stillbirth 
and Neonatal Death Alliance and updated for use in the trial. An English-language brochure tailored 
for Indigenous clients was also available. The tailored brochure was developed in south-east 
Queensland through consultations undertaken by an Aboriginal research officer from the Institute 
for Urban Indigenous Health, with ongoing guidance from an Indigenous Reference Group. 
Brochures in Arabic, Spanish, Hindi, Korean, Vietnamese, Chinese, Māori and Samoan were 
available for download on the PSANZ website: https://sanda.psanz.com.au/parent-
centre/pregnancy/ 
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 MBM: Your Movements Matter poster for trial sites 
This information brochure was developed by a multidisciplinary working group led by the Stillbirth 
CRE in partnership with the Stillbirth and Neonatal Death Alliance of the Perinatal Society of 
Australia and New Zealand (PSANZ-SANDA) and consumer advocacy and support organisation, 
Still Aware. The brochure was adapted with permission from materials developed by Tommy’s UK.  
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 MBM: DFM reporting by MBM cohort groups and maternal ethnicity 
Table 8-1. DFM reporting by MBM cohort groups and maternal ethnicity 
 No DFM reported DFM reported 
Maternal ethnicity 
MBM 
user 
Non-
user 
Total 
MBM 
user 
Non-
user 
Total 
Total 552 3139 3691 108 516 624 
Caucasian/European 423 2312 2735 80 380 460 
Asian 22 203 225 4 22 26 
Maori 16 153 169 2 28 30 
Indian 22 76 98 4 12 16 
Aboriginal or Torres Strait Islander 10 61 71 2 11 13 
Pacific Islander 5 31 36 1 5 6 
Filipino 5 31 36 0 2 2 
Mixed ethnicity 5 23 28 2 6 8 
South American 9 15 24 1 3 4 
African 0 13 13 0 4 4 
Pakistani 0 7 7 1 1 2 
Lebanese 0 5 5 0 1 1 
Afghani 0 5 5 1 1 2 
Egyptian 1 3 4 1 3 4 
Iranian 1 3 4 1 0 1 
Jordanian 1 3 4 0 0 0 
Papua New Guinean 2 2 4 0 1 1 
Bangladeshi 1 2 3 0 2 2 
Nepalese 0 3 3 0 1 1 
Sri Lankan 1 1 2 0 3 3 
Iraqi 0 2 2 0 0 0 
Fiji Islander 0 2 2 0 0 0 
Israeli 0 1 1 0 0 0 
Libyan 0 1 1 0 0 0 
Syrian 0 1 1 0 0 0 
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 Standard Australian Classification of Countries  
Code MAJOR GROUPS 
Minor groups 
Countries 
 OCEANIA AND ANTARCTICA 
111 Australia  Australia, Norfolk Island, Australian External Territories 
112 New Zealand New Zealand 
113 Melanesia New Caledonia, Papua New Guinea, Solomon Islands, Vanuatu 
114 Micronesia Guam, Kiribati, Marshall Islands, Federated States of Micronesia, 
Nauru, Northern Mariana Islands, Palau 
115 Polynesia (excludes 
Hawaii) 
Cook Islands, Fiji, French Polynesia, Niue, Samoa, American Samoa, 
Tokelau, Tonga, Tuvalu, Wallis and Futuna, Pitcairn Islands, 
Polynesia (excludes Hawaii) 
116 Antarctica Adelie Land (France), Argentinian Antarctic Territory, Australian 
Antarctic Territory, British Antarctic Territory, Chilean Antarctic 
Territory, Queen Maud Land (Norway), Ross Dependency (New 
Zealand) 
 NORTH-WEST EUROPE 
221 United Kingdom England, Isle of Man, Northern Ireland, Scotland, Wales, Guernsey, 
Jersey 
222 Ireland Ireland 
223 Western Europe Austria, Belgium, France, Germany, Liechtenstein, Luxembourg, 
Monaco, Netherlands, Switzerland 
224 Northern Europe Denmark, Faroe Islands, Finland, Greenland, Iceland, Norway, 
Sweden, Aland Islands 
 SOUTHERN AND EASTERN EUROPE 
331 Southern Europe Andorra, Gibraltar, Holy See, Italy, Malta, Portugal, San Marino, 
Spain 
332 Southeastern Europe Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, The 
former Yugoslav Republic of Macedonia, Greece, Moldova, 
Romania, Slovenia, Montenegro, Serbia, Kosovo 
333 Eastern Europe Belarus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, 
Poland, Russian Federation, Slovakia, Ukraine 
 NORTH AFRICA AND THE MIDDLE EAST  
441 North Africa Algeria, Egypt, Libya, Morocco, Sudan, Tunisia, Western Sahara, 
Spanish North Africa, South Sudan 
442 Middle East Bahrain, Gaza Strip and West Bank, Iran, Iraq, Israel, Jordan, Kuwait, 
Lebanon, Oman, Qatar, Saudi Arabia, Syria, Turkey, United Arab 
Emirates, Yemen 
 SOUTH-EAST ASIA 
551 Mainland Southeast 
Asia 
Myanmar, Cambodia, Laos, Thailand, Vietnam 
552 Maritime Southeast 
Asia 
Brunei Darussalam, Indonesia, Malaysia, Philippines, Singapore, 
Timor-Leste 
 NORTH-EAST ASIA 
661 Chinese Asia  China, Hong Kong, Macau, Mongolia, Taiwan 
662 Japan and the Koreas Japan, Democratic People's Republic of Korea (North), Republic of 
Korea (South) 
 SOUTHERN AND CENTRAL ASIA 
771 Southern Asia Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka 
772 Central Asia Afghanistan, Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, 
Tajikistan, Turkmenistan, Uzbekistan 
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Code MAJOR GROUPS 
Minor groups 
Countries 
 AMERICAS 
881 Northern America Bermuda, Canada, St Pierre and Miquelon, United States of America 
882 South America Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland 
Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, 
Venezuela 
883 Central America Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, 
Nicaragua, Panama 
884 Caribbean Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Cayman 
Islands, Cuba, Dominica, Dominican Republic, Grenada, 
Guadeloupe, Haiti, Jamaica, Martinique, Montserrat, Puerto Rico, St 
Kitts and Nevis, St Lucia, St Vincent and the Grenadines, Trinidad 
and Tobago, Turks and Caicos Islands, Virgin Islands (British), 
Virgin Islands (U.S.), St Barthelemy, St Martin (French), Bonaire, 
Sint Eustatius and Saba, Curaçao, Sint Maarten (Dutch) 
 SUB-SAHARAN AFRICA 
991 Central and West 
Africa 
Benin, Burkina Faso, Cameroon, Cabo Verde, Central African 
Republic, Chad, Republic of Congo, Democratic Republic of Congo, 
Cote d'Ivoire, Equatorial Guinea, Gabon, Gambia, Ghana, Guinea, 
Guinea-Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, Sao Tome 
and Principe, Senegal, Sierra Leone, Togo 
992 Southern and East 
Africa 
Angola, Botswana, Burundi, Comoros, Djibouti, Eritrea, Ethiopia, 
Kenya, Lesotho, Madagascar, Malawi, Mauritius, Mayotte, 
Mozambique, Namibia, Reunion, Rwanda, St Helena, Seychelles, 
Somalia, South Africa, Swaziland, Tanzania, Uganda, Zambia, 
Zimbabwe 
Source: Australian Bureau of Statistics, Standard Classification by Country (2016)230 
 
